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1    Prelude
This thesis comprises a set of explorations into vari-
ous intracellular and intercellular signaling pathways. 
Throughout these explorations, ‘translocations’ have 
been a constant theme. Scattered across various cell 
biological topics, this thesis reflects the discovery of 
three translocations and the experimental work aimed 
to unravel their molecular mechanisms and cell bio-
logical relevances. At first glance, the word ‘transloca-
tion’ is self-explanatory; moving from one place (‘lo-
cus’) to the other (‘trans’ is across). Circulating red 
blood cells can be considered to undergo continuous 
translocation, but the work presented here focuses on 
molecular movements within the micrometer-sized di-
mensions of the cell.
The interior of a cell is a tangle of continuous ac-
tivity. On the to-do-list: thousands of simultaneous 
interactions and enzymatic conversions that cooper-
ate to maintain healthy cellular physiology and, in 
addition, to accomplish cell type-specific functions. 
The immense ensemble of molecules that constitute 
a living cell requires strict regulation of all possible in-
teractions and enzymatic activities. We can formulate 
two basic principles that are prerequisites to control 
such ‘organized complexity’. First, interactions among 
constituents, be it proteins, lipids, ions or small mol-
ecules, are to be specific. It is not surprising that cell 
biology has described a vast amount of conserved rec-
ognition domains that confer specificity on molecular 
interactions. The specificity of a recognition domain is 
accomplished by the unique combination of its three-
dimensional structure and charge distribution, fitting 
to that of its binding partner following the principle 
of key-and-lock. Second, most enzymatic conversions 
are regulated. In other words, they can be ‘switched 
on and off’. For example, many enzymes undergo 
conformational changes that either silence or release 
their catalytic activities.
Regulation of specific interactions often results in the 
redistribution of molecules within the cell (see section 
3). Such ‘translocations’ can result in strong enrich-
ment at intracellular compartments where their action 
is required. Therefore, translocations are intrinsic to 
signaling cascades.
Translocations studied in this thesis are based on 
passive diffusion. Passive transport is distinct from ac-
tive transport by its use of energy. Passive transport 
is thermodynamically ‘downhill’, whereas active trans-
port requires input of energy to go ‘up the hill’. The 
latter can, for instance, be provided by coupling the 
transport process to the dissipating energy of adenos-
ine triphosphate (ATP) hydrolysis.
Active mechanisms enable transport of large 
cargo, such as that of vesicles along the microtubule 
network. Also transport against the chemical gradient 
is ATP-consuming, e.g. the strong enrichment of cal-
cium in the endoplasmic reticulum (105 over cytosolic 
concentrations). Other examples of active transport 
are the transfer of newly synthesized polypeptides 
across the ER membrane or import/export through 
the nuclear pore complex. However, active transport 
is relatively slow. In contrast, the ´downhill´ diffu-
sional redistributions are generally rapid processes.
Obviously, fluorescence microscopy is the meth-
od of choice to reveal and study rapid translocations in 
living cells. It allows visualization with high spatial and 
temporal resolution. Furthermore, it enables compari-
son of pre- and post-stimulus conditions and cell-to-
cell differences can be appreciated without disturbing 
averaging effects. Not surprisingly, the use of fluores-
cence microscopy has been a common denominator 
throughout the studies presented in this thesis. Thus, 
before advancing to mechanisms (section 3) and ex-
amples (section 4) of translocations in cell signaling, 
the employed microscopic techniques will be briefly 
introduced.
Box 1    Potential pitfalls of fluorescent tagging
A potential pitfall in fluorescence microscopy is the use of fusion proteins. Most 
fluorophores have molecular weights of ~30 kD. Thus, in the case of CLIC4 (29kD), 
fusion with a fluorophore doubles the molecular weight. Such bulky tags may steri-
cally hinder protein-protein interactions. In line with this, the choice to tag either 
the N- or C-terminus could influence subcellular localization of the fusion construct. 
We have observed the latter for both Epac1 and CLIC4 and used the tagged version 
whose localization was most comparable to that of the endogenous counterparts. 
In the case of gap junctional protein connexin43, C-terminal fusion of GFP even 
disrupted the formation of proper gap junctions. Therefore, a major challenge in 
fluorescence microscopy is to identify a genetically encoded fluorescent tag of mini-
mal size. The lab of Roger Tsien (Noble Prize, 2008) seemed to catch a glimpse of 
the holy grail when they introduced the tetracysteine-system [1]. The concept was 
to insert six residues (Cys-Cys-Pro-Gly-Cys-Cys) into a protein of interest and sub-
sequently label this motif specifically with a fluorescent dye (for comparison: GFP 
consists of ~240 amino acids). Unfortunately, the labeling conditions await further 





2  Measurement of translocations
    in living cells using 
    fluorescence microscopy
To monitor a protein of interest by fluorescence mi-
croscopy, it is genetically fused to a fluorescent pro-
tein moiety. The first, green fluorescent protein (GFP), 
was derived from the jellyfish Aequorea victoria and 
multiple others have been cloned from other sea or-
ganisms. Subsequent mutational modifications have 
led to optimizations in terms of spectral properties, 
brightness and stability (reviewed in [2]). The color 
palette spans the spectral range from blue (BFP) to 
red (mRFP). As described in Box 1, caution is de-
manded when tagging a protein of interest with a fluo-
rescent moiety.
Four different techniques have been employed in 
this thesis:
1)  Confocal laser scanning microscopy (CLSM), which 
yields high spatial resolution by selective rejection of 
out-of-focus emission from the detectors.
2)  Fluorescence Resonance Energy Transfer (FRET), 
which reports protein-protein interactions.
3)  Fluorescence Lifetime Imaging (FLIM), a technique 
to determine FRET.
4) Fluorescence Recovery After Photobleaching (FRAP), 
which reveals mobility of fluorescent molecules.
2.1   Fluorescence Resonance Energy 
Transfer (FRET)
FRET is the radiationless transfer of energy from an 
excited donor to an acceptor fluorophore. It occurs 
under stringent conditions. First, the donor emission 
spectrum must overlap with the absorption spectrum 
of the acceptor. Second, donor and acceptor fluoro-
phores must be in close proximity, i.e. < 8 nm when 
using fluorophores in the visible spectrum. A third de-
terminant is formed by the relative orientations of the 
fluorophore dipoles. FRET is evident from quenched 
donor fluorescence and gained acceptor fluorores-
cence. Thus, (a change in) FRET can be registered 
as (a shift in) relative donor and acceptor emission 
intensities.
The distance constraint is most important for 
the application of FRET in cell biology. When using 
common fluorophore combinations (e.g. CFP/YFP or 
GFP/mRFP), FRET is strictly limited to distances of 
less than 8 nm. Thus, FRET registers intermolecular 
distances comparable to the sizes of the studied pro-
teins themselves (5-15 nm) and has therefore been 
termed a ‘molecular ruler’ (to put this in perspective: 
confocal microscopy is limited to a resolution of ~200 
nm). FRET can be measured by several experimental 
approaches, each with its own advantages and dis-
advantages. As outlined in Box 2, the technique of 
choice depends on the question to be addressed.
Besides its use in revealing interactions between 
proteins, FRET is also employed in a growing num-
Box 2    Three approaches to measure FRET
FRET between CFP and YFP can be measured in several ways. The three major ones are: 
1) Monitoring of YFP/CFP ratio. Excite CFP and detect total CFP and total YFP emission from a single 
cell. The pooling increases signal-to-noise ratio (S/N), allowing sub-second sampling.
2) Sensitized YFP emission. Excite CFP and record CFP- and YFP-images. Post-acquisition analysis 
calculates YFP emission resulting from FRET by subtraction of false signals.
3) Measure donor lifetime (FLIM). Excite donor and follow kinetics of fluorescence decay (fluorescence 
lifetime, τ). FRET accelerates fluorescence decay and can thus be registered as a decrease in τ.
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ber of gene-encoded sensors that report intracellular 
signaling events. These are typically small molecules 
that can not be made fluorescent directly, such as the 
second messengers calcium, PI(4,5)P2, Reactive Oxy-
gen Species (ROS), cAMP or cGMP [3,4]. Other FRET 
sensors have been designed to report kinase/phos-
phatase activities towards specific consensus domains 
(for e.g. PKA [5] or PKC [6]) or to monitor activation 
of GTPases (e.g. RhoA [7] or Rap [8]). Because FRET 
sensors have been extensively applied in this thesis, 
the most important ones are here briefly introduced.
2.2   FRET-based sensors for calcium, 
PI(4,5)P2 and cAMP
One of the first genetically encoded FRET-based sen-
sors was the Yellow Cameleon calcium sensor [11]. 
Its core is composed of the C-terminus of Calmodu-
lin (CaM) and the CaM-binding domain of MLC-kinase 
M13. This core is flanked by CFP and YFP. The increased 
interaction between CaM and M13 upon calcium bind-
ing shortens the distance between the fluorophores 
and results in enhanced FRET. In this manner, the Yel-
low Cameleon sensor can register calcium changes 
with high spatial and temporal resolution.
Other FRET assays for signaling molecules require 
the co-expression of two separate constructs. For in-
stance, a CFP- and a YFP-tagged version of the Pleck-
strin Homology (PH) domain of PLCd1 (CFP- and YFP-
PH) can be combined to measure PI(4,5)P2 [12]. In 
resting cells, the PH-domains rapidly shuttle between 
cytosol and PM because PI(4,5)P2 binding is charac-
terized by fast on/off rates. Their partial presence at 
the PM suffices to induce FRET between the fluores-
cent moieties. PI(4,5)P2 hydrolysis results in translo-
cation of the PH domains into the cytosol and dilution 
of the fluorophores is detected as a loss of FRET. This 
assay has been important to define the role of PI(4,5)
P2 in the ligand-induced gating of connexin43-based 
gap junctions (chapter 7).
The first FRET-based sensors designed to mea-
sure the second messenger cAMP were based on the 
tetrameric Protein Kinase A (PKA) [9,13,14]. The con-
cept was to register the cAMP-dependent dissociation 
of the two catalytic subunits (YFP-PKA-Cat) from the 
two regulatory subunits (CFP-PKA-Reg). This sensor 
has been useful in the demonstration of cAMP oscil-
lations [15,16]. However, this first-generation sensor 
displays some serious disadvantages.
The recent discovery of Epac [17] provided an 
interesting alternative for the generation of a FRET-
sensor for cAMP, since binding of cAMP has a dramatic 
effect on Epac’s conformation. The concomitantly 
increased distance between the two termini can be 
measured as a loss of FRET between terminally fused 
fluorophores. In this manner, Epac-based FRET sen-
sors have been developed in our lab (chapter 5) and, 
independently, by the groups of Lohse [18] and Zhang 
[10]. Epac-based cAMP sensors have several advan-
tages over the earlier PKA-based sensor (chapter 5).
Below: catch a glimpse at chapters 5 and 8
Glimpse at ...
Chapter 5 & 8 : CFP-Epac-YFP: an improved sensor for cAMP
Several aspects of the PKA-based cAMP sensor [9] are suboptimal. First, the sensor is easily saturated 
due to its high-affinity cAMP recognition domain. Second, it has a narrow dynamic range of measurable 
cAMP concentrations due to non-linearity of the dissociation process. Third, variable expression levels of 
the two sensor halves hamper quantitative analyses.
Advantages of the Epac-based sensor over the PKA-sensor are (1) lower affinity for cAMP, (2) more 
or less linear dose-response relationship, (3) larger changes in FRET (resulting in improved signal/noise 
(S/N) ratio) and (4) the 1:1 ratio of donor and acceptor fluorophore. The first two advantages add to 
the increased dynamic range of measurable cAMP concentrations, while the constant fluorophore ratio 
greatly facilitates FRET analyses and enables straightforward cell-to-cell comparison. In addition, the 
single polypeptide sensor can be easily extended with subcellular targeting motifs to measure cAMP in 
specific compartments of the cell [10].
CFP-Epac-YFP was further optimized by removal of its PM-targeting DEP domain (∆DEP) and rupture 
of the catalytic activity by double point mutagenesis in the GEF domain (T781A/F782A). The resul-
tant CFP-Epac(∆DEP-C.D.)-YFP is cytosoic, catalytically dead (C.D.) and therefore our cAMP sensor of 
choice.
To further improve the Epac-based cAMP sensor, its fluorescent moieties have been optimized. For 
this, a series of sensor variants containing variable donor and acceptor fluorophores (in various combi-
nations) has been generated and compared in their ‘cAMP-sensorship’ (chapter 8). The lessons learned 




3  Diffusion-based translocations 
Translocation events are common to signaling cas-
cades. Several examples will be discussed in section 4 
and this thesis describes the translocation of signaling 
molecules CLIC4 (chapter 2) and Epac1 (chapters 3 
and 4). We will here describe the functional signifi-
cance of translocations in signaling cascades and ex-
plain how they can result from diffusion.
3.1   Plasma membrane translocation 
leads to strong enrichment of signaling 
proteins
Translocations of signaling molecules add a dimension 
of regulation to signaling cascades: translocation to 
the PM may bring signaling protein P in the vicinity of 
PM-localized effectors, whereas it is physically sepa-
rated from other binding partners. Importantly, the 
density of P-molecules increases dramatically when 
moving from the relatively voluminous cytosol (m3) 
to the limited surface (m2) of the PM. As briefly ex-
plained in Box 3, the increase in molecular density 
may amount to >2 orders of magnitude. Obviously, 
such enrichment has a huge impact on the reaction 
rates of signaling processes at the PM. Therefore, 
translocations are a major determinant of the switch-
like activation patterns of signaling proteins.
The impact of enrichment can be illustrated by 
the targeting technology that makes use of the ‘swit-
chable’ interaction between domains of the FK506-
binding protein (FKBP) and the FKBP-rapamycin 
binding (FRB) protein (see Fig. 1). The interaction is 
triggered by the membrane-permeable drug rapamy-
cin. Rapamycin binds FKBP with high affinity and the 
subsequent FKBP-rapamycin tandem has dramatically 
increased affinity for FRB. Thus, the drug links the 
two domains together. For the inducible hydrolysis 
of the phospho-inositide PI(4,5)P2, a 5-phosphatase 
has been fused to FKBP (FKBP-5-phosphatase) and 
coexpressed with a PM-anchored FRB domain (FRB-
CAAX) [19]. Thus, addition of rapamycin triggers 
translocation of the cytosolic FKBP-5-phosphatase to 
the PM, resulting in complete depletion of membrane 
PI(4,5)P2. Key to the success is the enrichment of the 
phosphatase enzymes. In the absence of rapamycin, 
PI(4,5)P2 levels remain unaffected, because the phos-
phatases remain diluted in the cytosol. Rapamycin-in-
duced translocation ‘turns the switch’. For this thesis, 
this assay has been used to establish the central role 
of PI(4,5)P2 in gating of connexin43-based gap junc-
tions (chapter 7).
Box 3    “Concentration by translocation”
A simple calculation suffices to estimate the increase in density of a particle that translocates from the 
cytosol to the PM. Two conditions are compared: 
1) all molecules locate to the cytosol, or 
2) all molecules locate to the PM. 
For both conditions we determine the particle concentration that allows an average intermolecular dis-
tance of 8 nm, which approximates the distance at which protein-protein interactions and FRET occur. For 
the dimensions of a cell we estimate that:
* its volume is 1 picoliter   (10-12 liter = 10-15 m3)
* its surface is 600 um2     (= 6 x 10-10 m2; precisely determined parameter in electrophysiology)
1) All particles locate to the cytosol
We subdivide the cytosolic volume in hypothetical volumes that are occupied by a single molecule:
 each molecule occupies (8nm x 8nm x 8nm) = (8 x 10-9)3 m3
 the cell (10-15 m3) contains 1.9 x 109 of such cubic sub-volumes, thus 1.9 x 109 molecules
 these are (1.9 x 109) / (6 x 1023) = 3.3 10-15 moles
 intracellular concentration: (3.3 10-15)/(10-12)= 3.3 10-3 = 3.3 mM
2) All particles locate to the PM
We subdivide the membrane surface in hypothetical surfaces that are occupied by a single molecule:
 each molecule occupies (8nm x 8nm) = (8 x 10-9)2 m2
 the surface (6 x 10-12 m2) contains 9.4 x 106 square sub-surfaces, thus 9.4 x 106 molecules
 these are (9.4 x 106) / (6 x 1023) = 1.6 10-17 moles
If these 1.6 10-17 moles of particles translocate back to the cytosol…
 intracellular concentration:(1.6 10-17)/(10-12)= 1.6 10-5 = 16 mM
These two concentrations are in a mutual ratio of ~200 x. 
In other words, translocation to the PM induce a ~200-fold particle enrichment.
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3.2   Diffusion-based translocation: a few 
scenarios
Because free diffusion (also known as Brownian mo-
tion) directs signaling molecules to all corners of the 
cell, signaling molecules encounter their downstream 
effectors by coincidence. Whether they truly transfer 
signals depends on binding specificity and on activa-
tion status, which is under the regulation of alterna-
tive signaling events. To explain translocations of sig-
naling modules, one element must be added: one of 
the interactors is tethered to a static subcellular com-
partment. We assume the PM-anchored target T and 
the cytosolic protein P. In resting conditions, there is 
no binding affinity between P and T. Brownian mo-
tion dictates the stochastic movement of P in an equi-
librium shuttling between cytosol and PM. However, 
when mutual affinity is ‘switched on’, the PM-localized 
target T becomes a sink for P. Diffusion drives P to 
accumulate, or translocate, to target T.
The ‘switch’ can be turned on at the level of the 
diffusible protein or that of the anchor at the PM. At 
the molecular level, switching can be done in several 
ways. One of the binding partners can be post-trans-
lationally modified. For instance, phosphorylation of 
protein P may define a new recognition domain that 
triggers translocation to T. Conformational changes 
may also expose affinity domains that are otherwise 
inaccessible. Such conformational rearrangements 
may, on their turn, be triggered by phosphoryation but 
also by binding of (upstream) signaling components. 
An example of the latter is the cAMP-induced confor-
mational change of Epac1 that triggers PM translo-
cation (chapter 3). An afffinity domain may further 
be released by dissociation from a complex in which 
it was previously shielded. Conversely, mechanisms 
where binding capacity is acquired by association into 
a protein complex can be considered ‘coincidence de-
tectors’.
These scenarios are summarized in Table 1 and 
are referred to in the next section. It must be stressed 
that this limited list represents only a fraction of all 
possible mechanisms in cell signaling.
Fig 1 PI(4,5)P2 depletion by rapamycin-
induced translocation of a 5-phosphatase
A phosphoinositide-specific inositide 5-phosphatase, 
fused to FKBP and mRFP, resides in the cytosol. 
Translocation towards the PM is triggered by rapamycin 
which induces the tight interaction of the FKBP moiety 
with the FRB of CFP-FRB-CAAX. Fluorophores allow 
registration of the translocation process. Note that 
the YFP emission spectrum can be used for readout of 
PI(4,5)P2-dependent processes.
Table 1      Scenarios of switchable interactions that underly translocation
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4  GPCR signaling is full of 
    translocations
This section surveys a subset of signaling pathways 
that are under the control of G Protein-Coupled Re-
ceptors (GPCRs). Selected are those that have been 
subject of study in the course of this thesis: via the G 
protein subunits Gα13, Gαs and Gαq. Meanwhile, these 
pathways illustrate the occurrence of translocations in 
cell signaling. Thus, the focus lies on localizations and 
translocation mechanisms rather than on the exten-
sive treatment of each and every signaling protein.
4.1    G Protein-Coupled Receptors
GPCRs constitute one of the largest mammalian pro-
tein families, with nearly 1000 members in the hu-
man genome [20]. They are characterized by seven 
transmembrane domains and coupling through heter-
otrimenric G proteins. GPCRs occur in all cells of the 
body, but expression depends on cell type, function 
and developmental stage. They can be activated by 
a wide variety of stimuli, including neurotransmitters, 
peptide hormones, lipids, ions, and light. GPCR func-
tions vary from transmission of sensory information 
(e.g. >200 family members expressed in the olfactory 
organ [21]) to stimulation of proliferation and migra-
tion [22].
The heterotrimeric G proteins consist of an alpha 
subunit (Gα) and a dimer beta/gamma subunit (Gβγ) 
[23]. For the many different signaling cascades, the 
human GPCR family utilizes a repertoire of at least 20 
Gα, 5 Gβ and 12 Gγ isotypes [24]. In the absence of 
receptor stimulation, Gα and Gβγ are tightly associ-
ated in the tripartite complex [25] and achieve PM 
localization by prenylation of Gγ and palmitoylation 
of Gα [20,25]. The GTPase activity is contained by 
the larger Gα subunit. Like all GTPases, Gα cycles be-
tween a GDP-bound, inactive state and a GTP-bound, 
active state (Fig. 2A). Guanine Exchange Factors 
(GEFs) enhance transition to the GTP-bound state, 
whereas GTPase Activating Proteins (GAPs) enhance 
GTP hydrolysis. The association with Gβγ stabilizes the 
inactive state of Gα [25].
Ligand binding, however, induces the activated 
conformation of the GPCR that binds Gα/Gβγ via the 
third intracellular loop [26] and serves as a GEF for 
the recruited Gα subunit. Using a rapid fluorescent 
readout, Vilardaga et al. showed that α2a-adrenergic 
receptors undergo this shape change within 50 mil-
liseconds [27]. Activation of Gα is, on its turn, ac-
companied by a conformational change that induces 
dissociation from Gβγ [28]. Next, Gα redistributes 
laterally along the PM (it remains palmitoylated) to 
find its downstream effector(s). Although not fully un-
derstood, some reports have claimed that dissociation 
from Gβγ reliefs the protection from depalmitoylation. 
As a consequence, the Gα subunit may rapidly loose 
its PM localization and the subsequent translocation 
towards the cytosol may constitute a shut-off mech-
anism for signaling towards PM-localized effectors 
[20].
Figure 2     The GTPase cycle
A)  Cycling of GTPase proteins between the inactive, GDP-bound and the active, GTP-bound conformation is 
regulated by guanine exchange factors (GEFs) and GTPase activating proteins (GAP). See text for details




4.2   Gα13 signaling
Activated Gα13 subunits mainly signal through Gua-
nine Exchange Factors (GEFs) for the small GTPase 
Rho. These include PDZ-RhoGEF, AKAP-Lbc [35], 
p115RhoGEF and LARG [25,36]. Together with Ras, 
Rac, Cdc42 and Rap, RhoA belongs to the family of 
small Rho-GTPases (21kD) [37], which, similar to the 
larger Gα subunit (43kD), cycle between the GDP- 
and GTP-bound state (Fig. 2A).
RhoA activation has dramatic effects on cellular 
morphology. It does so mainly via its effector Rho-
kinase (or ROCK), which induces actomyosin contrac-
tion by phosphorylation of myosin light chain (MLC). 
Pronounced Rho-dependent morphological changes 
can best be studied by stimulating the Gα13-coupled 
receptors for lysophosphatidic acid (LPA) in N1E-115 
cells (e.g. see chapter 2).
The cycling of RhoA is accompanied by dynamic 
shuttling between cytosol and PM, contributing to 
switchable signaling behavior. PM localization is ac-
complished by prenylation of its very C-terminus. The 
attached fatty acid tail tends to insert into the inner 
leaflet of the PM (scenario 1a), unless this is prevent-
ed by Guanine nucleotide Dissociation Inhibitor (GDI) 
proteins, which locate to the cytosol (Fig. 2B). As 
long as RhoA is complexed to GDI, which shields the 
C-terminus and the prenyl modification, it remains in 
the cytosol. LPA receptor stimulation dissociates this 
complex and thus triggers translocation of RhoA to 
the PM (scenario 1d). Interestingly, this translocation 
is independent of RhoA activation itself, since also 
the inactive mutant Rho(N19) translocates upon LPA 
stimulation [38]. Thus, LPA induces translocation of 
prenylated RhoA towards the PM, where its transition 
to the active state is catalyzed by Gα13-activated Rho-
GEFs.
In this thesis, we demonstrate that LPA-induced 
Gα13/RhoA signaling triggers an additional PM translo-
cation: that of chloride intracellular channel 4 (CLIC4). 
Although the biological function of CLIC4 recruitment 
to the PM has remained unclear, we could establish 
that cytosolic CLIC4 is targeted to the activated LPA 
receptor complex (chapter 2).
Below : catch a glimpse at chapter 2
Glimpse at ...
Chapter 2  :  CLIC4 translocates to activated, Gα13-coupled receptors at the 
plasma membrane
Chloride intracellular channels (CLICs) are a familiy of six proteins that are thought to function as 
chloride channels in intracellular organelles and, also, the PM [29]. Chloride conductances have been 
reported, but only in in vitro experiments using artifical membranes [30]. Altogether, the cellular roles 
of CLIC proteins are poorly understood.
Using time-lapse microscopy, we showed that LPA stimulation triggers the rapid translocation of 
CLIC4 from the cytosol to the activated receptor at the PM. CLIC4 recruitment is transient (lasting 5-10 
min) and strictly dependent on Gα13 and RhoA activation. In apparent contradiction to its nomenclature, 
we find no evidence that CLIC4 can insert into the PM or modulate chloride currents.
Although the biological function of CLIC4 translocation has not been resolved to date, we speculate 
that CLIC4 translocates to the receptor complex to regulate signal transfer from Gα13 towards RhoA (ac-
tivation) at the PM. Interestingly, CLIC4 has been reported to interact with the scaffold protein AKAP350 
[31], while a family member of the latter, AKAP-Lbc is a RhoGEF, that directly links Gα12 to RhoA [32]. 
Furthermore, CLIC4 binds the adaptor protein 14-3-3 [33], which is an activator of AKAP-Lbc [34]. 
Therefore, it is tempting to hypothesize that CLIC4 translocates to a protein complex containing the 
activated receptor, Gα13 and an AKAP scaffold with GEF activity towards RhoA. In this model, the spatial 
regulation of CLIC4 will undoubtedly add to the switch-like regulation of RhoA activity.
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4.3   Gαs signaling
Activated Gαs subunits stimulate adenylyl cyclases 
(ACs) to synthesize the second messenger cyclic ad-
enosine monophosphate (cAMP) from ATP. The sec-
ond messenger cAMP is involved in numerous cellular 
functions, depending on cell type and activated recep-
tor. For example, cAMP stimulates cell growth in many 
cell types while inhibiting it in others [41-43]. The di-
verse effects of cAMP are mediated by protein kinase 
A (PKA), exchange protein directly activated by cAMP 
(Epac) and cyclic nucleotide-gated channels (CNGCs). 
The classical cAMP effector PKA is a tetramer consist-
ing of two regulatory and two catalytic subunits [44]. 
The catalytic subunits are released when cAMP bind-
ing to the regulatory subunits dissociates the complex 
(scenario 1d). The released catalytic domains phos-
phorylate various substrates on typical PKA-consensus 
motifs. cAMP-mediated cell differentiation is charac-
terized by the induction of specific genes through the 
transcription factor CREB (cAMP responsive element 
binding protein), which translocates to the nucleus 
upon phosphorylation by PKA [41] (scenario 1a).
Given that PKA is involved in numerous parallel 
signaling cascades, it is a challenge to understand 
how the kinase is activated in the right place and at 
the right time. It is generally believed that specificity 
is achieved, in part, through the compartmentaliza-
tion of PKA at different subcellular locations through 
interaction with so-called A Kinase Anchoring Proteins 
(AKAPs) [35,45-47]. At least 50 different AKAP iso-
forms target the regulatory subunits of PKA to various 
intracellular compartments (reviewed in [35]).
To restrict cAMP signaling to these compart-
ments, AKAP anchors also cluster the cAMP-degrading 
phosphodiesterases (PDEs) [48,49], implying that 
cAMP levels are reduced in the vicinity of PKA. Inter-
estingly, PKA phosphorylation is known to upregulate 
PDE activity [50], establishing a feedback-loop that 
rapidly terminates the cAMP signal. Thus, the AKAP 
scaffold restricts cAMP turnover to the micrometer 
scale [51,52]. Indeed, using a FRET reporter for PKA 
activity, Saucerman et al (2006) demonstrated that 
the ocurrence of local cAMP gradients is enhanced by 
PDE activity [53]. Another study used an Epac-based 
cAMP sensor to show that following receptor stimula-
tion, cAMP elevations in the nucleus follow with a lag 
time and with decreased amplitude as compared to 
elevations near the PM [10].
cAMP is a small messenger molecule that can 
pass through gap junctions [54-57]. We have studied 
this gap junctional communication (GJC) of cAMP and 
observed that PDE activity determines the degree of 
cAMP exchange between adjacent cells (chapter 6).
Below : catch a glimpse at chapter 6
More recently, the discovery of Epac as a direct effec-
tor of cAMP [17] has triggered the elucidation of many 
cAMP-regulated processes that could not be explained 
by the classical effector PKA. Epac1 and Epac2 act as 
GEFs for the small G Proteins Rap1 and Rap2. Un-
like RhoA, Rap GTPases are permanently anchored to 
membrane compartments via its prenylated C-termi-
nus [62], including the Golgi network, vesicular mem-
branes and the plasma membrane [63-66]. It plays 
roles in diverse processes typical for the PM, including 
cell adhesion [58,64,67], adherens junction formation 
Glimpse at ...
Chapter 6  :  Gap junctional communication allows sharing of cAMP
Gap junctions are clusters of transmembrane channels that allow direct cell-to-cell transfer of ions and small 
molecules [39]. Apart from a few cell types, most cells in normal tissues show gap junctional communication 
(GJC) [40]. GJC of cAMP is of particular interest because cAMP has numerous effects on cell behavior, includ-
ing inhibition of proliferation and migration [41]. Using our FRET-based cAMP sensors, we directly monitored 
intercellular exchange of physiologically raised cAMP in monolayers of Rat-1 fibroblasts, that endogenously 
express Cx43. Our data show that cAMP translocation from cAMP donor to acceptor cells occurs over the 
entire range of physiological cAMP concentrations. We further indicate the phosphodiesterases (PDE) as the 
primary determinants for the relative cAMP levels in acceptor cells as compared to donor cells.
Importantly, these data demonstrate that GJC of cAMP may be relevant to the shared properties of 
Cx43-expressing tissue cells. Gap junctions are tumour suppressors in cells with affected signaling functions. 
It has been proposed that ‘normal’ cells may deliver signaling intermediates through junctional exchange, 
permitting survival of mutant cells with blocked enzymatic pathways [39]. cAMP may be a concrete example 
of such intermediate messenger. Furthermore, GJC is an important mechanism in the regulation of embryo-
genesis [40]. The several connexin isotypes are differentially expressed among embryonic tissue types and 
therefore, GJC of cAMP may tissue-specifically ensure concerted regulation of cAMP-dependent processes.
These examples are particularly interesting from the perspective of compartmentalization. Since cAMP is 
mainly produced at the PM, its diffusion through GJs may be relatively insensitive to PDE-mediated deg-
radation in the cytosol. As a consequence, intercellular exchangeof cAMP may be most relevant to cAMP-
regulated processes at the PM.
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[59] and insulin secretion [68,69].
Epac GEFs contain a regulatory region with one 
(Epac1) or two (Epac2) cAMP-binding domains, a Di-
shevelled, Egl-10, Pleckstrin (DEP) domain, and a cat-
alytic region for GEF activity [60]. Recently, the struc-
tures of both the inactive and the active conformation 
of Epac2 were solved [70,71]. This revealed that in 
the inactive conformation the regulatory region oc-
cludes the Rap binding site and that this is relieved by 
a conformational change induced by cAMP binding.
Similar to PKA, also Epac signaling is governed 
by compartmentalization. Interestingly, in cardiomyo-
cytes Epac1 has been found in the same complex as 
PKA, anchored by the muscle-specific mAKAP [72]. 
The complex, which also contains the PDE4D3, is a 
crossroad of cAMP signaling involved in the regulation 
of ERK5. Specifically Epac2 is part of the Rim2-piccolo 
complex involved in cAMP-dependent exocytosis [73]. 
Both Epac1 and Epac2 are targeted to microtubules via 
an the interaction with the Light Chain of Microtubule 
Associated Protein (MAP-LC) [74]. In addition, Epac 
translocations can be triggered by hormone stimula-
tion. Li et al. (2006) found that Epac2 translocates to 
the plasma menbrane by binding to the small GTPase 
Ras, when Ras acquires the active conformation  [75] 
(scenario 2b).
In this thesis, we uncovered two additional mech-
anisms of Epac1 targeting in response to extracellular 
signals. Epac1 translocates to the PM upon binding 
of cAMP (chapter 3) and upon activation of members 
of the Ezrin/Radixin/Moesin (ERM) family (chapter 4). 
Both types of PM recruitment appeared important for 
Epac1-mediated cell adhesion. This is not surprising, 
since activation of Rap at the PM is crucial for cell 
adhesion [64]. Thus, not only is Epac1 compartmen-
talized, several extracellular cues can regulate Epac1 
function via dynamic translocations from one com-
partment to the other.
Below : catch a glimpse at chapters 3 and 4
Glimpse at ... 
Chapter 3  :  Epac1 translocates to the plasma membrane upon cAMP binding
Epac1 is a GEF for the small G protein Rap and is thereby involved in processes such as integrin-mediated 
cell adhesion [58] and cell-cell junction formation [59]. In the absence of cAMP, Epac1 localizes to the 
nuclear envelope, the cytosol and, to a minor extent, the PM. Here, we report that cAMP induces the trans-
location of Epac1 towards the PM. Combining high-resolution confocal fluorescence microscopy with FRET 
assays, we observed that Epac1 translocation is a rapid and reversible process. This dynamic redistribution 
of Epac1 requires both the cAMP-induced conformational change and the DEP domain.
In line with its translocation, Epac1 activation induces Rap activation predominantly at the PM. Fur-
thermore, translocation-deficient Epac1 mutants were impaired in their ability to induce Rap-mediated 
adhesion of Jurkat T cells. This indicates that the cAMP-induced translocation enhances Rap-mediated cell 
adhesion.
Interestingly, our data imply that cAMP exerts dual regulation on Epac1. The cAMP-induced conforma-
tional change not only elicits GEF activity by Epac1 [60], it also induces its translocation to the compart-
ment where its GEF activity should activate Rap. This dual regulation guarantees that Epac1 acts as a binary 
switch for Rap activation.
Chapter 4  :  Epac1 is recruited to the PM by activated ERM proteins
Besides the cAMP-induced translocation, we revealed an additional translocation mechanism that targets 
Epac1 to the PM. This redistribution is mediated by direct interaction with members of the Ezrin/Radixin/
Moesin (ERM) family. Recruitment to ERM proteins is distinct from the cAMP-induced translocation in several 
aspects. First, it is not mediated by the DEP domain but by the N-terminal 49 residues that preceed the DEP 
domain. Second, it is independent of Epac1 conformational state. And third, it targets Epac1 to specific, 
asymmetrical regions of the PM, whereas cAMP-binding induces uniform PM targeting. 
We find that the Epac1-ERM interaction is regulated by conformational opening of ERM proteins. In 
agreement with this, thrombin receptor signaling, which induces the conformational opening of ERM pro-
teins [61], triggers the recruitment of Epac1 to asymmetrical zones of the PM.
Also ERM-mediated recruitment is important for activation of Rap signaling. Epac1(∆49), which is defi-
cient in ERM binding, was impaired in its ability to induce adhesion upon Epac1-activating stimuli. Consider-
ing that both the cAMP-dependent Epac1 translocation and the interaction with ERM proteins contribute to 
Rap activation (and hence cell adhesion), we suggest that these two targeting mechanisms synergetically 
cooperate to effectively couple GEF activity of Epac1 to its effector Rap. Within the context of transloca-
tions as enrichment mechanisms for signaling molecules (section 2.4), it is tempting to speculate that the 
marked asymmetrical PM distribution imposed by ERM proteins may further enrich Epac1 to the appropriate 
compartment for Rap activation, thereby increasing its efficiency of action.
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4.4    Gαq signaling
Activated Gαq subunits trigger the activity of phos-
pholipase C (PLCβ), which hydrolyzes the PM-specific 
phospho-inositide PI(4,5)P2. The cleavage generates 
the second messengers inositol-triphosphate (IP3) 
and diacylglycerol (DAG). PI(4,5)P2 itself is also a 
second messenger involved in a vast amount of PM-
localized processes, many of which are related to actin 
polymerization. In this way, PI(4,5)P2 plays roles in 
processes ranging from actin cytoskeletal remodeling 
to regulation of ion transporters [76].
In unstimulated cells, PLCβ is anchored to the PM 
via electrostatic interactions between its C-terminal 
domain (CT-domain) and negative charges at the in-
ner leaflet (Singer et al). When activated Gαq interacts 
with PLCβ [77], it elicits the PI(4,5)P2 hydrolyzing ac-
tivity. The loss of negatively charged PI(4,5)P2 induces 
translocation of PLCβ to the cytosol [78]. Probably, 
this cytosolic translocation is further enhanced by GAP 
activity of the PLCβ CT-domain [79], which inactivates 
Gαq and thereby disrupts the interaction. Thus, hydro-
lysis of its substrate PI(4,5)P2 and inactivation of its 
upstream signal form the switch to induce PLCβ trans-
location to the cytosol (scenario 1d; here transloca-
tion is away from the PM). Obviously, this negative 
feedback mechanism may contribute to the transient 
kinetics of Gαq-mediated PI(4,5)P2 hydrolysis.
PI(4,5)P2 hydrolysis is involved in the gating of 
several PM-localized channels, such as the KCNQ po-
tassium channel [80] and the transient receptor po-
tential cation channels TRPM7 [81] and TRPM8 [82]. 
In this thesis, we established the crucial role of PI(4,5)
P2 in ligand-induced closure of connexin43-based gap 
junctions (this thesis, chapter 7).
Below : catch a glimpse at chapters 7
Glimpse at chapter 7
Chapter 7  :  PI(4,5)P2 regulates communication via connexin43-based gap junctions
Cell-cell communication through connexin43 (Cx43)-based gap junction channels is rapidly inhibited upon 
activation of GPCRs, that couple through Gaq. However, the mechanism has long remained unknown. Here, 
we show that Cx43-based cell-cell communication is inhibited by depletion of PI(4,5)P2 from the plasma 
membrane. Knockdown of phospholipase Cβ3 (PLCβ3) inhibits PtdIns(4,5)P2 hydrolysis and keeps Cx43 
channels open after receptor activation. Furthermore, when PI(4,5)P2 is overproduced by overexpressed 
PI(4)P-5-kinase, Cx43 channel closure is impaired.
Next, we showed that PI(4,5)P2 depletion is not only required but also sufficient for gap junction 
closure. For this, we used the translocatable FKBP-5-phosphatase described in section 3.1. Rapamycin-
induced recruitment of FKBP-5-phosphatase towards PM-anchored FRB-CAAX induced immediate PI(4,5)P2 
depletion without generation of second messengers IP3 and DAG [80]. Thus, the observed reduction in gap 
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Abstract 
CLIC4 (“Chloride Intracellular Channel” 4) is a soluble protein structurally related to omega-type 
glutathione-S-transferases (GSTs) and implicated in various biological processes, ranging from 
chloride channel formation to morphogenesis. However, the function of CLIC4 and whether it is 
regulated remain unclear. Using time-lapse microscopy, we show that G13-coupled receptor agonists, 
such as lysophosphatidic acid and thrombin, trigger the rapid translocation of CLIC4 from the cytosol 
to the activated receptor at the plasma membrane. CLIC4 recruitment is transient (lasting 5-10 
min) and strictly dependent on G(α)13, RhoA activation and F-actin integrity. CLIC4 does not appear 
to enter the plasma membrane or to modulate chloride currents. CLIC4 translocation requires at 
least six conserved residues, including reactive Cys35, whose equivalents are critical for substrate 
binding in omega-GSTs. Our results show that CLIC4 is regulated by G13-linked RhoA pathway to be 
targeted to G13-coupled receptor complexes at the plasma membrane, and they suggest that CLIC4 




Chloride Intracellular Channels (CLICs) are a family of six 
proteins that are thought to function as chloride channels 
in intracellular organelles and at the plasma membrane. 
They have been implicated in several cellular functions 
linked to ionic transport, such as charge compensation 
required for tubule formation in the excretory cell of C. 
elegans [1,2], tubular morphogenesis in mammalian 
endothelial cells [3] and acid secretion in bone resorbing 
osteoclasts [4]. However, many other findings are difficult 
to reconcile with membrane ion transport, such as 
involvement of CLIC4 in keratinocyte differentiation [5] 
and apoptosis [6,7], binding of CLIC4 to the centrosome 
[8,9] and localization of CLIC1 and CLIC3 to the nuclear 
matrix [10,11]. In general, the cellular roles of CLIC 
proteins are poorly understood.
CLIC proteins are structurally distinct from members 
of the CLC chloride channel family, the Cystis Fibrosis 
Transmembrane Conductance Regulator (CFTR) or known 
ligand-gated chloride channels [12]. In contrast, the 220 
amino acid core region shared by the CLIC proteins shows 
significant structural homology to the omega-class of Glu-
thione S-Transferases (GST) [13]. The first CLIC proteins 
to be isolated were purified using IAA-94, an analogue of 
the GST-inhibtor ethacrynic acid [14]. To date, the evolu-
tionary relationship with omega-GSTs is not well under-
stood. Although cellular CLICs, like GSTs, are globular, sig-
nal peptide-less [14] proteins occurring predominantly in 
the soluble form, IAA-94-inhibitable chloride conductances 
have been demonstrated in artificial liposomes containing 
reconstituted CLIC1 [15], CLIC4 [16] or CLIC5 [17]. Im-
portantly, these chloride conductances emerge in the ab-
sence of any accessory protein, and were strictly depen-
dent on oxidative conditions and acidic pH (< 6.0). Impor-
tantly, however, the cell interior is a reducing environment 
with a pH that is mostly >7.2. These observations have 
led to the membrane-insertion model, wherein reactive 
oxygen species (ROS) trigger insertion of cytosolic CLIC 
proteins into lipid bilayer, enhanced by the local, relatively 
low pH at the inner leaflet of the plasma membrane. In 
support of this, CLIC1 undergoes a redox-controlled struc-
tural transition that is required for in vitro channel activ-
ity [15]. Moreover, β-amyloid-induced ROS generation has 
been proposed to cause a CLIC1-mediated chloride con-
ductance in microglia of Alzheimer patients [18]. Finally, 
Singh and co-workers have postulated that the chloride 
conductances of CLIC1 and CLIC5 are regulated by cy-
toskeletal actin filaments, adding a layer of control to the 
insertion model [19]. However, in vivo membrane recruit-
ment of CLIC proteins evoked by physiological signaling 
cascades has never been demonstrated to date. 
We here describe the translocation of CLIC4 towards 
Figure 1     Agonist-induced translocation of CLIC4 towards the plasma membrane.
A)  LPA-induced translocation of GFP-CLIC4 in N1E-115 cells visualized by confocal microscopy. In resting cells, GFP-CLIC4 resides 
mainly in the cytosol with some patch-like accumulation at the cell periphery. LPA (1 mM) induces a rapid but transient recruitment 
of GFP-CLIC4 towards the plasma membrane. Translocation can be measured semi-quantitatively by monitoring the accumulation of 
GFP fluorescence at the plasma membrane (PM, red trace) and the concomitant depletion of fluorescence from the cytosol 
(Cyt, blue trace). Net translocation is expressed as the ratio PM/Cyt (green trace).
B)  Localization of endogenous CLIC4 in resting and LPA-stimulated N1E-115 cells. Plasma membrane accumulation was markedly 
increased by LPA stimulation (1 min). 
C)  Failure of GFP-CLIC1 to translocate in LPA-stimulated N1E-115 cells. Scalebars in all shown images: 10 mm.
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the plasma membrane of N1E-115 neuroblastoma cells 
following stimulation of lysophosphatidic acid (LPA) re-
ceptors. CLIC4 translocation is immediate and transient, 
and depends on activation of the G(α)13-RhoA pathway as 
well as on actin polymerization. Interestingly, LPA stimu-
lation is known to evoke a transmembrane chloride efflux 
in N1E-115 cells, but the nature of the putative channel 
has remained elusive [20,21]. Therefore, we thoroughly 
tested the involvement of CLIC4 in LPA-induced chloride 
efflux, but found no evidence. In contradiction with the 
membrane-insertion model, our efforts to show CLIC4 
membrane insertion or inducible channel function in vivo 
were unsuccessful. Instead, we find that the LPA-induced 
translocation targets CLIC4 towards the upstream, acti-
vated LPA receptor complex. We further show that the 
conserved residues that confer GST-homology to CLIC 
proteins, including cysteine35, are essential for CLIC4 
translocation. As such, this is the first study to attribute a 
function to the GST-like structural features of CLIC4. De-
spite the crucial importance of reactive Cys35 [22] we find 
that CLIC4 translocation is not redox-regulated. Our data 
suggest that the GST-like structural fold harbors a recog-
nition domain for an as-yet unknown binding partner that 
is essential for translocation. We propose that transient 
recruitment of CLIC4 to the activated LPA receptor plays 
a role in coupling ligand-activated GPCRs to downstream 
G(α)13-RhoA signaling.
Results
We set out to examine if CLIC4 may function in one or 
more receptor-linked signaling pathways, particularly 
those involving Cl channel activation and cytoskeletal 
remodeling. To this end, we used N1E-115 neuronal cells, 
because receptor signaling, ion channel activation and 
cytoskeletal regulation have been extensively examined 
in these cells. Most, if not all, cell types express multiple 
CLIC family members. PCR analysis revealed that N1E-115 
cells express CLIC4, CLIC1 and CLIC6 (data not shown). 
Translocation of CLIC4 towards the plasma 
membrane mediated by the G(α)13-RhoA pathway
To monitor CLIC4 localization and trafficking, we generated 
constructs of CLIC4 fused to various fluorophores. When 
expressed in N1E-115 cells, GFP-tagged CLIC4 was 
distributed homogenously through the cytosol (Fig. 1A). 
Upon addition of LPA, we observed a rapid translocation 
of GFP-CLIC4 towards discrete domains of the plasma 
membrane, concomitant with depletion of CLIC4 from the 
cytosol (Fig. 1A). GFP-CLIC4 accumulation was maximal 
after ~1 min. and had disappeared after about ~10 min 
of LPA addition. A similar translocation was observed 
with C-terminally tagged CLIC4-YFP (data not shown). 
Importantly, this translocation pattern was also observed 
for endogenous CLIC4 (Fig. 1B), indicating that the GFP 
tag has little or no effect on CLIC4 targeting. In marked 
contrast, CLIC1 (GFP-CLIC1 and CLIC1-YFP) did not 
undergo detectable translocation upon LPA stimulation 
(Fig. 1C). CLIC4 depletion from the cysotol occurred in a 
homogeneous manner (Fig. 1A and supplementary movie 
1), strongly suggesting that cytosolic CLIC4 is freely 
diffusible. Indeed, photobleaching (FRAP) experiments 
showed that cytosolic GFP-tagged CLIC4 is as mobile as 
free GFP (data not shown).
What signaling events underlie the rapid recruitment 
of CLIC4? Translocation was insensitive to pertussis toxin 
(PTX), ruling out the involvement of Gi-linked signaling 
pathways. Instead, translocation was only observed with 
GPCR agonists that activate the G12/13-linked RhoA path-
way leading to cytoskeletal contraction in N1E-115 cells, 
notably LPA, thrombin receptor-activating peptide (TRP) 
and sphingosine-1-phosphate (S1P). In contrast, Gq-cou-
pled receptor agonists such as bradykinin failed to induce 
CLIC4 translocation, as summarized in Table 1. As a di-
rect test for involvement of the G12/13-RhoA pathway we 
used RNAi constructs to knockdown G(α)13 and RhoA. This 
abolished agonist-induced CLIC4 translocation, as did pre-
treatment of the cells with the Rho-inactivating C3 exo-
enzyme. That C3 and RNAi treatment were effective was 
evidenced by loss of agonist-induced cell rounding (Fig. 
Table 1    Signatures of depolarizing chloride 
efflux and GFP-CLIC4 translocation correlate
Responses to LPA, Thrombin, S1P and Bradykinin were 
tested in N1E-115 cells. Isoproterenol, the agonist of 
adrenalergic receptors, was added to A431 cells. 
G Proteins: bradykinin stimulation in N1E-115 cells 
results in strong and specific activation of Gαq-PLC 
pathway [37]. Isoproterenol stimulation evokes strong 
and specific Gαs-mediated cAMP production in A431 
cells due to high expression of adrenergic receptors. 
Inhibition of Gαi by PTX (200ng/ml, 16hr) did not affect 
chloride efflux or CLIC4 translocation . Thus, both 
chloride efflux and CLIC4 translocation involve Gα13 
and do not require Gαq (calcium release) or Gαs (cAMP 
synthesis) or Gαi (PI3K activation). 
Rho and downstream effectors: involvement of 
the Gα13 effector RhoA in chloride efflux and CLIC4 
translocation was shown by RNAi-RhoA and treatment 
with C3 toxin (30mg/ml, 16hr). All tested RhoA effectors 
were excluded from involvement (see Fig 2A,C).
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2A) and induction of neurite outgrowth (data not shown). 
Agonist-induced CLIC4 translocation was not unique for 
N1E-115 cells, as it was also observed in Rat-1 fibroblasts, 
HEK293 cells, Hela and A431 carcinoma cells stimulated 
with either LPA or TRP (data not shown). It thus appears 
that CLIC4 recruitment at the plasma membrane is a 
common cellular response to activation of the G12/13-RhoA 
pathway. 
RhoA is a key regulator of actomyosin-based contrac-
tility and its major downstream effectors are Rho kinase 
(ROCK), mDia1 and PIP5-Kinase. However, incubation 
with the ROCK inhibitor Y-27632, at doses that abol-
ished agonist-induced cell rounding (30 uM), did not af-
fect CLIC4 translocation, nor did expression of dominant-
negative mDia1 (FHZ∆N) or incubation with the PIP5K 
inhibitor Wortmannin. However, agonist-induced CLIC4 
translocation was inhibited by briefly pretreating the cells 
with latrunculin A (1 uM; 4 min.), a toxin that prevents 
F-actin polymerization and thereby disrupts the cytoskel-
eton (Fig. 2B). These results indicate that CLIC4 recruit-
ment depends on F-actin integrity rather than actomyosin 
contractility. 
CLIC4 recruitment can be dissociated from chloride 
channel activation
Ion conductance studies using artificial lipid bilayers have 
suggested that CLICs may auto-insert into membranes 
to form anion channels. However, the channel hypothesis 
has remained controversial to date. We note that the 
transient kinetics of CLIC4 translocation are strikingly 
similar to those of the G(α)13-mediated chloride current 
in LPA-stimulated N1E-115 cells. This current manifests 
itself as a transient membrane depolarization (from 
-60 mV to -15 mV), which can be monitored by using a 
voltage-sensitive dye (Fig. 2C). In common with CLIC4 
translocation, agonist-induced membrane depolarization 
was abolished after knockdown of G(α)13 and RhoA as 
well as by C3 treatment, but not by Y-27632 (Fig. 2C). 
However, membrane depolarization was insensitive to 
latrunculin A at doses that blocked CLIC4 translocation 
(even when incubated for >1hr) (Fig. 2D). We therefore 
conclude that CLIC4 recruitment to the plasma membrane 
does not underlie chloride channel activation. 
Yet, it cannot be ruled out that CLIC4 has channel-
forming ability or is a channel regulator in our system. We 
therefore performed patch-clamp experiments to measure 
LPA-induced chloride currents in N1E-115 cells. As shown 
Figure 2     LPA-induced CLIC4 
translocation and chloride efflux are 
both in the Gα13-Rho pathway but can 
be dissociated
A)  GFP-CLIC4 translocation and cell 
morphology controls under various conditions 
affecting G(α)13-RhoA signaling in N1E-115 
cells. RNAi-encoding vectors vectors were 
transfected for 48 hr together with GFP-
CLIC4 (or transfection marker H2B-mRFP 
in the cell morphology controls; not shown 
in the images). C3 toxin (30 mg/ml) was 
incubated for 16 hr and Y-27632 (30 mM) for 
30 min. Cells expressing dominant-negative 
mDia1 (YFP-mDia1-FHZ∆N) were selected for 
maximal YFP signal; imaging of co-expressed 
CFP-CLIC4 showed LPA-induced translocation 
(lower panels). 
B) Incubation with Latrunculin A (1 uM, 4 
min.) abolished LPA-induced translocation of 
GFP-CLIC4. Scalebars in (A,B) are 10 mm.
C)  Membrane potential measurements in LPA-
stimulated N1E-115 cells using the voltage-
sensitive dye (see M&M). Indicated RNAi or 
drug treatments corresponds with those shown 
in panel A  (n>100). (transfection marker 
H2B-CFP was used to avoid leak-through in 
the voltage-dye detection channel). These 
experiments revealed a marked correlation 
with CLIC4 translocation. All measurements 
were calibrated by using 150 mM KCl to 
eliminate the transmembrane potential.
D) Latrunculin A (up to 1 hour pre-incubation) 
does not affect LPA-induced membrane 
depolarization, whereas it abolishes CLIC4 




in Fig. 3A, knockdown (n=20) of CLIC4 did not significant-
ly modulate the kinetics or amplitude of the LPA-induced 
inward Cl current. Although CLIC4 knockdown was toxic 
to N1E-115 cells and the survivors showed approx. 20% 
residual CLIC4 levels, this result strongly suggests that 
membrane-targeted CLIC4 does not induce or modulate 
transmembrane chloride currents in our cell system.
When recruited to the cell periphery, could CLIC4 
conceivably bind to or even enter the plasma membrane? 
To address this question, we examined the fluorescence 
resonance energy transfer (FRET) between CFP-CLIC4 and 
membrane-anchored YFP-CAAX, a reporter that inserts 
into the plasma membrane through its prenylated K-Ras-
derived CAAX motif. Following LPA stimulation, there was 
no detectable increase in the YFP/CFP ratios relative to 
basal level (n=4, (∆F)/F= 1.01 +/- 0.05). Similar results 
were obtained with YFP-CLIC4 and CFP-CAAX (data not 
shown). The apparent lack of FRET strongly suggests that 
CLIC4 does not approach the plasma membrane closer 
than about 10 nm. Consistent with this, immunofluores-
cence studies on N1E-115 and HEK293 cells overexpress-
ing HA-CLIC4 failed to show externalization of the N-ter-
minal HA-tag, whereas the N-terminal HA-tag of the α1a-
adrenergic receptor, which externalizes a similar number 
of residues as expected for membrane insertion of CLIC4 
(34 amino acids, [16]), was readily detected extracellu-
larly (Fig. 3B). In conclusion, cortical CLIC4 accumulation 
at the plasma membrane does not lead to detectable ex-
ternalization of the N-terminus.
CLIC4 translocates specifically towards activated 
G13-coupled receptors
When comparing CLIC4 translocation induced by LPA 
to that induced by TRP, we noticed striking differences 
in the patterns of CLIC4 accumulation. LPA stimulation 
generally resulted in an asymmetric distribution of CLIC4 
at the plasma membrane, whereas TRP-stimulated cells 
showed a more homogeneous distribution of CLIC4 along 
the plasma membrane. This is best exemplified by the 
experiment of Fig. 4A, in which a cell was first stimulated 
with TRP and thereafter (after 10 min.) with LPA. It is clear 
that the resulting localizations of GFP-CLIC4 are markedly 
different. Such differential distribution was also observed 
for endogenous CLIC4 in cells stimulated with LPA or TRP 
(Fig. 4A). We hypothesized that this differential CLIC4 
localization may reflect different membrane localizations 
of the respective GPCRs. 
Indeed, in HEK293 cells expressing HA-LPA2 and 
GFP-CLIC4 we could co-precipitate GFP-CLIC4 with HA-
LPA2 (Fig 4B). This interaction was observed in stimulated 
as well as non-stimulated cells, likely due to constitutive 
activation of Rho signaling by the overexpressed HA-LPA2. 
We tested this hypothesis further by three different ap-
proaches. In the first approach, we took advantage of the 
finding that N1E-115 cells express LPA2 receptors (but 
not LPA1 or LPA3), which form a macromolecular com-
plex with the scaffold protein NHERF2 (sodium-hydrogen 
exchanger regulatory factor 2) through a PDZ-domain in-
teraction [23]. (In epithelial cells, NHERF scaffolds localize 
Figure 3     CLIC4 is not required 
for LPA-induced chloride efflux 
and does not pass the plasma 
membrane
A) Representative voltage-clamp recordings 
of inward chloride currents in LPA-stimulated 
N1E-115 cells. Black, control cells; red, 
cells expressing RNAi-CLIC4 (3 targeting 
constructs). The bar diagram shows mean 
peak amplitudes +/- s.e.m. Transmembrane 
currents are corrected for membrane 
conductance, which is a measure for total 
membrane surface (pA/pF). Western blot 
shows CLIC4 levels in untransfected and 
knockdown N1E-115 cells. 
B) Extracellular detection of HA-epitope 
in non-permeabilized HEK293 cells. Cells 
were transfected with transfection marker 
H2B-CFP plus HA-tagged (α1a)adrenergic 
receptor (HA-α1a-R) (upper panels) or HA-
CLIC4 (lower panels). HA-CLIC4-expressing 
cells were stimulated with LPA (2 min.) 
before fixation. In non-permeabilized cells, 
HA-α1a-R was detected selectively at the 
cell surface (upper right), in contrast to the 
intracellular signal in permeabilized cells 
(upper left). Expression and detection of 
HA-CLIC4 were verified in permeabilized 
HEK293 cells (lower left). Under non-
permeabilizing conditions, the HA-tag of 




Figure 4     CLIC4 translocation towards activated GPCRs and NHERF2
A)  Top panels: differential distribution of translocated CLIC4 in the same N1E-115 cell. The cell was first stimulated with TRP and 
thereafter with LPA. Lower panels: endogenous CLIC4 in N1E-115 cells stimulated with either TRP or LPA (immunofluorescence). 
Scalebars: 10 mm.
B)  HEK293 cells expressing HA-LPA2 and GFP-CLIC4 were lysed and HA-LPA2 was immunoprecipitated. Left lane : GFP-CLIC4 co-
precipitated with HA-LPA2, as detected with GFP antibody. Right lane : in the absence of HA-LPA2, co-precipitation of GFP-CLIC4 is 
not observed. 
C)  Colocalization of GFP-CLIC4 and DsRed-NHERF2 at polarized regions of the plasma membrane in N1E-115 cells. 
D)  Triple colocalization of endogenous CLIC4 (Alexa488-conjugated secondary antibody; shown in blue), DsRed-NHERF2 (shown in 
green) and HA-LPA2 (Alexa633-conjugated secondary antibody; shown in red). 
E) CLIC4 translocates to LPA1 receptors. Pictures taken from time-lapse recordings showing LPA1-GFP and CLIC4-mCherry in 
HEK293 cells before and after LPA stimulation. Arrows indicate plasma membrane regions where LPA1-GFP and CLIC4-mCherry 
transiently colocalize after LPA administration. Scalebars in (C,D,E) are 10 mm.
F)  CLIC4 accumulates in those membrane domains that are exposed to ligand (TRP). TRP was locally applied by combining an 
application and a suction pipet. Besides TRP (~3 mM), the application pipet contained Calcium Orange (~0.2 mM) for continuous 
monitoring of the flux between both pipets. After verifying the gradient steepness of the TRP/dye mix, a non-stimulated cell was 
positioned near the pipets and GFP-CLIC4 was imaged during local TRP application. Emissions of GFP and the pipet dye were 
detected in the same channel (500-555 nm). Top : fluorescence and transmission images before ligand stimulation; arrows indicate 
pipets (and cell debris attracted by the suction pipet). Bottom: t=0, temporary TRP flux touching the “north-east” flank of the cell; 
t=40 s, GFP-CLIC4 accumulates selectively at the TRP-exposed area of the plasma membrane; t=50 s, a second TRP flux; t=90 s, 
further accumulation of GFP-CLIC4. This experiment is representative for n=4. Scalebars: 20 mm.
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to the apical plasma membrane, where they assemble G 
protein-coupled receptors, transmembrane ion channels 
and transporters, [24]). We found that, in N1E-115 cells, 
GFP-CLIC4 and DsRed-NHERF2 showed perfect colocal-
ization in a polarized, restricted zone along the plasma 
membrane (Fig. 4B); colocalization was also observed for 
endogenous CLIC4 and DsRed-NHERF2. In addition, we 
observed triple colocalization of endogenous CLIC4 with 
the overexpressed LPA2 receptor (HA-tagged) and DsRed-
NHERF2 (Fig. 4C). These results indicate that CLIC4 is tar-
geted specifically to the LPA2-NHERF2 complex. 
In the second approach, we co-expressed the GFP-
tagged LPA1 receptor and CLIC4-mCherry in HEK293 cells 
and monitored their spatiotemporal regulation. As shown 
in Fig. 4D, LPA stimulation caused a rapid accumulation 
of CLIC4-mCherry at LPA1-GFP-containing subdomains at 
the plasma membrane, indicating that CLIC4 is being tar-
geted to the activated LPA1 receptor (see also supplemen-
tary movie 2). Finally, in yet another approach, we applied 
a precisely confined stream of TRP (generated through 
an application and a suction micropipette) to single GFP-
CLIC4-expressing N1E115 cells. This induced an immedi-
ate translocation of GFP-CLIC4 only to the agonist-exposed 
area of the plasma membrane (Fig. 4E and Suppl. Movie 
3), which is in contrast with the non-polarized membrane 
targeting observed after bath application of TRP (Fig 4A; 
n>50). Taken together, these results indicate that CLIC4 
is targeted specifically to activated G(α)13-coupled recep-
tor complexes. 
Mutational analysis of CLIC4 translocation
We next examined which residues are necessary for CLIC4 
translocation, taking into account the structural similarity 
of CLIC4 to the omega-class of glutathione S-transferase 
(GST) family [25,26]. The GST-fold itself has an N-terminal 
thioredoxin-like domain that binds glutathione, and an 
all-helical C-terminal domain with a binding site for the 
substrates to which glutathione is conjoined. The omega-
GSTs typically contain a reactive cysteine that activates 
glutathione by forming a mixed-disulfide [27]. This single 
reactive cysteine has been conserved in the CLIC proteins 
(Cys35 in CLIC4), but it is unclear why. Under reducing 
conditions, as normally found in the cytosol, CLICs exhibit 
very low affinity for glutathione and no substrates are 
known to which they display GST activity. Instead it has 
been proposed that the CLICs are structurally dynamic 
and possess both a soluble GST-fold and a transmembrane 
state [15,28]. 
Strikingly, when Cys35 was mutated into an alanine, 
the YFP-CLIC4(C35A) mutant failed to translocate to the 
plasma membrane upon agonist stimulation (Fig. 5A). 
Likewise, the plasma membrane localization observed with 
DsRed-NHERF2 was lost (Fig. 5B). In contrast, mutation of 
two other conserved cysteines, Cys189 and Cys234, did 
not affect CLIC4 translocation (Table in Fig. 5D; primary 
data not shown). So, if CLIC4 maintains an as yet unde-
tected enzymatic activity, homology to the omega-GSTs 
would suggest that Cys35 is essential for catalysis. 
Figure 5 Mutational 
analysis of CLIC4 
translocation 
A,B) Mutation of reactive 
residue Cys35 (YFP-
CLIC4(C35A)) abolishes LPA-
induced translocation (A) and 
colocalization with DsRed-
NHERF2 (B). Scalebars: 10 mm.
C)  Comparative structural analysis of omega-GST (left) 
and CLIC4 (right). The indicated residues were chosen 
for mutagenesis based on their analogy with the binding 
of glutathione (GSH) and secondary substrates in omega-
GSTs.
D)  Summary of the results obtained with the various point 
mutants of YFP-CLIC4. See text for further details. 
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Cys35 reactivity [22] could imply that reactive oxygen 
species (ROS) affect the resting state of CLIC4 and/or its 
translocation behavior. However, application of an oxidative 
burst (1 mM H2O2) did not trigger CLIC4 translocation, nor 
did it detectably affect the agonist-induced translocation. 
Conversely, CLIC4 translocation was not prevented by the 
anti-oxidant N-acetylcysteine (NaC, 5 mM). These results 
argue against a role for ROS in recruiting CLIC4 to the 
plasma membrane.
Next, we mutated residues whose equivalents make 
up the glutathione-binding site in omega-GSTs. Superpo-
sition of the CLIC4 and omega-GST structures revealed 
that the accommodation of glutathione involves three 
additional conserved residues, namely Phe37, Pro76 and 
Asp87 (Fig. 5C). Mutating Phe37 into an aspartate (F37D) 
adds a repulsive interaction to the carboxyl group of glu-
thatione’s gamma-glutamate. Mutating Pro76 will disrupt 
the gluthatione binding site in GST, while the D87A mu-
tation removes a residue that interacts with the amide 
of the glutathione gamma-glutamyl group in omega-GST. 
Mutation of any of these three residues abolished agonist-
induced translocation of YFP-CLIC4 as well as its colocal-
ization with DsRed-NHERF2 (Fig. 5D). These results sug-
gest that CLIC4 binds a substrate in a manner similar to 
GST-glutathione binding, and that this binding is required 
for CLIC4 to respond to GPCR stimulation. 
GSTs also bind a second substrate, namely the xe-
nobiotic compound to which glutathione is conjugated. 
Because this substrate must lie next to glutathione for 
conjugation, distance constraints reduce the number of 
residues that need to be considered. Phe122 and Tyr244 
are strongly conserved among the CLIC proteins and ap-
pear at positions equivalent to the secondary substrate 
binding site of the GSTs (Fig. 5C). We therefore generated 
mutants YFP-CLIC4(F122R) and YFP-CLIC4(Y244A). When 
expressed in N1E-115 or HEK293 cells, both mutants failed 
to undergo agonist-induced translocation, neither did they 
colocalize with co-expressed DsRed-NHERF2 (Fig. 5D). 
In conclusion, CLIC4 translocation requires residues 
Cys35, Phe37, Pro76 and Asp87 (equivalents of the GSH-
binding residues in GSTs) as well as Phe122 and Tyr244 
(equivalents of the secondary substrate-binding residues 
in GSTs). While the identity of the prospective CLIC4-
binding partner remains to be identified, our data strongly 
suggest that the substrate-binding features of the omega-
GSTs have been conserved in CLIC4 along with the fold it-
self, and that substrate binding is a prerequisite for CLIC4 
translocation.
Discussion
In this study we analyze the transient translocation of 
CLIC4 towards the plasma membrane upon stimulation 
of G(α)13-coupled GPCRs (Fig. 1). CLIC4 translocation 
is strictly dependent on G(α)13-mediated activation of 
RhoA (Fig. 2). Further, we find that the activated GPCR 
(complex) itself forms the anchor for CLIC4 translocation, 
explaining the rapid agonist-induced recruitment and 
receptor-specific distributions along the plasma membrane 
(Fig. 4). Whether translocated CLIC4 interacts directly 
or indirectly with the activated receptor awaits further 
studies. We identified six conserved residues essential 
for translocation, whose equivalents in the omega-GST 
enzymes serve substrate recognition (Fig. 5), putting the 
GST-derived features of the CLICs in a new perspective. 
Although it is tempting to hypothesize that plasma 
membrane translocation of CLIC4 (chloride intrancellular 
channel) underlies the LPA-induced chloride efflux de-
scribed previously [20,21], we failed to prove a causal re-
lationship. Neither membrane insertion of HA-CLIC4 (Fig. 
3B) nor modulation of LPA-induced currents by altering 
CLIC4 expression levels (Fig. 3A) could be observed. In 
addition, the translocation was eliminated upon disrup-
tion of the actin cytoskeleton using Latrunculin A, further 
dissociating CLIC4 translocation from the Latrunculin 
A-insensitive chloride channel activity (Fig. 2D). Similar 
results have been described for CLIC5 overexpressed in 
JEG-3 placental cells, although chloride channel activ-
ity was detectable in vitro [17]. It must be emphasized, 
however, that the present study was restricted to GPCR 
signaling in N1E-115 cells, hence the membrane-insertion 
model cannot be excluded for other cell systems or other 
subcellular organelles. This is underlined by the increased 
anion conductances demonstrated by electrophysiological 
characterization of CLIC4 overexpressed in HEK293 cells 
[29]. However, in these cells CLIC4 levels are unphysi-
ologically high (unpublished observation), possibly driv-
ing the spontaneous occurrence of artificial membrane 
insertion. Furthermore, membrane insertion triggered by 
endogenous signaling cascades has never been report-
ed. Finally, the observed effects on electrical membrane 
properties [29] might be explained by CLIC4 regulating 
alternative chloride channels. Tonini and coworkers [30] 
combined patch-clamp analyses with intracellular appli-
cation of antibodies via the recording pipette and found 
that antibody binding to the FLAG-epitope of CLIC1 fu-
sion constructs prevented the conductance increase only 
when the FLAG-tag was fused to the N-terminus. These 
experiments attribute a role to the N-terminus of (over-
expressed) CLIC1 in the transmembrane chloride conduc-
tance, but do not (as the authors claim) provide evidence 
for actual membrane insertion, since a regulatory role for 
CLIC4 cannot be excluded. Thus, the physiologically regu-
lated membrane insertion of endogenous CLIC proteins 
still awaits direct proof.
Another conceptual problem of N-terminal membrane 
insertion is the incompatibility with the high structural sim-
ilarity of the N-terminus with the cytosolic GST proteins. 
This has necessitated a model wherein the CLICs dynami-
cally switch from a soluble GST-fold to a transmembrane 
state [15,28]. We found that six conserved residues, 
whose equivalents in GST proteins interact with substrates 
of glutathione-conjugation, are indispensible for CLIC4 
translocation (Fig. 5). This underscores the importance 
of the GST-fold for substrate recognition in the anchoring 
receptor complex (Fig 4) rather than for switching to a 
membrane insertion domain (Fig. 3). Thus we ascribe an 
essential role to the enigmatic structural GST-homology 
of CLIC4. Despite the facts that GST functions are tightly 
CLIC4 translocation
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associated with redox-regulated conjugation processes 
and that in vitro channel properties of CLIC4 are redox-
sensitive, we find that CLIC4 translocation is insensitive to 
redox potential. Therefore, it remains uncertain whether 
CLIC4 translocation involves a GST-like enzyme activity 
or only the GST-derived substrate binding features. An 
interesting possibility is that the GST-homolgy domain is 
specialized to recognize a post-translationally modified 
binding partner. Such post-translational regulation could 
explain the transient nature of CLIC4 translocation. Fur-
ther structural understanding of the interaction will likely 
follow from identifying the direct binding partner in the 
activated GPCR complex.
As for the translocation of CLIC4, we have not yet de-
termined whether the interaction with the activated GPCR 
is direct or indirect. In this respect, it is interesting that 
CLIC4 binds directly to the C-terminal tail of the hista-
mine-receptor H3R [31], strengthening the link between 
CLIC4 and GPCRs. Likely, however, this interaction is func-
tionally distinct from the G(α)13-induced receptor recruit-
ment described here, since H3R does not couple to G(α)13. 
Furthermore, colocalisation with H3R appears to occur 
intracellularly and the authors did not show increased in-
teraction upon ligand stimulation. Our demonstration that 
translocating CLIC4 selectively migrates to a subpopula-
tion of locally activated receptors (Fig. 4F) indicates that 
the initiation of the translocation process is regulated 
at the level of the receptor complex rather than at the 
level of cytosolic CLIC4. Activated GPCRs are transiently 
decorated with a multitude of proteins, ranging from G 
protein subunits for downstream signaling to endocytosis 
machinery components for eventual receptor internalisa-
tion. Conceivably, one of these recruited proteins forms 
the temporary attractant in the dynamic process of CLIC4 
translocation. In this respect, it is interesting to note that 
Dynamin1 (Dnm1), a key player in receptor internalisa-
tion, has been found to directly interact with CLIC4 [32]. 
Still, this is a puzzling option, since we consider it unlikely 
that CLIC4 translocation is functionally linked to internali-
sation per se, because GPCRs that couple to other G pro-
teins (e.g. G(α)q, G(α)s or G(α)i; see Table 1) undergo 
dynamin-assisted internalization without recruiting CLIC4. 
Furthermore, our preliminary experiments showed that 
downregulation of CLIC4 does not prolong the kinetics of 
the LPA-induced MAP kinase response, suggesting that re-
ceptor internalisation was unchanged (data not shown). 
We speculate that CLIC4 recruitment to activated 
receptor complexes may play a role in the signal trans-
fer from G(α)13 to RhoA. First, this is expected to occur 
selectively on platforms of activated receptors, where 
we find translocated CLIC4. Second, we find that CLIC4 
translocation is unique for G(α)13-coupled receptors (Table 
1). Third, CLIC4 translocation requires RhoA in the acti-
vated, GTP-bound state (Fig. 2), possibly implying that 
its (activity-dependent) translocation to the plasma mem-
brane [33] is linked with that of CLIC4 (Fig. 2). Fourth, 
this hypothesis would explain why CLIC4 translocation is 
not affected by inhibition of any of the downstream Rho-
effectors ROCK, mDia, PKN (data not shown) and PIP(5)
Kinase (Table 1). We have interesting preliminary data 
showing that overexpressed mCherry-CLIC4(C35A) has a 
dominant negative effect on the LPA-induced translocation 
of co-expressed GFP-CLIC4. Importantly, these confocal 
timelapse recordings also reveal a loss of the LPA-induced 
contractile response (data not shown), suggestive of af-
fected RhoA signaling. This observation may indicate that 
translocatable CLIC4 is a prerequisite for signal transfer 
towards RhoA. In this context, it is interesting that G(α)12, 
a close family member of G(α)13, is directly linked to RhoA 
by the scaffold protein AKAP-Lbc [34]. Upon LPA stimula-
tion, G(α)12 activates AKAP-Lbc, which itself is a RhoA-
specific GEF [34]. Several other AKAP scaffolds directly 
interact with GPCRs [35], but for AKAP-Lbc this remains to 
be determined. Interestingly, the scaffold protein 14-3-3, 
which regulates the activation of RhoA by AKAP-Lbc [36], 
is a direct interactor of CLIC4 [32]. Furthermore, CLIC4 
interacts directly with the isoform AKAP350 [8,9]. Thus, 
it is tempting to speculate that CLIC4 translocates to a 
protein complex containing the activated receptor, G(α)13 
and an AKAP scaffold with GEF activity for RhoA. Further 
studies are required to test this hypothesis wherein CLIC4 
plays a central role in GPCR-Gα13-RhoA signaling. 
Materials and Methods
Reagents and antibodies
LPA, S1P, Y-27632, Wortmannin, Latrunculin A, sodium 
nitroprusside, N-acetyl-cysteine (NaC) and mouse 
monoclonal antibody were from Sigma Chemical Co. 
(St. Louis, MO). H2O2 was from MERCK chemicals. PTX 
was from List Biol. Laboratories (Campbell, California). 
Thrombin Receptor-activating Peptide (TRP, amino acid 
sequence SFLRRN) was synthesized in our institute. 
C3-toxin was received from Shuh Narumiya (Kyoto 
University). CLIC4 rabbit polyclonal was generated in 
the institute of MB;; HA rat monoclonal (3F10) was from 
Roche (Inc.); GFP rabbit polyclonal was generated in our 
institute (WHM); HRP-conjugated secondary antibodies 
were from DAKO. 
DNA constructs
The following expression vectors were described 
elsewhere: CFP-CAAX and YFP-CAAX [37], H2B-CFP [38]. 
Vector containing HA-tagged α1a-adrenergic receptor 
was purchased form www.cdna.org. For generation 
of GFP-CLIC4, CLIC4 cDNA was isolated from human 
placenta (clone 11-1a) using a forward primer with a 
BamHI adaptor im iately preceeding the endogenous 
start codon (CGCG/GATCC ATG GCG TTG TCG ATG CCG C) 
and a reverse primer with a HindIII adaptor immediately 
following the endogenous stop codon (GCA/AGCTT TTA 
CTT GGT GAG TCT TTT GGC). PCR product was subcloned 
into PCR2.1 Topo vector and from this a Bam-HI insert 
was ligated into peGFP-C1 vector and verified for proper 
orientation by sequencing. CFP-, YFP- and HA-CLIC4 were 
made by substituting GFP of GFP-CLIC4 with fluorophores 
from peCFP-C1, peYFP-C1 (NheI/KpnI) or oligonucleotides 
containing coding sequence for HA flanked by restriction 
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For translocation studies, series of 
confocal images were taken at 5 
or 10 s intervals. To quantitatively 
express the translocation of 
GFP- or YFP-CLIC4, the ratio of 
PM to cytosolic fluorescence was 
calculated by post-acquisition, 
automated assignment of regions 
of interest (ROI) using Leica Qwin 
software (see also van der Wal et 
al. [37]). 
Immunofluorescence stainings
Cells were fixed in paraformaldehyde 
(PFA) or (for endogenous CLIC4) 
methanol, permeabilized using 
0.1% Triton X100, blocked in 2% 
BSA, incubated with primary antibody and subsequently 
with Alexa-conjugated secondary antibodies. Mounted 
slides were examined on Leica TCS-SP5 confocal 
microscope (63x lense, N.A. 1.4). Immunofluorescence 
experiments attempting to detect externalized HA-epitope 
of overexpressed HA-CLIC4 (Fig 3) were performed under 
strictly non-permeabilizing conditions, i.e. without Triton 
X100-treatment and with PFA as a fixative. However, 
because even optimized conditions cannot exclude plasma 
membrane perforation on a subcellular scale (e.g. by 
shear stress, salt precipitation or cell death), we verified 
plasma membrane integrity for every studied cell by co-
staining of co-transfected H2B-CFP; this internal control 
showed immunostained H2B-CFP in ~2% of studied cells, 
underlining the potential for false positive results. Parallel 
experiments on cells transfected with the a1a adrenergic 
receptor (HA-a1a-R), which externalizes the N-terminal 
HA-tag with approx. the same number of externalized 
residues as the postulated CLIC4 externalization (~34, 
[15]), confirmed high effectiveness and signal strength of 
the HA immunostaining procedure.
Membrane potential recordings in N1E-115 cells
N1E -115 cells were loaded with fluorescent dye from the 
FLIPR Membrane Potential Assay Kit (Molecular Devices 
Inc., R8128) for 5-10 minutes and mounted on an inverted 
Zeiss microscope (40x lense, N.A. 1.2). Excitation was at 
515 nm from a monochromator Hg-lamp, fluorescence 
(longpass filtered >540 nm) was detected with a 
photonmultiplier tube (PMT) and excitation intensity was 
adapted to yield a standardized baseline output signal. 
Diafragms were used to collect emission selectively from 
transfected cells (discriminated by H2B-CFP transfection 
marker using 425 nm excitation light).
Dynamic monitoring of YFP/CFP FRET was performed 
as described in van der Wal et al., [37].
Patch clamp recordings
Electrophysiological recordings were collected using the 
HEKA EPC9 system. Current recordings were digitized 
at 100 kHz or 10 Hz (steady-state whole-cell currents). 
sites NheI/KpnI. For fluorophore-tagging at the C-terminus, 
CLIC4 insert was isolated from template GFP-CLIC4 by 
PCR (forward primer AGCTGATATCTGATGGCGTTGTCGAT; 
reverse primer AAAAGACTCACCAAGGCTAGCAGCT) and 
ligated (EcoRV/NheI) into pcDNA3.1 vectors containing 
YFP or mCherry C-terminal to a multiple cloning site 
(MCS). Point mutations in YFP-CLIC4 were generated 
using Phusion Site-Directed Mutagenesis Kit (Finnzymes 
Inc.) and verified by sequencing analysis. 
Generation of GFP-CLIC1 and CLIC1-YFP was identi-
cal to the approach followed for CLIC4 constructs. RNAi 
constructs were made by insertion (BglII/HindIII) of or-
dered oligonucleotides into empty pSuper-vector (Brum-
melkamp et al, 2002) and verified by sequencing analysis. 
Target sequences are listed below. 
YFP-mDia1(FHZ∆N) was a kind gift from Art Alberts, 
DsRed-NHERF2 was a kind gift from Th. Gadella, pSuper-
RNAi-RhoA was a kind gift from J. Collard. 
Cell Culture, transfections and live cell experiments 
N1E-115 neuroblastoma cells and HEK293, Rat-1, MDCK, 
HeLa and A431 cells were cultured in DMEM. Cells were 
seeded and cultured on glass coverslips and constructs 
were transiently transfected using Fugene 6 Transfection 
Reagent (Roche Inc.). Experiments were performed in a 
culture chamber mounted on an inverted microscope in 
bicarbonate-buffered saline (containing, in mM, 140 NaCl, 
5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, 23 NaHCO3, with 10 
mM HEPES added), pH 7.2, kept under 5% CO2, at 37°C. 
Agonists and inhibitors were added from concentrated 
stocks.
Live-cell confocal imaging and image analysis
Coverslips with cells expressing various constructs were 
mounted in a culture chamber and imaged using an 
inverted TCS-SP5 confocal microscope equipped with 
63x immersion oil lense (N.A. 1.4) (Leica, Mannheim, 
Germany). Imaging conditions were: CFP, excitation at 
442 nm, emission at 465-500 nm; GFP, exc. at 488 nm, 
em. at 510-560 nm; YFP, exc. at 514 nm, em. at 522-
570 nm; mCherry, exc. at 561 nm, em. at 580-630 nm. 
Table of the used RNAi targeting sequences
CLIC4 translocation
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Borosilicate glass pipettes were fire-polished to 2–4 MΩ. 
After establishment of the GΩ seal, the patched membrane 
was ruptured by gentle suction to obtain whole-cell 
configuration. Solutions were (in mM) 120 whole-cell 
pipette potassiumglutamate, 30 KCl, 1 MgCl2, 0.2 CaCl2, 
1 EGTA, 10 HEPES, pH 7.2, and 1 MgATP; 140 external 
solution NaCl, 5 KCl, 0–1 MgCl2, 0–10 CaCl2, 10 HEPES, 
and 10 glucose adjusted to pH 7.3 with NaOH. 
Co-immunoprecipitation, SDS-PAGE and 
immunoblotting
Cells were harvested in Laemmli sample buffer (LSB), 
boiled for 10 min. and subjected to immunoblot analysis 
according to standard procedures. Filters were blocked 
in TBST/5% milk, incubated with primary and secondary 
antibodies, and visualized by enhanced chemoluminescence 
(Amersham Pharmacia). For immunoprecipitation of HA-
LPAR2, cells were harvested in lysis buffer containing1% 
NP-40, 0.25% sodium desoxycholate, supplemented 
with protease inhibitor cocktail (Roche). Lysates were 
spun down and the supernatants were subjected to 
immunoprecipitation using protein A beads-conjugated 
antibodies for 4 hrs at 4°C. Beads were dissolved in 
LSB, proteins were eluted by sonication and analyzed 
by SDS page and immunoblotting according to standard 
protocols.
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Abstract
Epac1 is a GEF for the small G-protein Rap and is directly activated by cAMP. Upon cAMP binding, Epac1 
undergoes a conformational change that allows interaction of its GEF domain with Rap, resulting 
in Rap activation and subsequent downstream effects, including integrin-mediated cell adhesion 
and cell-cell junction formation. Here, we report that cAMP also induces the translocation of Epac1 
towards the plasma membrane. Combining high-resolution confocal fluorescence microscopy with 
TIRF and FRET assays, we observed that Epac1 translocation is a rapid and reversible process. This 
dynamic redistribution of Epac1 requires both the cAMP-induced conformational change as well as 
the DEP domain. In line with its translocation, Epac1 activation induces Rap activation predominantly 
at the plasma membrane. We further show that the translocation of Epac1 enhances its ability to 
induce Rap-mediated cell adhesion. Thus, regulation of Epac1-Rap signaling by cAMP includes both 




cAMP is an important second messenger that mediates 
many cellular hormone responses. It has become more 
and more appreciated that along with the cAMP effector 
protein kinase A (PKA), Epac proteins also play pivotal 
roles in many cAMP-controled processes, including insulin 
secretion [1.2], cell adhesion [3-7], neurotransmitter re-
lease [8-10], heart function [11-13] and circadian rhythm 
[14]. Epac1 and Epac2 are cAMP-dependent guanine nu-
cleotide exchange factors (GEFs) for the small G-proteins 
Rap1 and Rap2 [15,16]. They contain a regulatory region 
with one (Epac1) or two (Epac2) cAMP-binding domains, 
a Dishevelled, Egl-10, Pleckstrin (DEP) domain, and a 
catalytic region for GEF activity [17]. Binding of cAMP is a 
prerequisite for catalytic activity in vitro and in vivo [17]. 
Recently, the structure of both the inactive and active 
conformation of Epac2 was solved [18,19]. This revealed 
that in the inactive conformation the regulatory region oc-
cludes the Rap binding site, which is relieved by a confor-
mational change induced by cAMP binding. 
Like all G-proteins of the Ras superfamily, Rap cycles 
between an inactive GDP-bound and active GTP-bound 
state in an equilibrium that is tightly regulated by specific 
GEFs and GTPase-activating proteins (GAPs). GEF-induced 
dissociation of GDP results in the binding of the cellular 
abundant GTP, whereas GAPs enhance the intrinsic GT-
Pase activity of the G-protein, thereby inducing the inac-
tive GDP-bound state. Besides Epac, several other GEFs 
for Rap have been identified, including C3G, PDZ-GEF and 
RasGRP, and these act downstream of different signaling 
pathways [20]. Since Rap localizes to several membrane 
compartments, including the Golgi network, vesicular 
membranes and the plasma membrane [21-26], spatial 
regulation of its activity is expected to be established by 
the differential distributions of its upstream GEFs, each 
activating distinct pools of Rap on specific intracellular lo-
cations. 
Similar to Rap, Epac1 is also observed at many loca-
tions in the cell, including the cytosol, the nucleus and the 
nuclear envelope, endomembranes and the plasma mem-
brane [17,27,28-31]. These various locations may reflect 
the many different functions assigned to Epac1, such as 
regulation of cell adhesion, cell junction formation, secre-
tion, regulation of DNA-PK by nuclear Epac1, and regula-
tion of the Na+/H+ exchanger NHE3 at the brush borders 
of kidney epithelium [29,32,33]. Apparently, specific an-
chors are responsible for this spatial regulation of Epac1. 
Indeed, Epac1 was found to associate with phosphodi-
esterase 4 (PDE4) in a complex with mAKAP in carcio-
myocytes [11], with MAP-LC bound to microtubules [34] 
and with Ezrin at the brush borders of polarized cells (M. 
Gloerich, J. Zhao and J.L. Bos, in preparation). 
In this study, we report the unexpected observation 
that, in addition to the temporal control of Epac1 activ-
ity, cAMP also induces translocation of Epac1 towards 
the plasma membrane. Using confocal fluorescence mi-
croscopy, Total Internal Reflection Fluorescence (TIRF) 
microscopy and Fluorescence Resonance Energy Transfer 
(FRET)-based assays for high spatial and temporal resolu-
tion, we observed that translocation of Epac1 is immedi-
ate and that Epac1 approaches the plasma membrane to 
within ~7 nm. In line with this, Epac1-induced Rap activa-
tion was registered predominantly on this compartment. 
Epac1 translocation results directly from the cAMP-induced 
conformational change and depends on the integrity of 
its DEP domain. We further show that Epac1 transloca-
tion is a prerequisite for cAMP-induced Rap activation at 
the plasma membrane and enhances Rap-mediated cell 
adhesion. Thus, cAMP exerts dual regulation on Epac1 for 
the activation of Rap, controling both its GEF activity and 
targeting to the plasma membrane.
Results 
cAMP induces translocation of Epac1 towards the 
plasma membrane
To study the subcellular localization of Epac1 during acti-
vation by cAMP, we monitored GFP-Epac1 using time lapse 
confocal imaging in HEK293 cells. In accordance with pre-
vious reports [17,27,28,30,31], GFP-Epac1 is observed 
at the nuclear envelope, at the plasma membrane (PM), 
at endo-membranes and in the cytosol. Upon addition of 
forskolin, which activates adenylate cyclase to produce 
cAMP, we observed a pronounced redistribution of GFP-
Epac1 towards the periphery of the cell (Fig. 1A and Suppl 
Movie). Automated image analysis [35] showed that the 
GFP-Epac1 redistribution is manifest both as a decrease 
in cytosolic fluorescence and an increase in PM-localized 
fluorescence, occurring within 2 minutes after stimulation 
(τ1/2 ~40 s; Fig. 1A). In contrast, fluorescence in the nu-
cleus was constant throughout the experiment (Fig. 1A). 
We also employed Total Internal Reflection Fluorescence 
(TIRF) microscopy to monitor GFP-Epac1 selectively at the 
basal membrane. We observed forskolin-induced accumu-
lation of GFP-Epac1 as an increase of 60 +/- 4 % (mean 
+/- SEM; n=17) relative to pre-stimulus levels (Fig 1B), 
suggesting that Epac1 translocation represents a large-
scale recruitment to the PM.
Similarly, isoproterenol stimulation, which induces 
physiological cAMP increases via activation of β-adrenergic 
receptors, induced rapid Epac1 translocation in A431 cells 
(Fig. 1C). Epac1 translocation was observed in all cell 
types tested (HEK293, A431, OVCAR-3, ACHN, RCC10, 
MDCK, N1E-115, HeLa, Rat-1, GE11, H1299) and over the 
full range of expression levels (data not shown). Impor-
tantly, staining of OVCAR-3 cells with a monoclonal Epac1 
antibody showed an increased presence of endogenous 
Epac1 at the PM after treatment with forskolin, reflect-
ing the PM-translocation of endogenous Epac1 (Fig. 1D). 
Similar results were obtained with a polyclonal Epac1 an-
tibody (data not shown).  
Due to the limited resolution of conventional confocal 
and TIRF microscopy (~300 nm and ~90 nm, respective-
ly) it is difficult to judge whether GFP-Epac1 indeed trans-
locates to the PM or, alternatively, merely to the cortical 
actin cytoskeleton just below it. Therefore, we monitored 
Fluorescence Resonance Energy Transfer (FRET) between 
YFP-Epac1 and CFP-CAAX, which is membrane-anchored 
by its prenylated K-Ras CAAX-motif and in these cells con-
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stitutes a marker of the PM (see M&M). Forskolin induced 
immediate increases in the YFP/CFP ratio (10-15%, Fig. 
1E), indicating that translocated GFP-Epac1 approaches 
the PM to within approximately 7 nm. Similar results were 
obtained using a C-terminally tagged Epac1 (data not 
shown). 
The translocation of Epac1 can also be induced by 
the Epac-specific cAMP analogues 8-pCPT-2’-O-Me-cAMP 
(007) [36] and the more cell-permeable 8-pCPT-2’-O-Me-
cAMP-AM (007-AM) [37; chapter 9 of this thesis] (Fig. 1E), 
suggesting that cAMP induces Epac1 translocation through 
activation of Epac1 itself rather than via parallel pathways 
such as PKA. Indeed, Epac1(R279L), which is mutated in 
the cAMP binding domain and thereby locked in the au-
to-inhibited, inactive conformation ([31]; see also FRET 
analysis on CFP-Epac1(R279L)-YFP and the wildtype sen-
sor in Fig. 1F), lacked the ability to translocate (Fig. 1G), 
indicating that Epac1 must be in its open conformation to 
translocate. In addition, forskolin-induced translocation of 
GFP-Epac1 was not affected by inhibition of PKA with H89 
(data not shown). Thus, we show that Epac1 translocates 
towards the PM when it is bound by cAMP.
Figure 1.   Epac1 
translocates towards 
the PM upon elevation 
of cAMP levels
A) In HEK293 cells stimulation 
with forskolin (25 μM) induces 
translocation of GFP-Epac1 
towards the cell periphery. 
Inset: fluorescence intensity 
along the red line, showing 
sharp demarcation of the 
plasma membrane (width at 
half-maximum ~300 nm). 
Right: fluorescence intensity 
at the plasma membrane 
(red, PM) and in the cytosol 
(blue, Cyt) as well as the 
ratio PM/Cyt (green) during 
the response to forskolin; 
fluorescence levels in 
the nucleus (grey, Nucl) 
were constant. Traces are 
representative for n>15. 
B) Representative TIRF experiment showing the 
forskolin-induced accumulation of GFP-Epac1 
at the basal membrane of HEK293 cells. Mean 
increase relative to pre-stimulus levels was 60 
+/- 4% (mean +/- SEM; n=17).
C) A431 cells expressing GFP-Epac1 were 
imaged during isoproterenol (1 nM) stimulation. 
Translocation of GFP-Epac1 was observed within 
1 minute (n=8). 
D) Immunofluorescence of OVCAR-3 cells stained 
for endogenous Epac1. In resting cells little PM 
localization of Epac1 is observed. After forskolin 
stimulation (25 μM, 10 min) the amount of PM-
localized Epac1 is markedly increased. Note that 
the nuclear immunofluorescence is background 
staining rather than Epac1, as it insensitive to 
siRNAi-mediated silencing of Epac1 (data not 
shown). 
E) Measurement of FRET between the PM-marker 
CFP-CAAX (see M&M) and translocating YFP-tagged Epac1 (traces are representative for n>5). FRET, expressed as YFP/CFP ratio, 
increases upon addition of forskolin (25 μM, black). FRET increases were also induced by the Epac-specific cAMP analogue 8-pCPT-
2´-O-Me-cAMP (007, 100 μM; blue) or the more membrane-permeable analogue 8-pCPT-2´-O-Me-cAMP-AM (007-AM, 1 μM; red). 
F) Forskolin (25 mM) treatment of HEK293 cells transfected with the FRET sensor CFP-Epac1-YFP. The sensor reports the cAMP-
induced conformational change as a loss of intramolecular FRET. In contrast to the wild-type sensor (red), the mutant FRET construct 
CFP-Epac1(R279L)-YFP (blue) lacks the ability to change conformation upon changing cAMP concentrations. 
G) Mutagenesis of Arginine279 to Leucine eliminated the ability of YFP-Epac1(R279L) to translocate upon forskolin stimulation (25 
μM). Scale bars: 10 mm.
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Epac1 translocation dynamically follows cAMP 
levels 
High-resolution confocal imaging shows that translocat-
ing GFP-Epac1 is recruited from a homogeneous cytosolic 
pool. Indeed, fast FRAP experiments [35] confirmed that 
the mobility of GFP-Epac1 approaches that of free GFP 
(data not shown). Conversely, active transport appears 
not to be involved, since Epac1 translocation is insensitive 
to disruption of the actin cytoskeleton (Cytochalasin D, 
1μg/ml, or Latrunculin A, 1μM) or the microtubule net-
work (Nocodazol, 25 ng/ml) (data not shown). Thus, upon 
cAMP-binding Epac1 finds the PM by passive diffusion.
To examine the dynamics of Epac1 translocation, we 
loaded HEK293 cells with NPE-caged cAMP and transiently 
released cAMP by UV-induced photolysis of the NPE-cage. 
Using CFP-Epac(∆DEP-CD)-Venus [38], an improved vari-
ant of the previously published cAMP sensor [39], we first 
established experimental conditions to instantly saturate 
Epac1 with cAMP (Fig. 2A). When applying identical UV 
pulses to cells expressing comparable levels of GFP-Epac1, 
we observed very rapid translocation that was halfway 
within 5 seconds and near-complete in approximately 20 
seconds (Fig. 2A). 
To investigate whether PM recruitment of Epac1 is 
a reversible event, we photoreleased NPE-caged cAMP in 
GE11 cells, which rapidly clear cAMP, likely due to high 
PDE activity [39,40]. This allowed cAMP transients to be 
evoked repetitively, as detected by the FRET-based cAMP 
sensor (Fig. 2B). When similar amounts of cAMP were re-
leased in GE11 cells expressing GFP-Epac1, we observed 
rapid translocations to the PM followed by relocation to the 
cytosol (Fig. 2B). Analyses of the PM/cytosol ratio show 
that the translocation kinetics closely resemble the dy-
namic course of the cAMP levels. These experiments indi-
cate that Epac1 translocation is a rapidly reversible event 
and that the momentaneous cAMP levels dictate the de-
gree of PM localization. 
 
Epac1 conformational change rather than 
downstream signaling is required for its 
translocation
As opening up of Epac1, which is essential for cAMP-in-
duced translocation (Fig. 1G), also releases its catalytic 
activity, we examined whether downstream signals may 
be required for its recruitment to the PM. As shown in 
Fig. 3A, overexpression of RapGAP1 inhibits cAMP-in-
duced Rap activation by keeping both Rap1 and Rap2 in 
the GDP-bound, inactive state. RapGAP1 overexpression 
did not affect the translocation of GFP-Epac1 (Fig. 3A,B), 
suggesting that Rap activity is not required. In line with 
this, co-expression of constitutively active Rap1A(G12V) 
did not affect GFP-Epac1 localization in unstimulated cells 
(Fig. 3A), nor did it affect the magnitude or kinetics of the 
007-AM-induced translocation (Fig. 3A,B). Furthermore, 
in OVCAR-3 cells, the cAMP-binding mutant Epac1(R279L) 
does not translocate when Rap is transiently activated 
through activation of endogenous Epac1 (data not shown). 
Taken together, these data indicate that Epac1 transloca-
tion results from its conformational change rather than 
downstream signaling via Rap. This was further supported 
by using the CFP-Epac1-YFP probe, that allows the simul-
taneous visualization of localization as well as conforma-
tional state via intramolecular FRET. These experiments 
showed that the kinetics of Epac1 translocation closely fol-
low those of its conformational state (Fig. 3C).
The DEP domain is essential but not sufficient for 
Epac1 translocation 
To determine which domains of Epac1 are involved in the 
translocation, a series of deletion mutants were analyzed 
(Fig. 4A). Removal of the DEP domain, which is essential 
for proper intracellular targeting and functioning of DEP 
domain-containing proteins such as Dishevelled [39] and 
numerous RGS proteins [27,41-45], completely abolished 
Epac1 translocation (Fig. 4B). Mutation of Argenine 82 
Figure 2.   Epac1 
translocation is a 
highly dynamic and 
reversible event
A) cAMP-uncaging 
experiments in HEK293 
cells. Upper trace: release 
of NPE-caged cAMP 
(arrows; see methods for 
details) saturated the FRET-
based cAMP sensor CFP-
Epac(∆DEP)C.D.-Venus in 
that a subsequent UV-flash 
did not induce further FRET 
changes. Lower trace: ratio 
between PM and cytosolic 
fluorescence of GFP-Epac1 (expressed at comparable levels as CFP-Epac1(∆DEP)C.D.-Venus) showing the immediate translocation 
upon identical photolysis of caged-cAMP (τ1/2 < 5s). 
B) cAMP-uncaging in GE11 cells. Upper trace: due to high speed of cAMP clearing in these cells, dosed release of NPE-caged cAMP 
evokes transient cAMP rises. Amounts of released cAMP are approximately proportional to the duration of UV flashes. Lower trace: 
release of identical amounts of caged cAMP in GE11 cells induces transient translocations of GFP-Epac1. The PM/cytosol ratio shows 
that the degree of translocation correlates with the dose of released cAMP.
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within the DEP domain of Epac1, which localizes within a 
proposed interaction surface crucial for the DEP-mediated 
targeting of Dishevelled-1 and Ste2 [46-49], also abol-
ished the cAMP-induced translocation, further illustrating 
the critical role of the DEP domain in mediating the cAMP-
induced translocation. Nonetheless, GFP-DEP (comprising 
amino acids 50-148) was not observed at the PM (data 
not shown). Similarly, the YFP-tagged regulatory region of 
Epac1 (YFP-Epac1-Reg), comprising the DEP domain and 
the cAMP binding domain, did not localize at the PM nor 
did it translocate to the PM upon cAMP elevations (Fig. 
4A,B). However, application of 007-AM to cells transfected 
with both YFP-Epac1-Reg and the CFP-tagged comple-
mentary catalytic region of Epac1 (CFP-Epac1-Cat), which 
are able to reconstitute the structure of the full length 
protein (data not shown), induced the combined translo-
cation of both fragments (Fig. 4C). This demonstrates that 
the DEP domain is required for the translocation of Epac1 
to the PM, but that it can function only in conjunction with 
the catalytic region.
Epac1 translocation enhances Rap-dependent cell 
adhesion 
As the main pool of Epac1 redistributes to the PM after 
its activation, we explored whether the translocation of 
Epac1 is a prerequisite for activation of Rap at this com-
partment. For this, HEK293 cells were transfected with 
the YFP-tagged Ras-binding domain (RBD) of RalGDS 
(YFP-RBD(RalGDS)), which recognizes Rap1 specifically in 
its GTP-bound, activated state [23]. When cells were co-
transfected with HA-Epac1, addition of 007-AM resulted in 
the rapid accumulation of YFP-RBD(RalGDS) at the PM, as 
visualized both by TIRF (Fig 5A, left panel) and confocal 
microscopy (right panel). Interestingly, such accumula-
tion was not observed on other subcellular compartments, 
suggesting that in HEK293 cells cAMP signaling via Epac1 
activates Rap predominantly at the PM (Fig 5A). To test for 
the role of Epac1 translocation in Rap activation at the PM, 
we compared YFP-RBD(RalGDS) membrane recruitment 
in cells expressing either CFP-Epac1 or CFP-Epac1(∆DEP) 
by TIRF microscopy. 007-AM induced recruitment of the 
probe to the basal membrane in cells expressing CFP-
Epac1 (12 of 14 cells), whereas this was almost absent in 
cells co-expressing CFP-Epac1(∆DEP) (1 of 9 cells; p<< 
0.01; Fig. 5B). Thus, translocation of Epac1 is required for 
Rap activation at the PM. 
Epac1-Rap signaling is involved in integrin-mediated 
cell adhesion by regulating both the affinity and avidity 
of actin-associated integrin molecules [50]. For Jurkat T-
cells, it has been shown that this requires the presence 
of active Rap at the PM [23]. To study the role of Epac1 
translocation in its ability to mediate integrin regulation, 
we measured adhesion of Jurkat T-cells in response to 
007. For this, the cells were transfected with luciferase 
together with either wild-type Epac1 or the non-translo-
cating Epac1 variants mutated in their DEP domain, and 
Figure 3.    Rap activity is not involved in Epac1 translocation
A) Western blot: Rap activation assay (see methods) confirming that 
RapGAP1 overexpression effectively inhibits 007-AM-mediated activation 
of Rap1 and Rap2. Images: HEK293 cells expressing GFP-Epac1 plus 
overexpressed RapGAP1 (left) or constitutively active Rap1A(G12V) (right). 
Neither RapGAP1 nor Rap1A(G12V) overexpression had any effect on the 
distribution of unstimulated GFP-Epac1 (upper panels) or on the 007-AM-
induced translocation (lower panels). Scale bars: 10 μm
B)  Kinetic analyses were performed on cells transfected as in Fig. 3A. 
Kinetics of the 007-AM-induced translocation of GFP-Epac1 (black) were not 
affected by co-expression of RapGAP1 (dotted line) or Rap1A(G12V) (grey). 
Translocation was quantified from depletion of cytosolic fluorescence. Per 
condition, traces of >10 experiments were averaged after normalization to 
basal level (set to 100%) and end level (set to 0%).
C)  A431 cells expressing CFP-Epac1-YFP were imaged by simultaneous detection of CFP- and YFP emission (see Materials and 
Methods) allowing the analysis of both Epac1 activation state (FRET, Ratio YFP/CFP, upper trace) and its translocation to the PM 
(Ratio PM/Cyt, lower trace). Submaximal stimulation of A431 cells with 0.5 nM isoproterenol evokes slow cAMP accumulation and 
thereby induces gradual activation of Epac1; subsequently, forskolin (25 mM) was added to saturate CFP-Epac1-YFP. The experiment 
illustrates that the kinetics of the construct´s PM-translocation strongly resemble its gradual activation (representative for n=6).
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adhesion was quantified by detection of luciferase emis-
sion. Indeed, 007 induced strong adhesion to fibronectin 
of wildtype Epac1-transfected cells (Fig. 5C). In contrast, 
this cAMP-induced effect on cell adhesion was impaired 
when the translocation-deficient mutants Epac1(∆DEP) or 
Epac1(R82A) were expressed (Fig. 5C). Rap1-GTP pull-
down experiments in Jurkat T-cells show that expres-
sion of these mutants indeed result in less Rap1 activa-
tion compared to wildtype Epac1 (Fig. 5D), implying that 
a significant fraction of Rap1 resides at the PM in these 
cells. These data indicate that the translocation of Epac1 
significantly enhances the signaling cascade towards Rap-
mediated cell adhesion. 
Discussion
In the current study we have shown that cAMP induces 
the translocation of cytosolic Epac1 towards the PM. Epac1 
translocation is a generally occurring, physiological event, 
as it was observed in a wide array of cell types, both 
with overexpressed and endogenous Epac1 (Fig. 1). The 
translocation depends solely on the cAMP-induced confor-
mational state of Epac1, since it could be induced by the 
Epac-selective analogue 007(-AM) and was prevented by 
a mutation in the cAMP binding pocket (R279L, Fig. 1F,G). 
Furthermore, since neither activation nor inhibition of Rap 
could affect Epac1 translocation, involvement of Rap-me-
diated signaling could be excluded (Fig. 3). Finally, the 
degree of Epac1 translocation closely followed the levels 
of free cAMP within the cells and showed similar kinetics 
as the cAMP-induced conformational change (Fig. 2 and 
Fig 3C). Thus, in addition to releasing Epac1 from auto-
inhibition, direct binding of cAMP also regulates the trans-
location of Epac1 towards the PM. 
Epac1 translocation is based on passive diffusion, 
since fluorescence distribution in the cytosol is homoge-
neous throughout the translocation without discernible 
discrete moving structures that would indicate active 
transport. In line with the diffusion model, Epac1 trans-
location shows rapid and reversible kinetics after cAMP-
uncaging (Fig. 2) and is not affected by disruption of 
the actin cytoskeleton or the microtubule network (data 
not shown). These data imply that upon transition to its 
opened conformation, Epac1 acquires an affinity for an 
anchoring factor at the PM, to which it is subsequently 
targeted via passive diffusion.
Deletion and point mutations have indicated the DEP 
domain as an essential determinant of translocation. This 
Figure 4.     The DEP domain is essential but not sufficient for Epac1 translocation
A,B) Overview of Epac1-mutants and their abilities to translocate (TL) upon addition of 007-AM (1 mM). Full-length Epac1 consists 
of a DEP domain (amino acid 50-148), the cyclic nucleotide binding domain (CNB), the Ras exchange motive (REM), a putative 
Ras association (RA) domain and the catalytic CDC25 homology GEF domain. Removal of the DEP domain (amino acid 50-148) or 
disruption of the interaction surface within the DEP domain (R82A) abolishes the translocation of Epac1 in response to 007-AM. The 
separate regulatory region (YFP-Epac1-Reg, amino acid 1-328), containing both the DEP domain and cAMP binding domain (CNB), 
did not translocate after 007-AM stimulation, indicating that the DEP domain cannot mediate the localization of Epac1 at the PM in 
the absence of the catalytic region. In accordance with the crucial role of the DEP domain, the complete catalytic region (CFP-Epac1-
Cat, amino acid 330-881) was not present at the PM either. 
C)  In contrast to the separately expressed regulatory and catalytic region, coexpression of YFP-Epac1-Reg (upper panels) + CFP-
Epac1-Cat (lower panels) restored the 007-AM-induced translocation, resulting in colocalization of both constructs at the PM.
Scale bars: 10 μm
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is analogous to the targeting function of DEP domains in 
other proteins such as Dishevelled and RGS [1, 8, 27, 31, 
40]. However, crystal structure studies on Epac2 [52] sug-
gest that the DEP domain is solvent exposed regardless 
of cAMP binding. Therefore, a model wherein the cAMP-
induced conformational change renders the DEP domain 
accessible is unlikely. Indeed, the separate DEP domain or 
regulatory region of Epac1 did not localize to the PM (Fig. 
4). Thus, the DEP domain can only fulfill its function in 
the context of the structure of the full length protein. The 
interaction surface for PM anchoring is thus established 
by combined structural features of the DEP domain and a 
determinant in the catalytic region, which are dependent 
on the cAMP-bound conformation. The identification of the 
membrane anchor would likely help to define the underly-
ing structural mechanism.
Many downstream effects of Epac1 occur at the PM: 
cell adhesion, cell-cell junction formation and the regu-
lation of NHE3. These effects may require localized acti-
vation of Epac1 and, thereby, localized activation of Rap. 
Indeed, we showed that the translocation of Epac1 is a 
prerequisite for Rap activation (Fig 5B). Furthermore, 
translocation strongly enhances Rap-mediated cell adhe-
sion, as the translocation-deficient mutants Epac1(∆DEP) 
and Epac1(R82A) were impaired in their ability to induce 
Rap-dependent adhesion of Jurkat T-cells to fibronectin. 
It is important to note here, that purified Epac1(∆1-148) 
mediates GDP-dissociation from Rap1 in vitro equally well 
as full-length Epac1 does [51], indicating that the DEP 
domain is not required for the catalytic activity. The re-
sidual effect of the Epac1 mutants on cell adhesion may 
be due to the relatively high expression of Epac1 in this 
Figure 5.    The translocation of Epac1 enhances Rap activation and Rap-mediated adhesion of Jurkat T-cells
A)  Left panel, in vivo TIRF imaging of Rap1 activation in HEK293 cells using YFP-RalGDS(RBD). When co-expressed with HA-
Epac1, YFP-RalGDS(RBD) translocates to the basal membrane within seconds after 007-AM stimulation (1 μM). The 007-AM-
induced increase was 46 +/- 6 % (mean +/- SEM) relative to pre-stimulus levels (n=9). Right panel, confocal imaging of YFP-
RalGDS(RBD) translocation showing accumulation at the plasma membrane (PM) as well as the simultaneous depletion of cytosol 
(Cyt); fluorescence  in the nucleus was constant (Nucl). Accumulation of  YFP-RalGDS(RBD) was not observed on intracellular 
membranes. Scale bar: 10 mm.
B)  HEK293 cells were transfected with CFP-Epac1 or CFP-Epac1(∆DEP) and recruitment of co-transfected YFP-RBD(RalGDS) to 
the basal membrane was measured by TIRF microscopy. Cells expressing low levels of CFP- and YFP-tagged fusion proteins were 
selected. Traces are representative experiments. Bar graph shows relative occurrence of 007-AM-induced membrane accumulation 
of YFP-RBD(RalGDS): CFP-Epac1, 12 out of 14 cells; CFP-Epac1(∆DEP, 1 out of 9 cells) . 
C)  Jurkat T-cells were transfected with either wildtype Epac1 or the non-translocating Epac1 mutants (Epac1(∆DEP) and Epac1(R82A)) 
together with a luciferase reporter. Transfected cells were allowed to adhere to fibronectin-coated surface for 45 minutes and 
adhesion was subsequently detected as luciferase emission. Wildtype-Epac1, when activated by 007 (100 μM, black bars) greatly 
enhanced the adhesion as compared to unstimulated conditions (white bars). This effect was impaired when the translocation-
deficient mutants Epac1(∆DEP) or Epac1(R82A) were transfected and it was absent in empty vector-transfected cells (EV). Shown 
are data from a representative experiment performed in triplo (n=4). Total luciferase levels were comparable in all transfections. 
Right: western blot labeled with the Epac1 antibody (5D3) showing expression levels of the transfected wildtype- and mutant Epac1 
used in the adhesion assay. 
D) Jurkat T-cells were transfected with similar amounts of either wildtype Epac1 or the translocation-deficient mutants Epac1(∆DEP) 
and Epac1(R82A) and GTP-bound Rap1 was pulled down from lysates of cells after stimulation with 007 (100 μM, 10 min). 
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system, allowing a fraction of the mutant Epac1 to locate 
near the PM regardless of the DEP-dependent transloca-
tion, thereby activating Rap. Indeed, TIRF experiments 
showed membrane recruitment of YFP-RBD(RalGDS) in 
cells expressing CFP-Epac1(∆DEP) at relatively high levels 
(data not shown), but not at lower levels (Fig 5B).
Recently, the DEP domain of Epac1 has been shown 
to be essential for the ability of the regulatory region to 
disrupt TSH-mediated mitogenesis, further supporting the 
notion that proper localization of Epac1 via its DEP do-
main is required for its function [52]. Different anchors 
may target Epac1 to other cellular compartments and 
thereby regulate alternative functions of Epac1 that are 
not linked to (processes at) the PM. Indeed, in cardiomyo-
cytes Epac1 was found in a complex with muscle specific 
mAKAP, phosphodiesterase 4A and PKA to regulate ERK5 
activity [11]. Epac1 is also present at the nuclear mem-
brane (see Fig. 1A) and this binding is maintained during 
the early time points of cAMP stimulation, indicating that 
only a subfraction of Epac1 translocates to the PM. Thus, 
in this respect Epac1 resembles protein kinase A, which is 
targeted to distinct subcellular compartments through the 
binding to AKAPs. 
PM-localization has also been reported to be essential 
for signaling via Epac2, which is mediated by binding of its 
RA domain to activated Ras [30,53]. Originally this was 
proposed to be regulated by cAMP [30]. However, binding 
of Epac2 to Ras does not require the open conformation of 
Epac2 and is not affected by cAMP ([53] and Supplemen-
tal Fig 1). In addition, expression of an active Ras mutant 
suffices for targeting Epac2 to the PM [30,53]. Conversely, 
deletion of the putative RA domain within Epac1 does not 
affect its cAMP-induced translocation as demonstrated 
by increased FRET between CFP-CAAX and an YFP-Epac1 
mutant lacking the RA domain (see Supplemental Fig 2). 
These data exclude the possibility that the RA domain 
is the missing determinant within the catalytic region of 
Epac1. The different mechanisms of PM targeting distin-
guish the roles of Epac1 and Epac2, which may add to the 
understanding of their specific biological functions. 
Based on our data, we propose a model where bind-
ing of cAMP regulates Epac1 in two manners: it targets 
Epac1 towards the PM and simultaneously releases the 
activity of its GEF domain. Such dual regulation imposes 
signal specificity by guaranteeing that cAMP predominant-
ly affects PM-localized Rap molecules (Fig. 5A), whereas, 
for example, growth factors such as EGF activate a perinu-
clear pool of Rap [54]. Analogously, negative regulation of 
Rap by GAPs may also be spatially confined, as it has been 
reported that a PM pool of RapGAP restricts Rap activation 
in COS1 cells [55]. Thus, it appears that the localization 
of GEFs and GAPs rather than that of the G-protein itself 
determines the intracellular location of G-protein activity. 
We can only speculate why the activation of Epac1 is 
dynamically regulated by the simultaneous cAMP-depen-
dent translocation rather than by more static confinement 
via stable association to the PM. The translocation mecha-
nism may serve to dynamically regulate the availability 
of Epac1 throughout the cell. In addition, the separation 
between Epac1 and Rap in resting conditions may be an 
ultimate guarantee against stimulation of Rap by residual 
Epac1 activity. Adding a spatial component to the cAMP-
mediated regulation of Epac1 undoubtedly renders the 




Forskolin, IBMX and H89 were from Calbiochem-Novabio-
chem Corp. (La Jolla, CA); Isoproterenol, EGF, Cytochala-
sin D, Latrunculin A and Nocodazol from Sigma Chemical 
Co. (St. Louis, MO); 1-(2-nitrophenyl)ethyl adenosine-3-
’,-5’-cyclic monophosphate (NPE-caged cAMP) from Jena 
Bioscience GmbH (Jena, Germany); 8-pCPT-2’-O-Me-
cAMP (007) and 8-pCPT-2’-O-Me-cAMP-AM (007-AM) from 
Biolog Life Sciences (Bremen, Germany); Fura-Red-AM 
and BAPTA-AM from Molecular Probes Inc. (Eugene, OR); 
the Rap1 antibody from SantaCruz Biotechnology (SC-65) 
and the Rap2 antibody from BD Transduction laboratories 
(610216). The Epac1 antibody (5D3) has been described 
[56]. Fibronectin was purified as described [57].
DNA constructs 
The following expression vectors were described elsewhere: 
pcDNA3 CFP-Epac1-YFP and pcDNA3 CFP-Epac1-∆DEP-
C.D.-YFP [39], pcDNA3 CFP-Epac1(∆DEP-C.D.)-Venus 
(55), pMT2-SM-HA Rap1A(G12V) and pMT2-SM-HA Rap-
GAP1 [58], pMT2-SM-HA Epac1 [17], pcDNA3 CFP-CAAX 
[35]. Epac1 (RapGEF3, homo sapiens, GI: 3978530) was 
cloned C-terminal to YFP in a pCDNA3 vector. Mutations 
were introduced by site-directed mutagenesis. The sepa-
rate regulatory (amino acid 1-328) and catalytic (amino 
acids 330-881) region of Epac1 were cloned into pcDNA3 
with an N-terminal CFP and YFP tag, respectively. GFP-
RBD(RalGDS) was a kind gift from Mark Philips. 
Cell culture
HEK293 (Human Embryonal Kidney) cells and A431 hu-
man carcinioma cells were cultured in DMEM; OVCAR-3 
and the Jurkat T-cell line JHM1 2.2  were grown in RPMI 
medium, all supplemented with 10% serum and antibiot-
ics. 
Live cell experiments
Cells were seeded in 6-well plates on 25-mm glass cover 
slips and cultured in 3 ml medium. Constructs were tran-
siently transfected using Fugene 6 Transfection Reagent 
(Roche Inc.). Experiments were performed in a culture 
chamber mounted on an inverted microscope in bicarbo-
nate-buffered saline (containing 140 mM NaCl, 5 mM KCl, 
1 mM MgCl2, 1 mM CaCl2, 10 mM glucose, 23 mM NaHCO3, 
with 10 mM HEPES added), pH 7.2, kept under 5% CO2, 
at 37°C. Agonists and inhibitors were added from concen-
trated stocks.
Dynamic monitoring of YFP/CFP FRET
Cells on coverslips were placed on an inverted NIKON mi-
croscope equipped with 63x lens (N.A. 1.30) and excited 
cAMP-induced Epac1 translocation
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at 425 nm. Emission of CFP and YFP was detected simul-
taneously by two photon multiplier tubes (PMTs) through 
470 +/- 20 nm and 530 +/- 25 nm bandpass filters, re-
spectively. Data were digitized by Picolog acquisition soft-
ware (Picotech) and FRET was expressed as the normal-
ized ratio of YFP to CFP signals. The ratio was adjusted to 1 
at the onset of the experiment and changes are expressed 
as percent deviation from this initial value. For some of 
these experiments, a CFP-tagged version of K-Ras-CAAX 
was used as PM marker. Whereas in hippocampal neurons 
K-Ras-CAAX may translocate to endomembranes under 
certain conditions [59], under our conditions CFP-CAAX 
localizes to the plasma membrane as we have extensively 
documented [35,57]. For the experiment described in Fig. 
3C the YFP/CFP FRET ratio was determined in imaging 
mode, by detecting CFP- and YFP images simultaneously 
on a Leica fluorescence SP2 microscope equipped with a 
dual-view attachment and a Coolsnap-HQ CCD-camera 
(Roper Scientific), using ASMDW acquisition software. 
Confocal microscopy
Coverslips with cells expressing various constructs were 
mounted in a culture chamber and imaged at 37 °C using 
an inverted TCS-SP5 confocal microscope equipped with 
63x immersion oil lense (N.A. 1.4; Leica, Mannheim, Ger-
many). Imaging settings were: CFP, excitation at 442 nm, 
emission at 465-500 nm; GFP, exc. at 488 nm, em. at 
510-560 nm;  YFP, exc. at 514 nm, em. at 522-570 nm. 
For detection of endogenous Epac1 in OVCAR-3 cells, 
cells were grown on 12 mm glass cover slips for 72 h and 
after 10 min of stimulation with 25 μM Forskolin, fixed 
with 3.8% formaldehyde, permeabilized using 0.1% Triton 
X100 and blocked in 2% BSA. Cells were incubated with 
the Epac1 antibody (5D3) and subsequently with Alexa-
conjugated secondary antibodies (Invitrogen). Mounted 
slides were examined using a Axioskop2 CLSM microscope 
(Zeiss) (63x magnification lenses, N.A. 1.4).  
Digital image analysis
For translocation studies, series of confocal images were 
taken from a medial plane at 5 or 10 s intervals. To quan-
titate the translocation of constructs, the ratio of cytosolic 
to PM fluorescence was calculated by post-acquisition au-
tomated assignment of regions of interest (ROIs) using 
Leica Qwin software (see [35] and http://research.nki.nl/
jalinklab/Homepage%20%Phys&ImgGrp%200.htm). Note 
that in the individual traces gain of fluorecence at the PM 
appears small compared to the loss in the cytosol because 
of the under-representation of membrane area in medial 
sections; the majority of membrane is present in the basal 
membrane and in the strongly curved apical parts of the 
cell. Post-acquisition brightness and contrast adjsutments 
were performed with ImageJ software (NIH).
TIRF microscopy
Cells expressing GFP-Epac1 or YFP-RBD(RalGDS) were 
mounted in a culture chamber and imaged on a Leica 
TIRF setup, equipped with 488 argon excitation laser and 
Hamamatsu EM-CCD detector. A 63x, 1.45 NA objective 
was used and evanescent field penetration depth was set 
to 90 nm. TIRF imaging was at ambient temperature and 
analysis was with LAS-AF software.
 
Loading and flash photolysis of NPE-caged cAMP
Cells were loaded by incubation with 100 μM NPE-caged 
cAMP for 15 min. Uncaging was done with brief pulses 
of UV light (340-410 nm) from a 100 W HBO lamp using 
a shutter. To define exposure times and UV-light inten-
sities for desired cAMP-release, cAMP was monitored ra-
tiometrically (CFP/YFP) using the Epac-based sensor CFP-
Epac(∆DEP-C.D.)-Venus [38]. Translocation of GFP-Epac1 
was monitored in parallel experiments. 
Rap activation assay
Rap activity was assayed as described previously [61]. 
Briefly, HEK293 cells grown in 9 cm plates were lysed in 
buffer containing 1% NP40, 150 mM NaCl, 50 mM Tris-
HCl pH 7.4, 10% glycerol, 2 mM MgCl2 and protease and 
phosphatase inhibitors. Lysates were cleared by centrifu-
gation and active Rap was precipitated with a GST fusion 
protein of the Ras-binding domain of RalGDS precoupled 
to glutathione-sepharose beads. 
Adhesion assay
The adhesion of Jurkat T-cells to fibronectin was meas-
ured as described previously [62]. In brief, 96-Well Nunc 
Maxisorp plates were coated with 5 μg/ml fibronectin and 
blocked with 1% bovine serum albumin. 1.2 x 107 Jurkat 
cells were transiently transfected by electroporation (950 
µF, 250 V) with 5 μg CMV-luciferase plasmid and pcDNA3 
YFP-Epac1 plasmid adjusted to get equal expression lev-
els, supplemented with pcDNA3 empty vector to a total of 
40 μg plasmid DNA, using the Gene Pulser II (Bio-rad). 
Cells were harvested two days after transfection and re-
suspended in TSM buffer (20 mM Tris-HCl, pH 8.0, 150 mM 
NaCl, 1 mM CaCl2, 2 mM MgCl2). 2.5 x 10
4 cells for each 
well were allowed to adhere for 45 min and non-adherent 
cells were removed with 0.5% BSA in TSM buffer. Adher-
ent cells were lysed and subjected to a luciferase assay 
as described previously [63]. For Rap1 activity measure-
ments in Jurkat T-cells, transfected cells were subjected to 
the Rap activation assay after resuspension in TSM buffer 
and stimulation with 007 (100 μM, 10 min).
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The mechanism of Epac1 translocation is distinct from that of Epac2 translocation
A)  In accordance with Li et al. [30], YFP-Epac2 (RapGEF4, mus musculus, GI:9790086, cloned C-terminal to YFP in a pcDNA3 
vector) translocates to the plasma membrane in H1299 cells after both forskolin (25 μM) stimulation and EGF (25 ng/ml)-mediated 
activation of overexpressed K-Ras (left), while this translocation was not observed when omitting Ras overexpression (middle) or 
EGF stimulation (right). 
B)  In contrast, forksolin alone is sufficient for the translocation of Epac1 in H1299 cells. 
C)  In any of the other cell types positive for Epac1 translocation, such as HEK293 cells, we could not reproduce the translocation of 
Epac2, even under conditions of EGF-mediated activation of co-expressed Ras. Scalebars: 10 μm
Suppl Fig 2
The putative RA domain is not 
required for translocation of Epac1
As the catalytic region of Epac1 is required 
for PM translocation, we explored the 
requirement of the putative RA domain 
within this region (amino acids 519-
658). Since deletion of the entire domain 
abolishes proper folding of the protein 
(data not shown), we replaced it with the 
homologous region of the RasGEF Sos1 (GI: 
169234770, amino acids 741-776), which 
lacks an RA domain. The resultant YFP-
Epac1(∆RA+SOS) was expressed in HEK293 
cells together with CFP-CAAX and stimulated 
with 007-AM (1 mM). The observed FRET 
increase reports PM translocation of YFP-
Epac1(∆RA+SOS) similarly to wildtype YFP-
Epac1, indicating that the RA domain is not 
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Abstract
Epac1 is a GEF for the small G-protein Rap and is directly activated by cAMP. Epac1-Rap signaling is 
involved in plasma membrane-localized processes such as integrin-mediated cell adhesion and cell-
cell junction formation. We previously showed that cAMP induces the translocation of Epac1 to the 
plasma membrane, thereby enhancing Rap-mediated cell adhesion. We here report an additional 
mechanism of Epac1 recruitment to the plasma membrane via an interaction with members of 
the Ezrin/Radixin/Moesin (ERM) family. In contrast to cAMP-dependent Epac1 translocation, 
this recruitment depends neither on the DEP domain nor on the conformational state of Epac1. 
Instead, it is regulated by conformational opening of the ERM proteins. Furthermore, whereas 
cAMP binding targets Epac1 uniformly along the plasma membrane, ERM proteins recruit Epac1 
to polarized subcompartments. Finally, we show that the ERM-interaction contributes to Epac1-
mediated cell adhesion. Taken together, our data suggest that ERM proteins spatially confine Epac1 





cAMP is a second messenger in a wide variety of hormone 
responses. cAMP is produced at the plasma membrane 
by adenylate cylases, and subsequently becomes com-
partmentalized due to degradation by spatially restricted 
phosphodiesterases (PDEs) [1]. Further compartmentali-
zation of cAMP signaling is established by the confined 
targeting of cAMP effector proteins. For the classical cAMP 
target Protein Kinase A (PKA), more than  50 A-kinase 
anchoring proteins (AKAPs) have been identified. AKAPs 
differentially target PKA to subcellular compartments and 
are thereby implicated in distinct biological functions of 
PKA [2].
The discovery of Epac as a direct effector of cAMP 
[3,4] has triggered the elucidation of many cAMP-regulat-
ed processes that could not be explained by the known ef-
fectors PKA and cyclic nucleotide-regulated ion channels. 
Epac1 and Epac2 act as guanine nucleotide exchange fac-
tors (GEFs) for the small G proteins Rap1 and Rap2, and 
thereby function in processes such as cell adhesion [5-9], 
insulin secretion [10,11] and cell polarity [12,13]. Their 
catalytic region contains the enzymatically active CDC25 
domain, a Ras Association (RA) domain and the Ras Ex-
change Motif (REM). In auto-inhibited Epac, the catalytic 
site is sterically covered by the regulatory region, which 
harbors the cAMP-binding domain(s) and the DEP domain 
[14]. cAMP binding releases Epac from auto-inhibition by 
inducing a conformational change, as demonstrated by the 
crystal structures of active and inactive Epac2 [15,16].
Similar to the compartmentalization of PKA, cAMP-
Epac signaling is spatially regulated by several anchoring 
proteins. For instance, both Epac1 and Epac2 are targeted 
to microtubules by interacting with Microtubule Associated 
Protein-Light Chain (MAP-LC) [17]. Other anchors bind 
specifically to either Epac1 or Epac2, thereby contributing 
to their distinct functions. For instance, only Epac1 is tar-
geted to the mAKAP complex at the nuclear envelope [18] 
and, conversely, Epac2 is part of the Rim2-Piccolo com-
plex involved in cAMP-dependent exocytosis [19,20]. In 
addition, more dynamic targeting mechanisms allow the 
regulation by intracellular signalling events. For example, 
Epac2 is recruited to the plasma membrane by the acti-
vated GTPase Ras [21] and this was shown to be crucial 
for its involvement in neurite outgrowth [22]. Recently, we 
reported that Epac1 translocates to the plasma membrane 
upon binding of cAMP and we showed that this transloca-
tion enhances Rap-mediated cell adhesion [23]. Although 
the anchor at the plasma membrane remains elusive, it 
has become clear that cAMP-dependent Epac1 transloca-
tion involves the DEP domain (residues 50-148) and de-
pends on the cAMP-induced conformational opening. 
In an attempt to identify new binding partners for 
Epac1, we performed a yeast-two-hybrid screen, which 
revealed interactions with members of the Ezrin-Radixin-
Moesin (ERM) family. ERM proteins show high sequence 
similarity and function as scaffolding proteins that link the 
actin cytoskeleton to the plasma membrane [24]. Inactive 
ERM proteins reside in the cytoplasm in an auto-inhibited 
state maintained by an intramolecular interaction between 
the N-terminal FERM domain and the C-terminal Actin 
Binding Domain (ABD). For their transition to scaffolds 
at the plasma membrane, ERM proteins require PI(4,5)
P2 binding and acquisition of the open conformation [25]. 
The latter requires phosphorylation of the ABD, for which 
several kinases have been implicated, including PKCα and 
the Rho-effector Rock [26-30]. ERM proteins directly link 
the actin cytoskeleton to the PM and recruit of multiple 
signalling proteins. In this manner, ERM proteins function 
in numerous processes that involve actin dynamics, such 
as the formation of microvilli [31], adherens junctions sta-
bilization [24] and leukocyte polarization [32].
In the present study, we show that ERM proteins 
serve as membrane anchors for Epac1. The underlying in-
teraction is mediated by the Epac1 N-terminus (residues 
1-49) and is independent of its conformational state. These 
properties imply that ERM proteins do not constitute the 
anchor for the previously described cAMP-induced translo-
cation, which depends on the DEP domain and conforma-
tional opening [23]. Instead, the interaction is regulated 
on the level of the ERM proteins, which selectively bind 
Epac1 when they are in their active, open conformation. 
In line with this, ERM activation via thrombin stimulation 
triggers the immediate recruitment of Epac1 to cortical 
ERM proteins. This recruitment targets Epac1 to polar-
ized compartments along the plasma membrane, adding 
a component of spatial regulation to Epac1 functioning. 
Importantly, we find that the ERM-interaction enhances 
the ability of Epac1 to induce Rap-mediated adhesion of 
Jurkat T-cells. Taken together, our data suggest that spa-
tial regulation by ERM proteins regulates the coupling of 
cAMP-dependent Epac1 activity towards Rap.
Results
Epac1 interacts via its N-terminus to proteins of 
the ERM family
In an attempt to identify new binding partners for Epac1, 
a yeast two-hybrid screen was performed using a human 
placenta cDNA library and full length Epac1 as bait. Posi-
tive clones were isolated encoding partial cDNA for the 
membrane-associated proteins Ezrin and Radixin. Togeth-
er with Moesin, these proteins belong to the Ezrin/Radixin/
Moesin (ERM) family and function as adaptor proteins that 
link the actin cytoskeleton to the plasma membrane [33]. 
To confirm the interaction between Epac1 and the 
ERM family proteins in mammalian cells, HEK293 cells 
were transfected with HA-Epac1 and Flag-tagged vari-
ants of Ezrin, Radixin or Moesin. Indeed, all ERM proteins 
co-precipitated with Epac1 (Fig 1A). As the ERM proteins 
share high sequence similarity and bind Epac1 to a simi-
lar extent, Radixin was used as a representative family 
member to further explore the  interaction between Epac 
and ERM proteins. Epac1 and Epac2 are similar in domain 
architecture, except that Epac2 contains an additional 
cAMP binding domain [14]. However, Flag-Radixin was 
not able to co-immunoprecipitate with Epac2  (Fig 1B). 
Thus, binding to ERM proteins is specific for Epac1, sug-
gesting that the interaction is mediated by a region that 
ERM-mediated Epac1 recruitment
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B)  Co-immunoprecipitation of Flag-Radixin with HA-tagged version of Epac1 or Epac2 in HEK293 cells. In contrast to HA-Epac1, HA-
Epac2 is unable to co-immunoprecipitate Flag-Radixin. Note that upon co-immunoprecipitation of Radixin with Epac1 is less efficient 
than the inverse experiment in 1A. 
C)  Co-immunoprecipitation of Flag-Radixin with HA-tagged wildtype-Epac1, (∆DEP)-Epac1, ∆49-Epac1 and Epac1(N49) in HEK293 
cells. The 49 N-terminal amino acids of Epac1 are both required and sufficient for the interaction with Radixin, whereas the DEP 
domain is dispensable. Scheme represents domain structure of Epac1, showing the regulatory region with the N-terminal N49, the 
DEP domain and the cyclic nucleotide-binding domain (CNB), and the catalytic region which contains the REM, RA and the catalytic 
CDC25 domain.
is not conserved in Epac2. Mutational analyses revealed 
that the interaction with Radixin requires the N-terminal 
49 amino acids of Epac1 (Fig 1C), which are indeed absent 
in Epac2. To further establish this, we tested binding of 
bacterially purified Ezrin to a series of 20-mer peptides 
from the Epac1 N-terminus. This assay demonstrated that 
the Epac1-ERM interaction is direct and further revealed 
that the interaction surface resides between amino acid 19 
and 48 of Epac1 (Supplementary Fig S1). Thus, the Epac1 
N-terminal N49 is not only essential but also sufficient to 
bind ERM proteins. 
Importantly, these data exclude the possibility that 
the interaction with ERM proteins underlies the recently 
described cAMP-induced PM translocation of Epac1 [23], 
which is mediated by its DEP domain. In line with this, 
deletion of the DEP domain (residues 50-148) did not af-
fect the interaction with Radixin (Fig 1C). Thus, our data 
indicate that Epac1 binds ERM proteins via its N-terminal 
49 residues, providing a targeting mechanism that is dis-
tinct from the cAMP-induced PM translocation. 
Epac1 selectively binds to ERM proteins that are in 
the open conformation
In resting ERM proteins, binding to the plasma membrane 
and the actin cytoskeleton is prevented by the intramo-
lecular interaction between its N-terminal FERM domain 
and C-terminal actin binding domain (ABD) (see scheme 
in Fig 1A). This auto-inhibition can be relieved by threo-
nine phosphorylation within the ABD (in Radixin: Thr564) 
[26,34]. Co-immunoprecipitation experiments using ei-
ther the truncation mutant containing the N-terminal 
FERM domain and α-helical region (residues 1-492) or the 
separate C-terminal ABD (residues 493-584) showed that 
Epac1 binding is mediated by the N-terminal half of Ra-
dixin (Fig 2B). Since this region is partially buried in the 
globular, inactive ERM conformation, we tested whether 
Epac1 specifically binds ERM proteins that are in the open 
conformation. For this, two Radixin mutants were tested 
(see residues in Fig 2A). The first, Radixin(T564D), con-
tains a phospho-mimicking mutation at the threonine po-
sition [35]. The second, Radixin(I577D/F580D) is a novel 
mutant based on the crystal structure of Moesin [36]. In 
this mutant, residues of the ABD that form a hydrophobic 
interaction with the FERM domain were replaced by nega-
tively charged asparagines. Both mutations prevented the 
interaction between the N- and C-terminal truncation con-
structs of Radixin (data not shown), and thus result in the 
constitutively open conformation of full length Radixin. In-
deed, both Radixin mutants showed dramatically increased 
interaction with Epac1 compared to wildtype Radixin (Fig 
2C), indicating that Epac1 displays an increased affinity 
for the open conformation of the ERM binding partners. 
To test this further, we stimulated HEK293 cells with 
thrombin, which induces threonine phosphorylation and 
thus conformational opening of ERM proteins ([37] and 
Fig 2D). As shown in Fig 2D, the interaction between 
Epac1 and wild-type Radixin was enhanced upon throm-
bin treatment. This could also be measured in vivo by 
measurement of Fluorescence Resonance Energy Transfer 
(FRET) between YFP-Radixin and Epac1-TdTom. Addition 
of Trombin Receptor-activating Peptide (TRP) induced an 
increase in FRET (Fig 2E; ∆TdTom/YFP = 6.0 +/- 1.08 % 
(average +/- st-dev), n=3), reflecting the instant interac-
tion between Epac1 and Radixin. These data confirm that 
Epac1 preferably binds to the open conformation of ERM 
proteins. 
In a converse experiment, we examined whether the 
open conformation of Radixin is truly required for binding 
to Epac1. For this, the separate C-terminal ABD of Radixin 
was overexpressed to bind the N-terminus of full-length 
Fig 1.    Epac1 directly interacts with ERM proteins 
A)  Co-immunoprecipitation of HA-Epac1 with Flag-Ezrin, Flag-Radixin, 
and Flag-Moesin in HEK293 cells. 
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Radixin. This mimicks the intramolecular interaction and 
thus the closed conformation of FL-Radixin. Indeed, co-
expression of the Radixin C-terminus resulted in a dose-
dependent decrease in binding between Radixin and 
Epac1 (Fig 1F). All in all, our data show that the binding 
of Epac1 to ERM proteins is regulated on the level of ERM 
conformation.
Activated ERM proteins rapidly recruit Epac1 to the 
plasma membrane
Epac proteins are spatially regulated by interactions with 
diverse anchoring proteins, and the inducible Epac1-ERM 
interaction may also represent such a regulatory mecha-
nism. In the inactive, closed conformation, ERM proteins 
reside in the cytosol [34,38], whereas activated ERM 
proteins localize to the plasma membrane. To study the 
potential role of ERM proteins in regulating the subcel-
lular localization of Epac1, we used the constitutively open 
and thus PM-localized Ezrin(T567D). Whereas Epac1-YFP, 
when expressed alone, localized mainly to the cytosol and 
the nuclear envelope, it showed marked accumulation at 
the PM when Ezrin(T567D) was overexpressed. This was 
not observed with CFP-Epac1(∆1-49), while the isolated 
N-terminus of Epac1 (GFP-N49) was sufficient for PM 
targeting (Fig 3A), indicating that the PM accumulation 
of Epac1 is indeed mediated by the interaction with ERM 
proteins.
Strikingly, Ezrin(T567D) expression similarly induced 
PM accumulation of Epac1(R279L)-YFP, which is mutated 
in its cAMP binding domain and thereby locked in the auto-
inhibited conformation [23,39] (Fig 3A). The latter implies 
that recruitment by ERM proteins is independent of Epac1 
conformational state. 
Activated ERM proteins are tethered to the PM via 
their FERM domains [40], implying that they may recruit 
Epac1 closely to the PM. To test this, we drove Epac1-YFP 
to the constitutively open mutant Ezrin(T567D) in cells co-
expressing CFP-CAAX, which is membrane-anchored by its 
prenylated K-Ras CAAX-motif. We observed a prominent 
loss of FRET upon addition of Ionomycin (Fig 3B; average 
+/- s.e.m. 23 +/- 3% decrease in ratio YFP/CFP), which 
Fig 2.    ERM proteins require open conformation to bind Epac1
A)  Diagram of Radixin domain structure and the mutants used in experiments described in B) to E). Shown are the membrane 
binding FERM (four-point one, ezrin, radixin, moesin) domain, the region predicted to form an α-helical coiled-coil and the actin-
binding domain (ABD). 
B)  Co-immunoprecipitation in HEK293 cells of HA-Epac1 with either the N-terminal truncation construct containg the FERM domain 
and α-helical region of Radixin (residues 1-492) or its C-terminal Actin Binding Domain (ABD, residues 492-584). Epac1 specifically 
co-immunoprecipitates with the N-terminal construct. 
C)  Co-immunoprecipitation of HA-Epac1 with wildtype Flag-Radixin and the constitutively opened mutants Flag-Radixin(T564D) 
and Flag-Radixin(I577D/F580D) in HEK293 cells. The amount of co-immunoprecipitated HA-Epac1 is significantly higher with the 
conformationally open Radixin mutants, suggesting that Epac1 favors binding to Radixin in the open conformation.
D)  Co-immunoprecipitation of HA-Epac1 with Flag-Radixin in HEK293 cells stimulated with thrombin (0.2 mU/ml, 2 min). As shown 
by their phosphorylation-state (Ezrin-T567, Radixin-T564 and Moesin-T558), this induces release of ERM auto-inhibition. Thrombin 
stimulation results in increased interaction of HA-Epac1 with Flag-Radixin, further supporting that Epac1 favors binding to Radixin 
in the open conformation.
E)  Measurement of FRET between YFP-Radixin and Epac1-TdTom in HEK293 during stimulation with TRP. FRET, expressed as TdTom/
YFP ratio, increased upon TRP addition. Trace is representative for n=3. Average ratio increase was 6.0 +/- 1.08 % (st. dev.). 
F) Co-immunoprecipitation of HA-Epac1 with Flag-Radixin in the presence of increasing amounts of the V5-tagged C-terminal ABD 
of Radixin in HEK293 cells. Overexpression of V5-ABD dose-dependently decreases the interaction of HA-Epac1 with Flag-Radixin, 
indicating that HA-Epac1 binds Radixin in a region that is shielded during auto-inhibition of Radixin. 
ERM-mediated Epac1 recruitment
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removes CFP-CAAX from the PM (unpublished observa-
tion). This implies, that ERM-bound Epac1-YFP resides 
within 10 nm from the PM. This was not observed when 
Epac1(∆49)-YFP was used (average +/- sem 0.5 +/- 0.1 
%, data not shown). Without overexpressed Ezrin(T567D), 
Ionomycin-induced loss of FRET was significantly smaller 
(average +/- s.e.m. 5 +/- 1%; Fig 3B). The residual effect 
suggests membrane-targeting of Epac1 by endogenous 
ERM proteins.
Next, we used confocal microscopy to simultaneously 
monitor the subcellular localization of YFP-Radixin and 
Epac1-TdTom during TRP stimulation. Thrombin receptor 
activation drives ERM proteins into their open conformation 
[37] and induces their interaction with Epac1 (Fig 2D). We 
observed PM accumulation of YFP-Radixin and the simul-
taneous recruitment of Epac1-TdTom to these areas of ac-
cumulated YFP-Radixin (Fig 3C; movie can be on the web-
site), in agreement with the TRP-induced FRET increase 
shown in Fig 2E. Also without Radixin overexpression, 
TRP elicited the recruitment of Epac-YFP to the PM (Fig 
3D). This was disabled by deletion of N49 (Epac1(∆49)-
YFP, Fig 3E), implying that ERM proteins, when activated 
by thrombin receptor signaling, recruit Epac1 to the PM. 
TRP-induced recruitment was also observed for the auto-
inhibited Epac1(R279L)-YFP (Fig 3F) and GFP-N49 (data 
not shown). Furthermore, it was sensitive to the RhoA-
inhibitor C3 toxin (Fig 3G), establishing that TRP induces 
ERM proteins activation through Rho signaling [28,29]. 
Thus, from our data we conclude that Rho-dependent ac-
tivation of ERM proteins causes their translocation to the 
PM and releases their ability to recruit Epac1. 
Fig 3.    Activated ERM proteins recruit Epac1 to the plasma membrane
A)  Subcelular localisation of Epac1-YFP in HEK293 cells. From left to right : Epac1-YFP alone; with coexpressed Ezrin(T567D); 
Ezrin(T567D) coexpression with deletion mutant Epac1(∆1-49)-YFP, with GFP-N49 and with Epac1(R279L)-YFP.
B) Measurement of FRET between the PM-marker CFP-CAAX (see [23]) and Epac1-YFP in the presence of constitutively active mutant 
Ezrin(T567D) (red trace). Disruption of FRET following Ionomycin-induced CFP-CAAX depalmitoylation revealed high degree of initial 
FRET (23 +/- 3% decrease in ratio relative to baseline value 1.0 (average +/- s.e.m.; n=4)), which was significantly less (p<<0.01) 
in the absence of Ezrin(T567D) (5 +/- 1%; n=4, blue trace). Shown are representative traces.
C)  Stills from time lapse confocal imaging of HEK293 cells expressing YFP-Radixin and Epac1-TdTom. In resting cells Radixin and 
Epac1 resided in the cytosol. In response to TRP (50 uM) both constructs redistributed to restricted domains at the PM. 
D)  TRP stimulation induces PM recruitment of Epac1-YFP in the absence of overexpressed Radixin. 
E)  Epac(∆49)-YFP is not recruited to the PM upon TRP stimulation. Note the cell contraction triggered by thrombin receptor 
signaling.
F)  TRP induces PM recruitment of the cAMP-binding mutant Epac(R279L)-YFP
G)  Epac1 recruitment is prevented when cells are incubated with the exo-enzyme C3, the inhibitor of RhoA (16 hr, 30 mg/ml). 
Scalebars in all images: 10 mm. 
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Activated ERM proteins recruit Epac1 to polarized 
areas of the PM
Interestingly, the distribution patterns induced by ERM-
activating differ notably from those described for cAMP-
induced translocation of Epac1 [23]. Activated ERM pro-
teins, which localize asymmetrically themselves (Fig 4A, 
left panel), recruit  Epac1 to polarized areas of the PM, 
whereas cAMP-bound Epac1 distributes more uniformly 
along the PM (Fig 4A right panel; see also Fig 3C,D,F). 
This becomes even more apparent when Rho signaling 
is promoted by co-expression of a the separate DH-PH 
domain of p190-RhoGEF (p190(DHPH)) [41], resulting in 
heavily polarized distributions of Epac1-YFP (Fig 4C) and 
Epac1(R279L)-YFP (data not shown). Colocalization in 
polarized PM areas was also observed with endogenous 
radixin, as visualized by immunofluorescence stainings 
in HEK293 cells stimulated with TRP or transfected with 
p190(DHPH) (Supplemental Fig 2). 
Thus, cAMP-induced translocation and ERM-mediated 
recruitment induce differential localization patterns of 
Epac1. To demonstrate this more directly, we transfect-
ed HEK293 cells with CFP-N49 and YFP-Epac1(∆49) and 
stimulated these cells with both TRP and 007-AM. PM tar-
geting was observed for both constructs, however, lead-
ing to different localizations at the PM. YFP-Epac1-(∆49), 
which can translocate upon binding of 007-AM but lacks 
the ERM interaction domain, distributed uniformly along 
the PM. On the other hand, CFP-N49, which can interact 
with ERM proteins but is insensitive to 007-AM, accumu-
lated asymmetrically along the PM (Fig 4B). Thus, in con-
trast to cAMP-induced Epac1 translocation, activated ERM 
proteins have the potential to recruit Epac1 to polarized 
areas of the PM.
Epac1 recruitment by ERM proteins is independent 
of Epac1 activation state (Fig 3A, 3F), in marked contrast 
with its cAMP-dependent translocation. Thus, in the ab-
sence of cAMP-raising stimuli, ERM proteins recruit auto-
inhibited, inactive Epac1 to polarized areas of the PM. We 
wondered whether this spatial confinement is affected 
when cAMP binding subsequently elicits the DEP-depen-
dent affinity of Epac1 for the PM. Therefore, we added 
007-AM to cells expressing Epac1-YFP and p190-(DHPH). 
As shown in Fig 4C, 007-AM did not induce lateral redis-
tribution of the asymmetrically localizing Epac1. Thus, al-
though cAMP induces homogeneous PM translocation in 
the absence of ERM interactions (YFP-Epac1(∆49); Fig 4B 
and data not shown), active ERM proteins can restrict the 
localisation of cAMP-activated Epac1 to polarized areas 
along the PM. Taken together, our data imply that ERM 
proteins can target  the cAMP-dependent GEF activity of 
Epac1 to specialized areas of the PM.
 
The Epac1-ERM interaction facilitates 007-induced 
cell adhesion
Since active ERM proteins are capable of restricting ac-
tivated Epac1 to a subcompartment of the PM, we won-
dered whether this interaction facilitates Epac1-mediated 
Rap signalling. In Jurkat T-cells, activation of Epac1-Rap 
signaling induces adhesion by increasing the affinity of in-
tegrins for their extracellular matrix substrates [42]. To 
assess whether the interaction of Epac1 with ERM pro-
teins contributes to its ability to induce adhesion, we 
transfected Jurkat T-cells with wildtype Epac1 or deletion 
mutants lacking the ERM interaction region (∆1-49), the 
DEP domain (∆50-148) or both domains (∆1-148). In all 
cases, a luciferase contruct was cotransfected so that ad-
hesion to fibronectin could be quantified by measurement 
of luciferase activity. As previously described [23], the 
007-induced increase in adhesion was greatly impaired, 
albeit not completely abolished, upon deletion of the DEP 
domain (Fig 5). Interestingly, a similar intermediate effect 
was observed upon deletion of N49 (Fig 5). This implies 
that besides the cAMP-induced, DEP-dependent translo-
cation, also the ERM interaction is involved in Rap sign-
aling by Epac1. Indeed, in Jurkat T-cells expressing an 
Epac1 mutant deficient in both recruitment mechanisms 
(Epac1(∆1-148)), the 007-induced adhesion was entirely 
lost. These data strongly suggest that the DEP and the 
N49 domains cooperate to convey Epac1 GEF activity to 
PM-localized Rap, thereby inducing cell adhesion. 
Fig 4.      Activated ERM proteins recruit Epac1 to polarized areas of the PM
A)  Example of TRP-stimulated HEK293 cell showing polarized localisation of YFP-Radixin and Epac1-TdTom.
B)  HEK293 cells were transfected with CFP-N49 and Epac1(∆49)-YFP and stimulated with TRP (50 uM) and 007-AM (1 uM). Both 
constructs accumulate at the PM, but show different subcellular distributions. 
C)  Epac1-YFP shows strongly polarized localisation when p190-RhoGEF(DHPH) is co-transfected. This pattern remains unaltered 
upon addition of 007-AM (1 uM). 




In the current study we reveal the direct interaction be-
tween Epac1 and members of the Ezrin/Radixin/Moesin 
(ERM) family (Fig 1). We determined that the Epac1 N-ter-
minus (residues 1-49, or N49) interact with the N-terminal 
half of ERM proteins, which also harbors the FERM domain 
(Fig 2). Importantly, the Epac1-ERM interaction is inde-
pendent of the conformational state of Epac1, since it also 
applies to the cAMP binding mutant Epac1(R279L), which 
is locked in the inactive, auto-inhibited conformation (Fig 
3). Instead, we show that the interaction is regulated on 
the level of the ERM proteins. To bind Epac1, ERM proteins 
require the open, activated conformation that is triggered 
by threonine phosphorylation in the ABD (Thr564 in Ra-
dixin) (Fig 2). 
Recently, we reported that conformational opening 
upon cAMP binding also triggers the translocation of Epac1 
to the PM. To date, the identity of the involved membrane 
anchor has remained unknown. Although the ERM pro-
teins, which can directly bind the PM, appear interesting 
candidates, their role as anchors in the cAMP-dependent 
translocation is excluded by their ability to recruit the 
auto-inhibited Epac1(R279L). Furthermore, cAMP-depen-
dent translocation is mediated by the DEP domain (resi-
dues 50-148) and does not require the N-terminal N49 
(Fig 4B), which is the determinant for ERM-interaction. 
Instead, we show that ERM proteins are anchors for 
an alternative mechanism of Epac1 recruitment. To local-
ize to the PM, ERM proteins require the activated, open 
conformation [26], which is also a prerequisite for Epac1 
binding (Fig 2). Taken together, recruitment of Epac1 to 
the PM directly follows from targeting of ERM proteins 
themselves. This was clearly illustrated by the simultane-
ous PM recruitment of YFP-Radixin and Epac1-TdTom (Fig 
3C) when we activated ERM proteins via thrombin recep-
tor stimulation [37]. Using FRET sensors for cAMP [43] 
and for PKA-activity [44] we further established that cAMP 
levels are not elevated upon TRP stimulation (data not 
shown), supporting the notion that ERM-mediated Epac1 
recruitment is independent of Epac1 activation state. 
The recruitment to ERM proteins contributes to the 
ability of Epac1 to induce Rap-dependent [8] adhesion of 
Jurkat T-cells. The 007-induced adhesion of cells express-
ing Epac1(∆1-49) was significantly reduced as compared 
to cells expressing wildtype Epac1 (Fig 5). Interestingly, 
we previously reported that also the DEP-dependent trans-
location of cAMP-bound Epac1 enhances Jurkat cell adhe-
sion [23]. Indeed, while deletions of DEP or N49 alone 
resulted in partial decreases in adhesion, their combined 
deletion (Epac1(∆1-148)) could suppress 007-induced ad-
hesion completely. These data suggest that the two tar-
geting mechanisms involving DEP and N49 cooperate to 
establish Rap activation. This implies that the interaction 
with ERM proteins facilitates the coupling between cAMP-
activated Epac1 and its effector Rap. 
In our current model, ERM proteins contribute to the 
Epac1-mediated activation of Rap by spatial confinement 
of the RapGEF. First, they position Epac1 in the vicinity of 
the PM (<10 nm), as demonstrated by FRET experiments 
using the PM-marker CFP-CAAX (Fig 3). Second, Epac1 
accumulates at subdomains of the PM due to the asym-
metrical distribution of ERM proteins themselves (Fig 4). 
Although the ERM proteins provide PM targeting of Epac1, 
Rap-mediated cell adhesion is still dependent on Epac1 
activation by 007. The observation that Epac1 activation 
does not affect the ERM-induced spatial confinement (Fig 
4) implies that ERM proteins can spatially regulate the GEF 
activity of Epac1. 
The observation that spatial regulation of Epac1 ac-
tivity by ERM proteins facilitates Rap-dependent adhesion 
may be explained in multiple ways. First, the combina-
tion of ERM- and cAMP-dependent targeting is expected 
Fig 5.    The Epac1-ERM interaction 
facilitates 007-induced cell adhesion
Jurkat T cells were transfected with luciferase 
together with a series of Epac1 constructs: wildtype 
Epac1, Epac1(∆50-148), Epac1(∆49) or Epac1(∆1-
148). Transfected cells were allowed to adhere 
to fibronectin-coated surface for 45 minutes and 
thoroughly washed. Adhesion was subsequently 
detected as luciferase activity. Wildtype-Epac1, 
when activated by 007 (100 μM, black bars) 
greatly enhanced the adhesion as compared to 
empty vector-transfected cells (EV). This effect 
was reduced when cells were transfected with 
Epac1(∆50-148), which does not translocate in 
response to cAMP, or with Epac1(∆1-49), which is 
deficient in binding to ERM proteins. Only in cells 
transfected with Epac1(∆1-148), the 007-induced 
increase in adhesion was entirely lost. Shown are 
data from a representative experiment performed in 
triplo (n=3). Total luciferase levels were comparable 
in all transfections. Inset: western blot labeled with 
the Epac1 antibody (5D3) showing expression levels 
of transfected wildtype- and mutant Epac1 used in 
the adhesion assay. 
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to increase the avidity for the PM, thereby increasing the 
frequency of interaction events between Epac1 and Rap 
molecules. Second, the asymmetrical localizations, to 
which Epac1 is targeted, may reflect signaling platforms 
specialized for the coupling between Epac1 and Rap. in 
support of this, Rap has been shown to display polarized 
PM distributions in several cell types [12,45-47].  Third, 
the inhomogeneous targeting may result in the activation 
of a specific pool of Rap and, thereby, of specific Rap ef-
fectors. For example, ERM proteins may confine Rap activ-
ity to areas where integrin-mediated adhesion can occur. 
Finally, ERM-mediated Epac1 targeting may serve a com-
bination of these functions. 
Signaling via RhoA has been reported to induce ERM 
activation [37]. Using the RhoA-inhibitor C3, we estab-
lished that TRP induces Epac1 recruitment via RhoA activa-
tion (Fig 3G). Thereby, the Epac1-ERM interaction further 
connects the actions of RhoA and Rap. Both GTPases play 
central roles in actin remodeling and share involvement in 
processes such as cell morphology, regulation of focal ad-
hesions [48] and migration [49]. Interestingly, crosstalk 
between Rap and RhoA at several levels has been report-
ed. Two Rho-GAPs,  ARAP3 [50] and RA-RhoGAP [51] have 
been identified as effectors of Rap1. Conversely, RhoA can 
activate the atypical PLCε [52], which acts as a GEF for 
Rap1 [53]. In addition, Schmidt and co-workers found 
that PLCε  can be activated downstream of Rap2B activ-
ity [54]. Our current data add to this interconnectivity by 
showing that RhoA signaling confers spatial regulation to 
Epac1-mediated Rap activation. Besides RhoA signaling, 
ERM proteins can be activated by several other signaling 
pathways, including phosphorylation by PKCα [27], PKCθ 
[55] and NIK [56]. This implies that such pathways also 
cross-talk to Rap via spatial regulation of Epac1.
Epac1 targeting by ERM proteins may also be of 
major importance in epithelial cells, where ERM proteins 
strongly accumulate to the microvilli at the apical mem-
brane. ERM proteins are involved in the dynamic regula-
tion of actin assembly, which underlies the highly curved 
architecture of the microvilli [57]. Indeed, along with ERM 
proteins, Epac1 strongly accumulates in the microvilli of 
epithelial cell types (e.g. MDCK, HeLa, OVCAR; data not 
shown) and we we find that this depends on ERM binding 
(data not shown). Epac1 has been reported to inhibit the 
apically localized sodium-proton (H+) exchanger 3 (NHE3) 
in the proximal tube of the kidney [58] and in the in-
testinal epithelia [59]. Since NHE3 functions in signaling 
complexes that also contain Ezrin [60,61], it is likely that 
ERM-mediated Epac1 targeting is of great importance for 
this function. 
Spatial confinement of Epac1 by ERM proteins is an-
other example of compartmentalized Epac1 signaling. The 
ensemble of Epac anchors, also containing MAP-LC [17], 
mAKAP [18] and the Rim2-piccolo complex [19], allows 
the involvement of Epac in several functions at different 
subcellular locations. In addition, our recruitment studies 
indicate that the anchoring function of ERM proteins are 
subject to dynamic regulation. Analogously, signaling of 
cAMP effector PKA is extensively compartmentalized by 
>50 AKAPs. It is interesting to note that Ezrin also serves 
as an AKAP [59,62,63]. Thereby, Ezrin may form a cross-
road for two cAMP-dependent signaling routes. 
Our current data show that ERM-mediated PM re-
cruitment facilitates Rap-dependent cell adhesion. This 
strongly suggests that the ERM proteins define a compart-
ment at the PM where Epac1-Rap signaling is efficiently 
coupled to downstream adhesive events. 
Materials and Methods
Reagents and antibodies
8-pCPT-2’-O-Me-cAMP (007) was obtained from Biolog Life 
Sciences (Bremen, Germany), human Thrombin from Sig-
ma-Aldrich (T7572). Thrombin Receptor-activating Pep-
tide (TRP, residues SFLRRN) was synthesized in our insti-
tute . The mouse monoclonal GFP antibody was obtained 
from Roche, the FlagM2 antibody from Sigma-Aldrich, the 
phospoERM (Ezrin T567, Radixin T564 and Moesin T558) 
antibody from Cell Signaling Technology and the mono-
clonal anti-HA antibody from Covance (HA11). Ezrin re-
combinant protein was purified as described previously. 
DNA constructs
Ezrin (EZR, homo sapiens, GI: 161702985), Radixin (RDX, 
homo sapiens, GI: 62244047), Moesin (MSN, homo sa-
piens, GI: 53729335), Epac1 (RapGEF3, homo sapiens, 
GI: 3978530) and Epac2 (RapGEF4, mus musculus, 
GI:9790086) were cloned C-terminal to either a Citrine, 
TomatoRed or Flag-His tag in a pCDNA3 vector or an HA 
tag in a PMT2-SM vector, using the Gateway system (Inv-
itrogen). cDNA for Ezrin, Radixin and Moesin was obtained 
from RZPD (Berlin, Germany). ∆DEP-Epac1 (amino acid 
50-148 deleted), ∆49-Epac1 (N-terminal 49 amino acids 
deleted), N-terminal Radixin (amino acid 1-492), C-termi-
nal Radixin (amino acid 492-584) and the indicated point 
mutants were generated by site-directed mutagenesis. 
Yeast two-hybrid screening
Human full length Epac1 (RapGEF3, homo sapiens, GI: 
3978530) cloned in a pB27 vector was screened with a 
randomly primed human placenta library by Hybrigenics 
S.A. (Paris, France), as previously described (ref). 
Cell culture
HEK293 (Human Embryonal Kidney) cells were cultured in 
DMEM, supplemented with 10% serum and antibiotics. 
Immunoprecipitation
HEK293 cells cultured in 5cm dishes were transfected with 
Fugene 6 Transfection Reagent (Roche Inc.) with the indi-
cated contructs. For experiments in which Epac1 was im-
munoprecipitated, cells were lysed in a buffer containing 
50mM Tris pH 7.5, 200mM NaCl, 20mM MgCl2, 1% NP40, 
10% glycerol and protease and phosphatase inhibitors. 
For the reverse experiments in which ERM proteins were 
immunoprecipitated, a buffer containing 1% Triton X100, 
0,5% DOC, 50mM Tris pH 7.5, 150mM NaCl, 2mM EDTA 
pH 8.0 and protease and phosphatase inhibitors was used. 
Cell pellets were spun down by centrifugation and lysates 
were incubated with sepharose A beads (Pharmacia) cou-
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pled to the appropriate antibody. After extensive washing 
with lysis buffer, bound proteins were eluted in Laemmli 
buffer and analyzed by SDS-Page.  
Live cell experiments
Cells were seeded in 6-well plates on 25-mm glass cover 
slips and cultured in 3 ml medium. Constructs were tran-
siently transfected using Fugene 6 Transfection Reagent 
(Roche Inc.). Experiments were performed in a culture 
chamber mounted on an inverted microscope in bicarbo-
nate-buffered saline (containing 140 mM NaCl, 5 mM KCl, 
1 mM MgCl2, 1 mM CaCl2, 10 mM glucose, 23 mM NaHCO3, 
with 10 mM HEPES added), pH 7.2, kept under 5% CO2, 
at 37°C. Agonists and inhibitors were added from concen-
trated stocks.
Dynamic monitoring of TomatoRed/YFP FRET
Cells on coverslips were placed on an inverted NIKON mi-
croscope equipped with 63x lense (N.A. 1.30) and excited 
at 490 nm. Emission of YFP and TomatoRed was detect-
ed simultaneously by two photon multiplier tubes (PMT) 
through 555 +/- 20 nm and 610 +/- 25 nm bandpass 
filters, respectively. Data were digitized by Picolog acquisi-
tion software (Picotech) and FRET was expressed as the 
normalized ratio of TomatoRed to YFP signals. Changes 
are expressed as percent deviation from this initial value. 
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Polarized distribution of 
endogenous radixin in TRP-
stimulated HEK cells
A)  Colocalization of GFP-N49, 
the ERM-interaction domain of 
Epac1, and endogenous Radixin 
(labeled with Alexa594-conjugated 
secondary antibody) in fixed 
HEK293 cells. Upper panels: in the 
absence of ERM activating stimuli, 
radixin showed modest peripheral 
accumulation and so did GFP-N49. 
Lower panels : in cells stimulated 
with TRP, endogenous radixin shows 
polarized accumulation at the PM, 
to which GFP-N49 colocalizes. Note 
that GFP-N49 tends to accumulate 
in the nucleus, likely due to basic 
residues in the N49-sequence 
constituting a pseudo-NLS.
Suppl Fig 1.  
Mapping the residues essential for interaction with ERM proteins.
Binding of GST-Ezrin to a peptide array of 20-mer peptides comprising the N-terminal region of Epac1. The region between amino 
acid 18 to 48 within Epac1 is essential for the interaction with ezrin. 
B)  When cells were transfected with p190-RhoGEF(DHPH) for activation of RhoA, endogenous radixin and Epac1-YFP colocalized to 
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Running title: Epac as a FRET-based cAMP sensor
Abstract 
Epac1 is a guanine nucleotide exchange factor for Rap1 that is activated by direct binding of 
cAMP. In vitro studies suggest that cAMP relieves the interaction between the regulatory and 
catalytic domains of Epac. Here we monitor Epac1 activation in vivo by using a CFP-Epac-YFP 
fusion construct. When expressed in mammalian cells, CFP-Epac-YFP shows significant fluorescence 
resonance energy transfer (FRET). FRET rapidly decreases in response to the cAMP-raising agents, 
whereas it fully recovers after addition of cAMP-lowering agonists. Thus, by undergoing a cAMP-
induced conformational change, CFP-Epac-YFP serves as a highly sensitive cAMP indicator in vivo. 
When compared to a protein kinase A (PKA)-based sensor, Epac-based cAMP probes display an 
extended dynamic range and a better signal-to-noise ratio; furthermore, as a single polypeptide, 
CFP-Epac-YFP does not suffer from the technical problems encountered with multi-subunit PKA-
based sensors. These properties make Epac-based FRET probes the preferred indicators for 




cAMP is a common second messenger that activates pro-
tein kinase A (PKA), cyclic nucleotide-regulated ion chan-
nels and Epac (for exchange proteins directly activated 
by cAMP). Epacs are guanine nucleotide exchange factors 
(GEFs) for Rap1 and Rap2 [1]. Rap GTPases cycle between 
an inactive GDP-bound and an active GTP-bound state, 
with GEFs mediating the exchange of GDP for GTP. Rap 
proteins are involved in a number of biological processes, 
most notably the regulation of cell adhesion through in-
tegrins and cadherins [2]. The GEF Epac1 consists of a 
C-terminal catalytic domain characteristic for exchange 
factors for Ras family GTPases and an N-terminal regula-
tory domain. The latter domain contains a cAMP-binding 
site similar to those of protein kinase A (PKA) and, in addi-
tion, a DEP domain that mediates membrane attachment 
[3,4]. 
In vitro studies have shown that cAMP is absolutely 
required for the activation of Epac [5]. It has been hypoth-
esized that the regulatory domain of Epac functions as an 
auto-inhibitory domain, which is relieved from inhibition 
by cAMP, but direct proof for this notion is lacking. In this 
model, Epac is folded in an inactive conformation at low 
cAMP levels, thereby preventing Rap binding due to steric 
hindrance. cAMP binding unfolds the protein, allowing Rap 
to bind. This is somewhat analogous to the mechanism of 
PKA regulation by cAMP; in its inactive conformation, two 
regulatory subunits are bound to two catalytic subunits. 
Upon binding of cAMP this complex falls apart, resulting in 
the release of active enzymes.
In the present study, we set out to measure Epac 
activation in vivo by sandwiching Epac between cyan fluo-
rescent protein (CFP) and yellow fluorescent protein (YFP) 
and then measure fluorescence resonance energy trans-
fer (FRET) between the two fluorescent moieties. FRET, 
the radiationless transfer of energy from a fluorescent 
donor to a suitable acceptor fluorophore, depends on fluo-
rophore orientation and on donor-acceptor distance at a 
molecular scale. We show that in mammalian cells, CFP-
Epac-YFP displays significant energy transfer which rap-
idly diminishes following a rise in intracellular cAMP and 
increases again in response to a fall in cAMP. This indicates 
that cAMP causes a significant conformational change in 
vivo and supports the unfolding model for Epac activation. 
Taking advantage of this property, we characterized CFP-
Epac-YFP as a FRET sensor for cAMP and generated cyto-
solic, catalytically dead mutants. We show that the Epac-
based cAMP indicators outperform the previously reported 
PKA-based cAMP sensor [6-8] in several aspects. 
Results and Discussion
cAMP induces a conformational change in Epac
To monitor cAMP-induced conformational changes in Epac, 
we generated a construct in which Epac1 was fused N-
terminally to CFP and C-terminally to YFP, as shown in 
Fig.1A. Using a GST-RalGDS assay (see supplementary 
information), it was checked that this construct was able 
to activate Rap1. CFP-Epac-YFP was transiently expressed 
in human A431 cells, where it localized to membranes and 
the cytosol (see further). Fluorescence spectra of these 
cells revealed significant FRET (Fig. 1B, red line), indicat-
ing that CFP and YFP are in close proximity (~ 3-4 nm). 
Stimulation with forskolin, a direct activator of adenylyl 
cyclase, significantly decreased FRET (green line). Simi-
lar responses were observed in other cell types, including 
HEK293, N1E-115 and MCF-7 cells. Thus, cAMP induces a 
significant conformational change in Epac, in support of 
the unfolding model (Fig. 1A). 
We next analyzed the kinetics of cAMP-induced FRET 
changes by ratiometric recording of CFP and YFP emission 
using a dual-photometer setup (see Methods). Within sec-
onds after addition of forskolin, FRET started to decrease, 
usually dropping to a minimum level within 2-3 minutes 
(Fig 1C). In the presence of the phosphodiesterase inhibi-
tor IBMX (100 mM), forskolin evoked an average decrease 
Figure 1.       A cAMP-induced conformational change in Epac detected by FRET
A) Model for the conformational change upon binding of cAMP to the regulatory domain of Epac (adapted from Bos, 2003). Upon 
cAMP binding, the VLVLE sequence can interact with the regulatory domain, releasing the inhibition of the GEF domain by the REM 
domain. FRET between the CFP- and YFP-tags allows detection of this conformational change. B) Emission spectra of CFP-Epac-YFP, 
excited at 430 nm. Red line, resting level; green line, 3 min after forskolin treatment (25 mM). C) Time course of cAMP-induced 
CFP-Epac-YFP activation, monitored in A431 cells by FRET. Increases in the ratio CFP/YFP reflect unfolding of Epac. Arrow, addition 
of forskolin (Fors, 25 mM). D) Cells were treated with forskolin (25 mM) and IBMX (100 mM) and subsequently permeabilized using 
digitonin (Digi, 10 mg/ml) in the presence of 2 mM cAMP.
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of 30 +/- 3 % in  CFP/YFP emission ratio. This reflects 
near-complete saturation of cAMP binding to Epac as de-
duced from experiments where cells were subsequently 
permeabilized with digitonin (10 ug/ml) in the presence of 
2 mM extracellular cAMP (Fig. 1D). This caused at most a 
moderate (on average 3%) further drop in FRET.
Epac activation is independent of subcellular 
localization
CFP-Epac-YFP localized to the cytosol and to membranes, 
in particular to the nuclear envelope and to perinuclear 
compartments. We confirmed proper targetting of CFP-
Epac-YFP by comparing its distribution with that of im-
munolabeled endogenous Epac in OVCAR3 cells. Identical 
localization patterns were observed (Zhao et al., in prepa-
ration), in agreement with a previous report [9]. Thus, 
CFP-Epac-YFP can be used as a FRET probe to image Epac 
activation. As activation of its downstream target Rap1 
is membrane-delimited [10,11], we set out to visualize 
Epac activation throughout the cell by two different im-
aging FRET techniques (see supplementary information). 
The results reveal that, at least in these cells, agonists 
induce homogeneous FRET changes throughout the cell. 
Thus, Epac activation is not confined to membranes, indi-
cating that cAMP binding is the main determinant of Epac 
activation.
CFP-Epac-YFP as a novel fluorescent cAMP 
indicator
Having shown that FRET changes in CFP-Epac-YFP reflect 
cAMP binding, we next investigated how well the Epac 
construct performs as an in vivo sensor for cAMP. We first 
tested whether CFP-Epac-YFP is insensitive to cGMP, given 
that cGMP binds to Epac with an affinity similar to that of 
cAMP, but fails to activate the enzyme [12]. In N1E-115 
neuroblastoma cells, which express soluble guanylyl cycla-
se, a massive increase in intracellular cGMP levels ensued 
upon stimulation with the NO-donor sodium nitroprusside, 
as recorded by the cGMP-sensitive FRET sensor Cygnet-1 
[13]. In contrast, the Epac FRET signal was not affected by 
nitroprusside treatment (Fig. 2A). We conclude that cGMP 
does not detectably affect the conformation of Epac. 
We next tested two cAMP analogues that are specific 
for either Epac or PKA. As shown in Fig. 2B, the Epac-spe-
cific compound 8-p-CPT-2’-O-Me-cAMP [14] reduced FRET 
in the Epac-, but not in the PKA-cAMP sensor. Conversely, 
the PKA-specific compound 6-Bnz-cAMP [15] specifically 
diminished the FRET signal only in cells expressing the 
PKA-based sensor (Fig. 2B). Thus, the Epac-cAMP sensor 
preserves its specificity for cAMP analogues. 
We further tested the Epac-FRET construct in various 
cell types, including Rat-1 and NIH3T3 fibroblasts, mouse 
GE11 epithelial cells, mouse N1E-115 neuroblastoma and 
human MCF7 breast carcinoma cells. Addition of various 
cAMP-raising agents and recep tor agonists, including for-
skolin, epinephrine, prostaglandin E1 and neurokinin A 
caused robust FRET decreases in all cases. In general, 
forskolin induced a sustained decrease in FRET, whereas 
in most cell types receptor agonists such as PGE1 and 
epinephrine elicited transient signals lasting for 10-15 
minutes (Fig. 2C and data not shown). The transient na-
ture of the epinephrine-induced signal is due to homolo-
gous receptor desen sitization, since a second but distinct 
stimulus is still capable of decreasing FRET. We conclude 
that CFP-Epac-YFP is a specific, highly sensitive and reli-
able indicator of both transient and sustained changes in 
intracellular cAMP levels. 
Figure 2.      CFP-Epac-YFP is a specific sensor for cAMP
A)  N1E-115 cells expressing either the cGMP-sensor (Cygnet 2.1, upper trace) or 
the Epac-cAMP sensor (lower trace) were treated with sodium nitroprusside (SNP, 1 
mM) and forskolin (25 mM). The traces depict cAMP- or cGMP-induced loss of FRET 
as an upward change in 
CFP/YFP ratio. 
B)  The PKA-and the Epac-cAMP sensor were tested for their sensitivity to 8-pCPT-
2’-O-Me-cAMP (alias 007; 100 mM), a speci fic activator of Epac, and Benzoyl-cAMP 
(6-Bnz-cAMP, 1 mM), which specifically activates PKA. In accordance with biochemical 
data (not shown), the slow and incomplete increases in CFP/YFP ratio in the upper 
right and lower left panels are caused by limited diffusion of these compounds over the plasma membrane. 
C)  Typical example of an agonist-induced cAMP response recorded with CFP-Epac-YFP in a Rat-1 fibroblast. Epi, epinephrine (250 
nM); forskolin (25 mM) was added to calibrate the response.
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Chapter 5
A catalytically inactive, cytosolic mutant displays 
increased FRET responses
To generate a cytosolic variant, we next deleted the DEP 
domain (aa 1-148), which is the main determinant of 
membrane DEP)-YFP, located almost exclusively to the 
cytosol (Fig. 3A) in HEK293δlocalization [16,17]. Indeed, 
this chimera, CFP-Epac( and other cells. This mutation also 
diminished Epacs ability to activate Rap1 significantly (see 
supplementary information). We further introduced muta-
tions (T781A, F782A) to render the indicator catalytically 
dead. These residues were predicted to affect Rap1-bind-
ing based on the crystal structure of SOS, a closely related 
GEF [18]. The resulting construct, CFP-Epac(DDEP-CD)-
YFP displayed no detectable Rap1 activation (see supple-
mentary information).  
Spectral analysis revealed that the basal FRET level 
in the cytosolic variants was significantly above that of the 
full-length chimera (Fig. 3B). FRET in CFP-Epac(DDEP-CD)-
YFP expressing cells reliably decreased upon stimulation 
with cAMP-raising agonists. Importantly, maximal changes 
in CFP/YFP ratio outper formed that of the full-length chi-
mera by approximately 50% in magnitude (~45% versus 
~30%), significantly increasing the signal-to-noise ratio 
(Fig 3C). Because selectivity remained unaltered as com-
pared to CFP-Epac-YFP (not shown), the cytosolic localiza-
tion, catalytic inactivity and improved signal-to-noise ratio 
make CFP-Epac(DDEP-CD)-YFP the indicator of choice for 
monitoring cytosolic cAMP levels.
Epac-based cAMP sensors display an extended 
dynamic range
Previously described PKA-based cAMP sensors are tetram-
ers consisting of two catalytic and two regulatory do-
mains. These probes contain four cAMP binding sites and 
have submicromolar (~300 nM) affinity in vivo [19]. cAMP 
binding in PKA displays coope rativity with an apparent Hill 
coefficient of 1.6 [20]. As a consequence, this probe has a 
steep dose-response relationship that rapidly reaches sat-
uration. In contrast, in vitro studies have shown that the 
affinity of the single cAMP binding site in Epac is at least 
an order of magnitude lower [21]. We determined the 
affinities of the different fluorescent Epac constructs for 
cAMP in vitro by fluorescence ratiometry (see supplemen-
tary information). The results revealed affinities of ~50, 
~35 and ~14 mM for CFP-Epac-YFP, CFP-Epac(DDEP-CD)-
YFP, respectively. Thus, the Epac-cAMP sensors should 
display right-shifted and extended dynamicδDEP)-YFP and 
CFP-Epac ( ranges. 
To test this notion in vivo, cells expressing either 
CFP-Epac-YFP or the PKA-cAMP sensor were cocultured on 
coverslips and neighboring cells expressing comparable 
amounts of Epac and PKA, respectively, were analyzed 
for FRET changes. Dosed photorelease of NPE-cAMP, a 
membrane-permeable caged cAMP analogue, was used to 
evoke identical incremental changes in intracellular cAMP 
in the two neighbor cells (Fig. 4A). Sequential increases 
in cAMP caused a rapid decrease in FRET and subsequent 
apparent saturation of the response in the PKA sensor, 
whereas the Epac sensor showed a much larger dynamic 
range. In line with these observations, the responses to 
forskolin-induced robust cAMP increases (Fig 4B) were 
rapid and saturating for the PKA-based sensor, whereas 
FRET in the Epac-based sensor changed more gradually 
and often did not saturate completely (Fig. 1D). 
The shifted and extended dynamic range of Epac for 
cAMP has important consequences for measuring physi-
ological cAMP levels. As shown in Fig. 4C, in GE11 cells 
isoproterenol triggers a rapid and rather sustained FRET 
change (~ 30%). In isoproterenol-pretreated cells, ad-
dition of lysophosphatidic acid (LPA) resulted in a rapid 
recovery of the FRET signal, as one would expect for a 
Gi-coupled receptor agonist that lowers cAMP levels [22]. 
Of note, the PKA-based sensor failed to record this rapid 
effect of LPA, apparently due to saturation of the probe, 
but rather reported a substantial lag period (up to several 
minutes; Fig. 4C, middle trace). That it fails to record the 
true kinetics of the LPA-induced cAMP response becomes 
evident when the Epac-based sensor is used. As is shown 
in Fig. 4C, CFP-Epac-YFP detects the initial fall in cAMP 
levels within seconds after LPA addition.
Figure 3.  CFP-Epac(DDEP-CD)-YFP is cytosolic, catalytically inactive, and has improved signal-to-noise ratio
A) Confocal micrograph of HEK293 cells expressing CFP-Epac(DDEP-CD)-YFP shows absence of membrane labeling. 
B) Emission spectra of CFP-Epac-YFP (dashed line) and CFP-Epac(DDEP-CD)-YFP (solid line), excited at 430 nm. 
C) Comparison of forskolin-induced change in CFP/YFP ratio in cells expressing CFP-Epac-YFP (FL) and CFP-Epac(DDEP-CD)-YFP. 
Representative traces from seven experiments each.
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Conclusions
Our results support a model in which cAMP binding to the 
regulatory domain of Epac releases an inhibitory confor-
mation that prevents binding to Rap1 [23]. Importantly, 
the FRET signal not only reflects binding of cAMP but also 
activation of Epac because cGMP, which binds with a simi-
lar affinity but fails to activate Epac [24] is without effect. 
We employed this property to show that the local, mem-
brane-delimited activation of Rap-1 [25,26] is not due to 
local activation of Epac. The here observed uniform Epac 
activation contrasts with the findings of Zaccolo and Poz-
zan (2000) who detected subcellular  cAMP gradients in 
cardiac myocytes with the PKA-based cAMP sensor. This is 
likely  explained by cell-type specific differences in activ-
ity and intracellular distribution of the phosphodiesterases 
that shape such cAMP gradients, because we failed to de-
tect gradients of cAMP using the PKA probe in our cells. 
Of note, our in vivo data based on photolysis of NPE-
caged cAMP (Fig. 4A) strongly support the notion that 
cAMP differentially regulates its effectors, i.e. low cAMP 
concentrations signal mainly via PKA, while at higher 
doses cAMP exerts additional effects via Epac activation 
[27].
This study further shows that Epac-based FRET con-
structs are ideally suited as cAMP sensors in that they dis-
play improved characteristics compared to the commonly 
used PKA-based sensors. First, the moderate affinities of 
our Epac constructs (14 to 50 mM) result in a right-shifted 
dose-response relationship that matches physiological 
cAMP levels (Fig. 4). During review of this manuscript, 
a Kd of 2.3 mM was reported for a FRET sensor based on 
Figure 4.     The Epac-cAMP sensor 
exhibits an extended dynamic range 
as compared to the PKA-cAMP sensor
A) Flash photolysis (thin arrows, 1/15 sec; 
thick arrows, 1/4 sec) of NPE-caged cAMP 
in neighboring A431 cells expressing either 
PKA-cAMP sensor or Epac-cAMP sensor 
(as recognized by partial decoration of 
membranes). Forskolin (50 mM) was added 
to further increase cAMP levels. Traces 
are normalized for comparison. B) Typical 
responses to forskolin (50 mM), recorded with 
the PKA- and the Epac-cAMP sensor in A431 
cells. 10-90% response rise times differed 
significantly (34 ± 5 s for PKA, n=9; 248 ± 
38 s for Epac, n=9; p<0.005). Note the sharp 
transition from the dynamic response range 
to the saturated plateau phase in the PKA 
sensor trace. C) Upper trace, sustained cAMP 
elevation evoked by isoproterenol (10 mM) in a 
GE11 epithelial cell. Middle and lower traces, 
registration of cAMP decreases induced by 
subsequent addition of LPA (5 mM), visualized 
with the PKA probe and the Epac probe, 
respectively. Note that Epac reveals the 
immediate LPA effect, whereas it is obscured 
by saturation of the PKA-cAMP sensor.
Epacs isolated cAMP-binding domain [28]. Thus, Epac-
based sensors provide a wide range of affinities which al-
lows matching the sensors to the anticipated cAMP levels. 
Second, the PKA regulatory subunits contain two cAMP 
binding sites each that exhibit cooperative binding (Hill 
coefficient of 1.6) resulting in a very steep response. In 
contrast, the single cAMP binding domain of Epac1 results 
in an extended dynamic range. Third, Epac needs only 
a single cAMP molecule for a ~30% FRET change while 
four molecules of cAMP are needed to cause a comparable 
change in two donor-acceptor pairs in PKA. Together with 
the lower affinity of Epac, this results in reduced buffering 
of cytosolic cAMP. This is not trivial since expression levels 
of cytosolic FRET probes commonly are in the micromolar 
range (0.1-5 mM [29]), i.e. at cAMP levels found in the 
cytosol upon receptor stimulation. Fourth, the Epac-cAMP 
sensor is a single polypeptide, eliminating expression- 
and stoichiometry-related problems encountered with the 
PKA-based versions. For instance, imbalanced expression 
levels of regulatory and catalytic subunits of PKA ham-
pers quantitative analyses of FRET changes. Furthermore, 
a single cDNA construct allows easy generation of sta-
bly transfected cell lines, which is often a problem with 
the PKA-based sensor (unpublished observations). Fifth, 
monomeric Epac sensors show faster activation kinetics 
than the slowly dissociating PKA-based sensors [30]. In 
addition, the cytosolic CFP-Epac(δDEP-CD)-YFP construct 
exhibits even larger cAMP-induced FRET changes, result-
ing in a superior signal-to-noise ratio. Together, these 
properties make Epac-based FRET probes the preferred 
fluorescent indicators for monitoring elevated cAMP levels 





Isoproterenol, 1-oleoyl-LPA, prostaglandin E1, epine-
phrine and sodium nitroprusside were from Sigma Chemi-
cal Co. (St. Louis, MO); IBMX , forskolin, and neurokinin A 
were from Calbiochem-Novabiochem Corp. (La Jolla, CA); 
1-(2-nitrophenyl)ethyl adenosine-3’,-5’-cyclic monophos-
phate (NPE-caged cAMP) was from Molecular Probes Inc. 
(Eugene, OR); 8-p-CPT-2’-O-Me-cAMP and N6-Benzoylad-
enosine-3’,-5’-cyclic monophosphate were kindly provided 
by Hans Gottfried Genieser (Biolog Life Sciences (Bremen, 
Germany). 
DNA Constructs
eCFP (“non-sticky”, A206K [1]), a multiple cloning site with 
BglII/EcoRV/NheI/SacI restriction sites, and eYFP (A206K) 
were cloned in-frame, and inserted in pCDNA3 (Invitro-
gen) using HindIII/XbaI. Full-length Epac1 was generated 
by PCR using human Epac1 (#AF103905) and cloned in-
frame into the restriction sites EcoRV/NheI of the MCS 
using the primers 5’-TTGATATCTGAT GGTGTTGAGAAG-
GATGCACC-3’ and 5’-GGGGCTAGCTGGCTCCAGCTCT-
CGG G-3’. The resultant construct contained the linker 
SGLRSRYL, separating eCFP from Epac1, and ASEL, sepa-
rating Epac1 from eYFP. 
CFP-Epac1(δDEP)-YFP was generated using the up-
stream primer 5’-TTGATATCAGC CCGTG GGAAC TCA TG-3’ 
instead, deleting aa 1-148. The latter construct was ren-
dered catalytically dead (CFP-Epac1(δDEP-CD)-YFP) by 
pointmutating T781A and F782A in the GEF domain. The 
chosen residues were predicted to affect Rap1-binding 
based on the crystal structure of the Son of Sevenless 
(SOS) protein, a GEF for H-Ras and a close family member 
of Epac[2].
The PKA-based cAMP sensor, consisting of two ex-
pression vectors encoding the YFP-tagged catalytic and 
CFP-tagged regulatory domain of PKA, was as published 
[3,4]. The FRET-sensor for cGMP, termed Cygnet-2.1 for 
cyclic GMP indicator using energy transfer, consists of a 
truncated form of the cGMP-dependent protein kinase 
sandwiched between CFP and YFP and was used as pub-
lished [5]. 
Cell Culture, transfections and live cell experiments
Cells were seeded on glass coverslips, cultured, and 
transfected with constructs as described [31]. Experi-
ments were performed in a culture chamber mounted 
on an inverted microscope in bicarbonate-buffered saline 
(containing, in mM, 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 
glucose, 23 NaHCO3, with 10 mM HEPES added), pH 7.2, 
kept under 5% CO2, at 37°C. Agonists and inhibitors were 
added from concentrated stocks. Expression levels of fluo-
rescent probes were estimated as described [32].
Dynamic FRET monitoring
Cells on coverslips were placed on an inverted NIKON Mi-
croscope and excited at 425 nm. Emission of CFP and YFP 
was detected simultaneously through 470 +/- 20 and 530 
+/- 25 nm bandpass filters. Data were digitized and FRET 
was expressed as ratio of CFP to YFP signals, the value 
of which was set to 1.0 at the onset of the experiments. 
Changes are expressed as percent deviation from this ini-
tial value of 1.0. 
Loading And Flash Photolysis of NPE-caged cAMP
Cells were loaded by incubation with 100 mM NPE-caged 
cAMP for 15 min. Uncaging was with brief pulses of UV 
light (340-410 nm) from a 100 W HBO lamp using a shut-
ter. For comparison, traces were normalized with respect 
to baseline and final FRET values.
Confocal FRET imaging
We recently described FRET imaging by sensitized emis-
sion on a Leica TCS-SP2 confocal microscope (Mannheim, 
Germany) in detail [6]. Briefly, reference cells express-
ing only CFP or YFP were seeded together with the CFP-
Epac-YFP expressing cells and simultaneously imaged in 
the same field of view. Three images were collected: the 
donor image (CFP, excited at 430 nm and detected from 
460-510 nm), sensitized emission image (YFP, excited 
at 430nm and detected from 528-603 nm) and the ac-
ceptor image (YFP, excited at 514 nm and detected from 
528-603 nm). All images were shading-corrected. Donor 
leakthrough in the sensitized emission channel and false 
acceptor excitation that occured at 430nm were corrected 
using correction factors derived from the reference cells 
as descibed [7]. Fret efficiency was expressed by dividing 
the sensitized emission image with the donor image. 
Fluorescence spectra were recorded with the λ-scan 
functionality of the Leica confocal microscope from living 
cells, excited at 430 nm. Spectra are the mean of 10 scans 
from different cells.
Fluorescence Lifetime Imaging. 
FLIM experiments were performed on a Leica inverted 
DM-IRE2 microscope equipped with Lambert Instruments 
(Leutingewolde, the Netherlands) frequency domain life-
time attachment, controlled by the vendors EZflim soft-
ware. CFP was excited with ~4 mW of 430 nm light from 
a LED modulated at 40 MHz and emission was collected 
at 450-490 nm using an intensified CCD camera. Calcu-
lated CFP lifetimes were referenced to a 1 mM solution of 
Rhodamine-G6 in medium, set at 4.11 ns lifetime. CFP-
Epac-YFP expressing cells were cocultured with reference 
cells that expressed CFP only.
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Different fluorescently tagged Epac constructs were tested 
for their guanine exchange activity towards Rap1. Indicated 
constructs were transfected in NIH3T3 cells, which do not 
express detectable amounts of endogenous Epac1. After 48 
hours, cells were stimulated with 100 µM 8-p-CPT-2’-O-Me-
cAMP for 15 min. Cells were lysed and assayed for GTP-bound 
Rap1 using GST-RalGDS as an activation-specific probe [1]. 
Upper panel, pull-down samples were probed with an 
antibody against Rap1 (Santa Cruz, SC-65). The upper band 
is HA-tagged Rap1, the lower band is endogenous Rap1. 
Middle panel, expression of HA-Rap1 as detected with 
an anti-HA monoclonal antibody (12CA5). Lower panel, 
expression of Epac1 constructs was verified using an Epac1 
specific mouse monoclonal antibody (5D3). Note that, in line 
with the reported dependence of Epac on correct subcellular 
localization, loss of the DEP domain significantly interferes 
with Rap activation. Residual activity is completely lost in CFP-
Epac1(∆DEP-CD)-YFP, the mutant that lacks Rap1 binding. 
Activation of the downstream target of Epac1, Rap1, 
reportedly is membrane-delimited, but conflicting views 
exist on whether this predominantly occurs at endomem-
branes or at the plasma membrane [2,3]. We therefore 
set out to visualize Epac activation throughout the cell 
by two different FRET techniques. Initially, we confirmed 
that tagging of Epac with GFPs does not interfere with its 
proper localization by comparing the cellular distribution 
of CFP-Epac-YFP to that of  immunolabeled endogenous 
Epac in OVCAR3 cells. In good agreement with published 
data for untagged Epac [4], CFP-Epac-YFP localized in 
the cytosol as well as to membranes (the nuclear enve-
lope, perinuclear membranes, and to a lesser extent the 
plasma membrane).  
Widefield Fluorescence Lifetime IMaging (FLIM; see 
Methods) reports FRET quan ti tatively as a decrease in 
the excited-state lifetime of the fluorescent donor mole-
cule. For reference, A431 cells expressing CFP-Epac-YFP 
were imaged along with HEK293 control cells expressing 
cytosolic CFP. In resting cells, our FLIM analysis failed to 
reveal spatial differences in FRET efficiency (Fig. 2A, left 
panel). Furthermore, activa tion of Epac with cAMP-rais-
ing agonists caused a similar FRET decrease throughout 
the cells (Fig. 2A, right panel).
To better resolve subcellular details, we employed a 
recently developed, highly corrected confocal laser scan-
ning FRET microscopy approach [5] that allows discrimi-
nation of CFP-Epac-YFP activation in the cytosol and at 
membranes. In the cell types studied, Epac activation 
state as deduced from FRET did not depend on mem-
brane localization (lower left panel). cAMP-raising ago-
nists such as epinephrine (250 nM) caused similar FRET 
changes at membranes and in the cytosol (lower right 
panel). The homogeneous FRET values determined for 
CFP-Epac-YFP throughout the cells are likely due to the 
rapid diffusion of cAMP in the cytosol. Taken together, 
our data demonstrate that Epac1 activation is not local-
ized to membranes and further indicate that binding to 
cAMP is the main determinant of Epac activation. 
Suppl Figure 2. Spatial distribution of Epac activity as 
detected by fluorescence resonance. 
A) (left panel) FRET in CFP-Epac-YFP expressing A431 cells 
as detected by FLIM. The homogeneous lifetime of ~1.7 
ns throughout the cell indicates ~30% FRET efficiency. For 
reference, CFP in control cells displays a lifetime of ~2.4 
ns. (right panel) Stimulation with fors ko lin (1 µM) decreases 
FRET, causing the lifetime to increase to ~2.2 ns. 
B) Confocal images of an A431 cell expressing CFP-Epac-
YFP. Upper left, YFP fluorescence; upper right, sensitized 
emission, i.e. calculated YFP emission resulting from FRET; 
lower left, calculated FRET efficiency in resting cell; lower 
right, FRET efficiency after epinephrine treatment (250 
nM). 
Suppl fig 2.       Epac activation is independent of subcellular localization
Suppl Fig 1.     In vivo guanine nucleotide exchange (GEF) activity of Epac-based FRET probes
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To determine dissociation constants (Kd) to-
wards cAMP, five 15-cm petridishes of HEK293 
cells were transfected for each of the constructs. 
Cells were harvested 24h post transfection, 
washed in PBS and homogenized in hypotonic 
medium (PBS:H2O, 1:2) with a Downs piston. 
The homogenate was cleared by high-speed 
centrifugation for 10 minutes and subsequently 
ionic concentrations were corrected towards 
intracellular levels (in mM: 140 KCl, 5 NaCl, 1 
MgCl2 and 10 HEPES for pH 7.2).
FRET changes caused by consecutive addi-
tions of cAMP were recorded in the stirred cuvet 
of a PTI Quantamaster dual channel spectro-
fluorimeter (Lawrenceville, NJ). FRET was ex-
pressed as the ratio of the YFP channel (530 
+/-10 nm) and the CFP channel (490 +/- 10 
nm), when excited at 420 +/-3 nm. For analy-





Suppl fig 3.     Fluorescently tagged Epac constructs bind cAMP with micromolar affinities 
Suppl Figure 3. 
Dose-response relationship for cAMP-induced FRET changes for CFP-Epac-
YFP (red), CFP-Epac(δDEP)-YFP (green), and CFP-Epac(δDEP-CD)-YFP (blue) 
in vitro. Apparent disso ciation constants were 50 +/- 3 μM, 35 +/- 3 μM, and 
14 +/- 2 μM, respectively (N=3). Hill coefficients did not differ significantly 
from 1 (0.97, 0.95 and 0.94, respectively). Shown are data and fitted curve 
of a representative example.
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Abstract
Gap junctions (GJ) are clusters of transmembrane channels that allow direct cell-to-cell transfer of ions and small 
molecules. The GJ-permeant signaling molecule cAMP is of particular interest because of its numerous cellular 
effects. However, to assess the biological relevance of GJ-mediated cAMP transfer, quantitative aspects must 
be determined. Here we employed cAMP indicators based on fluorescence resonance energy transfer (FRET) to 
study propagation of cAMP signals to neighbor cells through connexin43 (Cx43)-based gap junctions in Rat-1 
cells quantitatively. Intracellular cAMP levels were selectively raised in single cells by either photorelease of 
caged cAMP or stimulation of G(s)-coupled receptors. cAMP elevations spread to adjacent cells within seconds 
in a Cx43-dependent manner. We determined that Rat-1 cells follow cAMP rises in surrounding monolayer cells 
to approx. 40% in amplitude. This degree of cAMP transfer sufficed to evoke a well-characterized response to 
cAMP in neighbour cells, i.e. the PKA-mediated phosphorylation of the ER transcription factor in A431 carcinoma 
cells. We conclude that contacting cells can cooperatively regulate cAMP-sensitive processes via gap junctional 




The second messenger cAMP signals a wide variety of 
cellular activities including changes in metabolism, gene 
transcription and secretion. Furthermore, in many cell 
types cAMP is a negative regulator of cell proliferation and 
migration. Basal cytosolic cAMP levels are in the low mM 
range [1], tightly controlled by the counteracting activities 
of adenylyl cyclases (AC) and phosphodiesterases (PDEs). 
ACs are activated by G(α)s subunits and inhibited by G(α)i. 
Activated ACs can evoke transient cAMP elevations, while 
PDEs mediate subsequent degradation and are the main 
determinants of basal cAMP levels. Members of both AC 
and PDE enzyme families differ in their regulatory and 
pharmacological characteristics. The cell type-dependent 
expression of AC and PDE isoforms therefore determines 
the balance in cAMP turnover.
Gap junctions (GJs) are transmembrane channels 
that are formed by docking of two connexons, each con-
tributed by one of the adjoining cells and each consist-
ing of 6 connexin molecules. GJs allow the intercellular 
exchange of small molecules (<1-2 kD), including ions, 
small peptides [2] and second messengers such as IP3 
and cyclic nucleotides [3,4]. The gap junctional commu-
nication (GJC) of cAMP is of special interest because of 
cAMP’s involvement in multiple signaling cascades. It re-
mains unclear, however, whether intercellular cAMP diffu-
sion has signaling functions between adjacent cells. This 
may critically depend on GJ permeability for cAMP, tissue 
geometry and PDE activity in receiving cells. Quantitative 
studies in a relevant cell system are required to assess the 
importance of cAMP-GJC.
Thus far, studies on cAMP-GJC employed indirect, 
non-quantitative readouts [5-9], while direct, quantitative 
readouts such as radiolabeled cAMP have been applied in 
artificial systems of gap junctions reconstituted in lipo-
somes [10,11]. Here, we use recently developed fluores-
cent cAMP sensors as direct readouts for GJC of cAMP in 
Rat-1 cells. The used FRET-reporters are the fluorescent 
equivalents of PKA [12] and the exchange factor Epac1 
[13] and therefore allow direct readout of cAMP. The te-
trameric PKA sensor is most suitable for the detection of 
subtle cAMP changes due to its high affinity (~300 nM). 
However, the relative expression levels of its subunits in-
Figure 1       Flash photolysis 
of NPE-caged cAMP 
demonstrates GJ diffusion 
of cAMP
A)  Rat-1 fibroblasts were seeded 
at low density and transfected 
with Epac-based FRET sensor. Left: 
after incubation with NPE-caged 
cAMP (5 min, 100 mM), cAMP was 
photo-released with UV light (0.5 
sec from a 10-fold attenuated 
Hg arc lamp) while FRET was 
recorded ratiometrically by confocal 
microscopy (ratio changes in %). 
Right: 4 sex exposure induced 
saturation of the  Epac sensor as 
judged from response kinetics. 
Essentially identical results were 
obtained with the PKA-based 
sensor. 
B)  Left: flash-photolysis of caged 
cAMP in one cell of a Rat-1 doublet 
(see inset; red, illuminated cell; 
blue, neighbor cell). 0.5 ses UV 
flashes caused non-saturating 
rises in cAMP that were followed by 
increases in the neighbor cells with 
5 to 15 sec delay in ~55% of all 
experiments. If cAMP transfer was detected, 50 mM 2-APB was added to close GJs. Subsequent UV flashes caused cAMP increases 
that were restricted to the illuminated cell (9 out of 10). Essentially identical results were obtained with the PKA sensor (not shown, 
n=6). Right: typical FRAP experiment (see methods) showing that 50mM of 2-APB effectively abolishes transfer of the widely used 
GJC tracer calcein (n=9). 
C)  Left: experimental setup similar to B), except that here the high-affinity PKA sensor was used. A 0.5 sec UV flash caused [cAMP] 
to increase in both the illuminated cell and its neighbor. The GPCR agonist TRP (12.5 mM), which blocks GJC in a physiological manner, 
abolished the neighbor response after a subsequent flash (2 sec; 4 out of 6 exp.). Right: calcein-FRAP experiments confirmed GJ 
closure by TRP (6 out of 8 exp.). 
D)  Left: similar uncaging experiment in a doublet of Rat-RNAi-Cx43 cells. No increases in neighbor cells were observed (n=8). 
Calibration was performed by UV-illumination of both cells. Right trace: calcein FRAP experiments confirming the lack gap junctional 
communication in Rat-RNAi-Cx43 cells (n=12). 
Inset: Western blot analysis with anti-Cx43 antibody to show downregulation of Cx43 protein.
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evitably vary from cell to cell and this hampers quantita-
tive analyses. The single-polypeptide  Epac sensor, that 
was previously developed in our lab, provides a more 
quantitative readout and thus enables to determine the 
exact relationship between source cells and receiving cells. 
Using this fluorescent toolbox we determined that Rat-1 
cells follow cAMP rises in surrounding monolayer cells to 
approx. 40% in amplitude. Furthermore, we present evi-
dence that cAMP diffusion can mediate structural changes 
in transcription factors in adjacent A431 carcinoma cells. 
Finally, we show that PDE activity is a major limiting factor 
in the degree of cAMP spreading in a monolayer. 
Results and Discussion
Direct measurement of gap junctional diffusion of 
cAMP using flash photolysis
We first examined gap junctional diffusion of cAMP using 
the cAMP sensor based on Epac [13]. We used Rat-1 cells 
as a model system since these cells are well coupled by 
connexin43(Cx43)-based gap junctions. Fig. 1A shows the 
dosed release of cAMP by flash-photolysis of NPE-caged 
cAMP in a single, isolated Rat-1 cell as detected by the 
Epac-based sensor. It can be seen that this sensor ac-
curately monitors the rapid increase in cAMP induced by 
a 0.5 s UV flash (details in Methods) and its subsequent 
clearance, which presumably represents breakdown by 
intracellular phosphodiesterases (PDEs; left trace). Pro-
longed UV exposure induced a marked plateau reflecting 
saturation of the Epac sensor (right trace).
Next, we examined the intercellular diffusion of cAMP 
in contacting Rat-1 cells. When caged cAMP was photo-
released in one of two neighboring Rat-1 cells (using a di-
rected UV beam; Fig. 1B), a substantial rise in cAMP levels 
was observed in the neighboring cell in 55% of all experi-
ments. The ~10 s response delay reflects gap junctional 
diffusion. Occasional lack of cAMP transfer most likely re-
flects poor GJC between these subconfluent cells because 
a similar success rate was observed in FRAP experiments 
with the GJ-permeable tracer calcein (hundreds of experi-
ments over the years); see right panels in Fig. 1B,C for 
example traces). To confirm that this effect was medi-
ated by gap junctional diffusion rather than an alternative 
(paracrine) mechanism, we used the (non-specific) GJC 
blocker 2-APB [16]. As shown in Fig. 1B, 2-APB completely 
blocked the cAMP elevation in the neighboring cell (9 out 
of 10 experiments). Identical results were obtained with 
the PKA-based FRET sensor (n=6; data not shown). The 
PKA-FRET experiments confirm that 2-APB blocked GJC 
completely, as the high affinity of this sensor is expected 
to pick up even minor changes in [cAMP]. Similarly, when 
GJC was disrupted by addition of GPCR agonists, such as 
Thrombin Receptor activating Peptide (TRP, SFLRRN) or 
endothelin (ET) [17], the rise in cAMP was strictly con-
fined to the UV-flashed cell (Fig. 1C). 2-APB- and agonist-
induced inhibition of GJC was confirmed by calcein FRAP 
experiments (Fig. 1B,C, right panels).
Rat-1 cells express Cx43 as the only GJ protein [17] 
as confirmed by RNAi-mediated knockdown of Cx43. Cx43 
knockdown cells were completely communication-deficient 
(Rat-RNAi-Cx43; Fig. 1D, right panel and data not shown). 
Figure 2       cAMP-GJC 
measurements using the Rat-GR 
Donor cell line
A)  Upper trace: native Rat-1 cell is 
unresponsive to glucagon (20 nM), as 
monitored by the highly sensitive PKA 
sensor. Middle and lower trace: responses 
of Rat-GR cells to saturating (20 nM) 
and submaximal (2 nM) glucagon doses, 
respectively, measured with the Epac 
sensor. All experiments were calibrated 
by addition of forskolin (50 mM) and 
IBMX (100 mM). Below: dose-response 
relation ship characteristic for the Rat-
GR cell line determined with Epac-FRET; 
amplitudes as % of maximal FRET 
changes induced by forskolin and IBMX. 
Each data point stems from multiple cells 
(n=10 to 15) simultaneously recorded 
in multiple-position mode experiments 
(mean +/- s.e.m.).
B) Two Acceptor cells adenovirally 
transduced with the  Epac sensor 
bordered on a single Rat-GR Donor cell expressing the nuclearly localizing H2B-mRFP for recognition. Following addition of glucagon 
(20 nM) Epac-FRET detects cAMP increased in both neighbor cells (observed 17 out of 23). The difference in amplitude may be 
explained by differing degrees of GJC. Consistent with this, the left cell showed a faster rise time than the right one. Traces were 
normalized to maximal FRET changes induced by forskolin (50mM). 
C)   Epac-measurement in a Rat-RNAi-Cx43 cell adjacent to a Rat-GR Donor. No cAMP elevations were detected after administration 
of glucagon (n=14). 
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Chapter 6
When cAMP was photoreleased in one of two neighboring 
Cx43-deficient Rat-1 cells, the resulting rise in cAMP was 
not mirrored in the neighboring cell. In conclusion, Cx43-
based gap junctions allow rapid and efficient exchange of 
cAMP between neighboring cells.
Gap junctional diffusion of cAMP following receptor 
stimulation
We next raised cAMP in the “Donor” cell in a more physi-
ological manner, namely by stimulating a prototypic Gs-
coupled hormone receptor. Rat-1 cells retrovirally trans-
duced with the G(α)s-coupled glucagon receptor (Rat-GR) 
were stimulated with glucagon and the Gs-mediated rise 
in cAMP was monitored over time using the Epac sensor. 
Glucagon-induced cAMP elevations were sustained for up 
to 1 hour. Whereas high glucagon concentrations saturat-
ed the  Epac sensor (Fig. 2A, middle trace), lower doses of 
the hormone evoked intermediate responses (lower trace). 
The dose-response curve, determined with the quantita-
tive Epac sensor, indicates an EC(50) value of ~4 nM, in 
agreement with the literature [18]. In co-culture, Rat-GR 
cells serve as cAMP Donors for wildtype Rat-1 cells, which 
lack functional glucagon receptors (Fig. 2A, upper trace). 
We co-cultured Rat-GR Donor cells (expressing H2B-
mRFP as a transfection marker) with wild-type Rat-1 cells 
expressing the  Epac sensor (1:50 ratio) to ensure that 
Acceptors contact single Donors only. Addition of 20 nM 
glucagon, which elicits near-maximal responses in the 
Donors, caused substantial cAMP rises in adjacent Ac-
ceptors (17 out of 23 experiments). In the representative 
experiment in Fig. 2B, the two Acceptors showed ~75% 
and 50% cAMP responses compared to maximal activation 
induced by forskolin. 
When Rat-GR Donors were mixed 1:50 with Cx43-
knockdown cells expressing the  Epac sensor, no cAMP sig-
nal was observed in the neighboring cells (Fig. 2C, n=14), 
consistent with a requirement for gap junctions to transfer 
cAMP. Thus, the specific sensitivity to glucagon and the 
ability to tune its responses (Fig. 2A) make the Rat-GR 
cell line a convenient tool to investigate gap junctional 
diffusion of cAMP.
cAMP diffusion mediates transcription factor 
phosphorylation in adjacent cells
To show that the intercellular exchange of cAMP can serve 
a signaling function, we monitored the cAMP-sensitive 
modification of the estrogen receptor (ER). The ER, a 
cytosolic transcription factor, plays a key role in breast 
cancer development; anti-estrogens such as tamoxifen 
find wide clinical application. Using a FRET-based ER con-
struct (YFP-ER-CFP), Michalides and coworkers showed 
that tamoxifen induces a conformational change in the ER 
that inactivates this transcription factor. Strikingly, a rise 
in cAMP abrogates the tamoxifen-induced shape change 
[14]. These authors further showed that cAMP acts via 
PKA-mediated phosphory lation of the ER at Ser305 [14], 
thereby rendering the cells resistant to tamoxifen. 
We used this system to study whether intercellular 
diffusion of cAMP may confer tamoxifen-insensitivity to 
neighboring cells. To this end, we used Cx43-expressing 
human A431 carcinoma cells (A431/Cx43) as Acceptors. 
When co-cultured with glucagon-sensitive Rat-1 cells, 
A431/Cx43 cells form functional heterotypic gap junc-
tions with the Rat-1 cells (data not shown). As expected, 
A431 cells expressing the YFP-ER-CFP reporter became 
resistant to tamoxifen after addition of forskolin (Fig. 3A). 
When these cells were co-cultered with glucagon-sensitive 
Rat-1 cells, addition of glucagon caused a significant rise 
in cAMP in adjacent A431/Cx43 Acceptor cells (Fig. 3B). As 
shown in Fig. 3C (upper trace), glucagon completely pre-
vented the tamoxifen-induced ER shape change in A431 
cells. Again, this effect was not observed in wildtype A431 
cells lacking gap junctions (Fig. 3C, lower trace). From 
these results we conclude that gap junctional diffusion of 
cAMP from normal fibroblasts to adjacent carcinoma cells 
can influence the conformation state of the ER transcrip-
tion factor in the cancer cell. 
Figure 3     cAMP-GJC mediates PKA-dependent structural changes in estrogen receptor (ER) in adjacent 
cells.
A)  YFP-ER-CFP FRET in A431/Cx43. Upper trace: the anti-estrogen tamoxifen forces the ER reporter into the inactive conformation 
as reported by FRET in CFP-ER-YFP (n=20). Lower trace: after pretreatment with 25 mM forskolin (10 min) the tamoxifen-effect is 
abolished (11 of 13 exp.). 
B)  Following addition of glucagon (20 nM), Epac-FRET measures cAMP increases in A431/Cx43 cells that are adjacent to Rat-GR 
Donors (9 of 10 exp.). A431/Cx43 cells themselves are unresponsive to glucagon (data not shown).
C)  Upper trace: glucagon-stimulation of Rat-GR Donor cells prevents the response of YFP-ER-CFP to tamoxifen in neighboring A431/
Cx43 cells (representative trace, n=7). Lower trace: the preventive action of Rat-GR stimulation is not observed when cocultured 
with native A431 cells expressing YFP-ER-CFP (n=8).
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Single cells proportionally follow the cAMP levels of 
surrounding cells
We next set out to quantify to which degree single cells 
follow the cAMP signal in neighboring monolayer cells. 
The  Epac sensor was transduced into Donor and Acceptor 
Rat-1 cells and both were seeded scarsely on a monolayer 
of non-fluorescent Rat-GR Donors (Fig. 4A). cAMP levels in 
the Donor monolayer were increased with various doses of 
glucagon and responses in both  Epac sensor expressing 
Donor and Acceptor cells were monitored in multiple-posi-
tion acquisition mode. As can be seen from the represent-
ative experiment in Fig. 4B, cAMP levels in Acceptor cells 
closely follow the kinetics of the Donor responses with a 
lag time of less than one minute. The Donor and Acceptor 
response amplitudes, plotted in Fig. 4C, show a striking 
proportionality (regression coefficient 0.38, p<0.001) in-
dicating that Acceptors, although surrounded by Donors, 
maintain (or ‘clamp’) their cAMP levels down to 38% of 
the Donor levels, by counterbalancing the cAMP influx via 
clearance mechanisms (e.g. PDE-mediated degradation). 
This proportionality is observed for all cAMP concentra-
tions in the Donor monolayer down to micromolar con-
centrations (see legend for considerations regarding the 
relationship between FRET and [cAMP]), suggesting that 
cAMP diffusion through gap junctions is relevant for cAMP 
levels in the entire physiological range. 
When monitored over a period of 2 hours, the Donor 
response was continuously mirrored in the Acceptor cells, 
even when imposing relatively minor cAMP elevations in 
the Donor monolayer (Fig. 4D). More precisely, the inte-
grated response amplitude of the Acceptors (n=15) in Fig. 
4D was 37% of that of the Donors, in excellent agreement 
with a regression coefficient of 0.38 (Fig. 4A).
Thus, as a result of GJC, the cAMP levels in individual 
cells proportionally follow those of the surrounding cells 
over the entire range of physiological cAMP levels.
PDE activity is a major determinant of cAMP 
spreading
Penetration of cAMP from source cells into surrounding 
Acceptor cells depends both on the diffusional resistance 
of the GJ and clearing by the Acceptor cells. As shown in 
Fig. 4C, cAMP levels in Acceptor cells reach an equilibrium 
Figure 4       Quantification of 
cAMP-GJC shows relevance over 
entire physiological range
A)  Coculture graphic: Donors and 
Acceptors, both expressing the  Epac 
sensor (green), were jointly seeded 
on a sub-confluent monolayer of non-
fluorescent Rat-GR Donors. Donors were 
discriminated by selective labeling with 
Cell Tracker Orange (red). Glucagon 
responses in several Donors and several 
Acceptors were simultaneously measured 
in multiple-position acquisition mode (15 
min, measurement interval 1 min).
B)  Average responses of 15 Donors 
(red) and 15 Acceptors (blue) from 
a representative multiple-position 
experiment. The kinetics of Acceptor 
cAMP levels closely follow the Donor 
responses. Shown are intracellular cAMP 
concentrations calculated from the FRET 
data as follows: glucagon-induced FRET 
changes were expressed as percentages 
of the forskolin + IBMX response (see 
example in Fig. 4A) and subsequently 
converted to [cAMP] according to 
previously determined sigmoidal 
relationship between [cAMP] and FRET. 
Note that [cAMP] is given in arbitrary units because the in vitro Kd (14 mM, Ponsioen et al.[13]) may not necessarily reflect the in 
vivo affinity; however, the shape of the converted curves is independent of Kd. 
C)  Double-log plot of Acceptor versus Donor responses, where Acceptors are singular cells while Donor responses represent the 
entire Donor monolayer. Each point in the plot combines Donor and Acceptor responses recorded in the same experiment (mean +/- 
s.e.m., 15<n<20 for each cell type). Plotted are [cAMP] (a.u.), calculated as described for B). A linear regression fit yields a slope of 
0.38 (p < 0.001). Note that the slope of the regression line does not depend on absolute calibration of [cAMP].
D)  Similar experimental setting as in B) and C), but stimulated with 2 nM glucagon and monitored for 2 hours. N=15 for both 
Donors and Acceptors. Although glucagon induced modest responses in the Donor monolayer, the Acceptor cAMP levels followed 
proportionally. FRET curves are normalized to saturating forskolin responses. Inset: same responses converted to [cAMP] as 
described in B). Dashed lines are zero. 
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state (~40% of Donor levels) within minutes, showing 
that at this stage clearance compensates for the continued 
influx. What are the main determinants of cAMP clearing? 
We set out to compare Rat-1 cells with A431/Cx43 cells, 
since the latter exhibit slower cAMP decay. This is evident 
from the experiments shown if Fig. 5A (red traces), in 
which 2-APB is used to instantly block cAMP supply from 
glucagon-stimulated Donors to the Acceptors. Whereas 
Rat-1 Acceptors cleared cAMP with a half time (t50) of ap-
prox. 1 min (Fig. 5A, left panel, red trace), the t50 in A431/
Cx43 Acceptors was approx. 9 min (Fig. 5A, right panel, 
red trace). To distinguish PDE-mediated cAMP breakdown 
from other possible clearing mechanisms we conducted 
similar experiments in the presence of the broad-spec-
trum PDE inhibitor IBMX. When added simultaneously 
with 2-APB, IBMX caused a marked increase in the decay 
t50 in Rat-1 Acceptors (Fig. 5A, left panel, blue line; for 
quantification see bar graph), indicating that in these cells 
PDE activity is a major determinant of cAMP clearance. In 
contrast, in A431/Cx43 cells clearance of cAMP was only 
marginally slower in the presence of IBMX, indicating that 
in these cells PDE-mediated breakdown plays a minor role 
(Fig. 5A, right panel). 
We next tested penetration of cAMP from single Rat-GR 
Donors into monolayers of either of the two Acceptor cell 
types (seeded 1:50). In Rat-1 Acceptor monolayers, stim-
ulation of single Rat-GR Donors induced cAMP increases 
in direct neighbors and, with much lower amplitudes, in 
second-order neighbors (Fig. 5B), but not in third-order 
neighbor cells. In contrast, in monolayers of A431/Cx43 
Acceptor cells, cAMP often penetrated well into third-order 
neighbors (Fig. 5C). Importantly, control calcein-transfer 
experiments showed lower coupling in A431/Cx43 cells 
than in Rat-1 cells (data not shown), excluding the pos-
sibility that the observed differences are explained by dif-
fering degrees of GJ-coupling. Therefore, our data indicate 
that, depending on the cell type, the PDE activity can be a 
major factor determining cAMP penetration into surround-
ing Acceptor cells.
Figure 5       PDE degradation rate determines spreading of cAMP over multiple cell layers
A)  Acceptor cells expressing the  Epac sensor (left traces, Rat-1; right traces, A431/Cx43) were seeded on monolayers of Rat-GR 
Donors. The supply of cAMP from glucagon-stimulated Donors was instantly blocked by addition of 2-APB (50mM) in the absence (red 
traces) or presence (blue traces) of IBMX (200 mM). Bar graphs: 50% decay time (t50; mean +/- s.e.m.; Rat-1 Acceptors, -IBMX 
n=5, +IBMX n=3, * p<0.001; A431+Cx43 Acceptors, -IBMX n=4, +IBMX n=4).
B)  A single Rat-GR Donor cell (expressing H2B-mRFP) feeds into a number of surrounding Rat-1 Acceptors expressing the  Epac 
sensor. Traces represent cAMP kinetics in the first-order and second-order neighbor cell (representative for n=4). Measurements 
were done in sub-confluent cultures allowing easy definition of successive neighbors.
C) Same experiment as in B), but the Rat-GR Donor now feeds into an island of  Epac sensor expressing A431/Cx43 Acceptors. 
Rat-GR Donors were discriminated by morphology. Figures examplify the assigned neighbor orders. In A431/Cx43 Acceptors, cAMP 
increases were observed up to the 3rd order neighbors (representative for n=4). Right panel: rising phases display the propagation 
of cAMP through the consecutive Acceptor layers.
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Concluding Remarks
In this study, we have used FRET-based sensors to study 
gap junction-mediated transfer of cAMP in normal fibrob-
lasts. Both the Epac-based sensor and the high-affinity PKA 
sensor revealed that subtle cAMP rises rapidly spread to 
neighbor cells and that the kinetics of the rise and fall are 
nearly synchronous in Donor and Acceptor cells (Fig. 1). 
Using the more quantitative Epac sensor, we determined 
that cAMP levels in single Rat-1 cells follow the collective 
cAMP changes in surrounding monolayer cells to ~40% 
(Fig. 4). This proportional relationship was observed over 
the entire range of physiological cAMP concentrations, in-
cluding (sub-)micromolar deviations (Fig. 4A). These data 
suggest that GJC can establish concerted regulation of 
cAMP-sensitive processes among tissue cells.
The observed Acceptor-Donor proportion of ~40% is 
determined by the cAMP permeability of Cx43 as well as 
by PDE degradation rates in the Acceptor cells. In a recent 
study, Bedner and coworkers reported the order of cAMP 
permeabilities for a number of connexin family members: 
Cx43 > Cx26 > Cx45 = Cx32 > Cx47 > Cx36 [8]. How 
these different permeabilities affect the Acceptor-Donor 
proportion of cAMP levels in cell systems as described 
here, remains to be determined. The same is true for the 
extrapolation of our findings to the 3D architecture of real 
tissues. It is expected that in 3D tissue the number of gap 
junctional connections per cell exceeds those encountered 
in a 2D monolayer, which would only further increase 
synchronization of cAMP levels between contacting cells. 
Our data further indicate that, depending on the cell type, 
PDE activity in receiving cells can critically determine the 
extent of cAMP-GJC: A431/Cx43 Acceptors, which exhibit 
relatively low PDE activity, follow Donor cAMP levels more 
efficiently than Rat-1 cells (Fig. 5) despite their poorer 
coupling when compared to Rat-1 cells. Physiological rises 
in cAMP were sufficient to confer tamoxifen-resistance to 
neighboring A431/Cx43 carcinoma cells (Fig. 3), illustrat-
ing how cell behaviour is influenced by GJ diffusion of 
cAMP. Among the many processes regulated by cAMP, its 
anti-proliferative effects on most cell types [19-21] is of 
special interest. Although speculative, it remains tempting 
to consider cAMP-GJC as a mechanism for the growth in-
hibitory effects of Cx43-based gap junctions [5,6,22].
Materials and methods
Chemicals
Glucagon, endothelin and 4-hydroxytamoxifen were from 
Sigma, 1-(2-nitrophenyl)ethyl adenosine-3’,-5’-cyclic 
monophosphate (NPE-caged cAMP) and Cell Tracker Or-
ange were from Molecular Probes Inc. (Eugene, OR), 
(2-aminoethoxy)diphenylborane (2-APB) was from Cay-
man Chemical (Ann Arbor, MI), Calcein-AM, forskolin and 
IBMX were from Calbiochem-Novabiochem Corp. (La Jolla, 
CA), and Anti-Cx43 polyclonal mouse antibody was from 
Sigma. All other chemicals were of analytical grade.
DNA Constructs 
pcDNA expression vectors with the following inserts were 
described elsewhere: CFP-Epac-DDEP-C.D.-YFP [13]; 
the PKA-based sensor consisting of RII-CFP and Cat-YFP 
[12] and YFP-ER-CFP [14]. CFP-Epac-DDEP-C.D.-YFP 
was cloned into the adenoviral vector from Invitrogen’s 
Virapower Adenoviral Expression System via its pENTRy 
intermediate vector (NotI/NotI into NotI-site of a pENRTy 
variant whose ccdB gene was removed from the MCS). 
The human Glucagon Receptor (hGR) was purchased from 
UMR cDNA Resource Center (Rolla, USA) and cloned di-
rectly into a retroviral LZRS-vector (EcoRI, XhoI).
Cell lines 
Rat-RNAi-Cx43; Cx43 was knocked down in Rat-1 cells 
by stable expression of retroviral pSuper containing the 
RNAi target sequence (GGTGTGGCTGTCAGTGCTC) (pRS 
Cx43). To generate virus, Phoenix-Eco package cells were 
transfected with pRS Cx43 and the supernatant contain-
ing viral particles was harvested after 72 hrs. Rat-1 cells 
were infected with 1 ml of viral supernatant supplemented 
with 10 µl Dotap (Roche; 1 mg/ml) and plated in selec-
tion medium 48 hrs later (puromycin, 2ug/ml, Sigma). 
After two weeks of selection, colonies were picked and 
tested for Cx43 expression and GJIC. The monoclonal Rat-
RNAi-Cx43 cell strain was cultured from the colony that 
expressed lowest Cx43 and, as a result, was deficient in 
communication.
Rat-GR Donor cells were generated as follows: 
Phoenix-Eco package cells were transfected with LZRS-
hGR and Rat-1 cells were transduced following procedures 
as described above. In this case, however, a polyclonal 
population was cultured by continuous puromycin selec-
tion (2 mg/ml). Test assays with Epac-FRET indicated that 
the resultant population was 100% glucagon responsive. 
Human A431 carcinoma cells stably transfected with Cx43 
cDNA were kindly provided by B. Giepmans [15].
Cell culture, transfection and live cell imaging 
Rat-1 fibroblasts and derivatives (Rat-GR and Rat-RNAi-
Cx43) and A431(/Cx43) cells were seeded in 6-well plates 
on 25-mm glass cover slips and cultured in 3 ml Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented with 
10% serum and antibiotics. Constructs were either tran-
siently transfected using Fugene 6 Transfection Reagent 
(Roche Inc.) or transduced via the Virapower Adenoviral 
Expression System (Invitrogen). For co-cultures contain-
ing cAMP Donor and Acceptor cells (see text), cells were 
separately transfected or transduced with sensor (YFP-ER-
CFP,  Epac sensor) or transfection marker (H2B-mRFP); 
after 24 hrs donors and acceptors were jointly seeded for 
the experiment one day later (48 hrs). Depending on the 
experiment, donors were stained with Cell Tracker Orange 
before mixing with the Acceptors. Live cell imaging was 
performed in a culture chamber mounted on an inverted 
microscope in bicarbonate-buffered saline (containing 
(in mM) 140 NaCl, 5KCl, 1MgCl2, 1CaCl2, 10 glucose, 23 
NaHCO3, with 10 mM HEPES added), pH 7.2, kept under 
5% CO2, at 37°C. 
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Confocal FRET measurements and photolysis of 
caged cAMP
Rat-1 fibroblasts were loaded with NPE-caged cAMP by 5’ 
incubation in a concentration 100 mM. Uncaging of cAMP 
was with brief pulses of UV light (340-410 nm) from a 
100 W HBO lamp using a shutter. For spatially resolved 
imaging of cAMP we measured FRET of the Epac- or PKA-
based sensor ratiometrically on a Leica TCS-SP2 confocal 
microscope (Mannheim, Germany). 
GJC assays using calcein-FRAP
Monolayers of cells were loaded with the GJ-permeable 
dye calcein-AM (10 min, 5 mM) and subsequently washed 
with DMEM to de-esterify the AM-moiety for 15’. Cytosolic 
calcein was bleached by high-intensity laser illumination 
directed at a single cell (~3 s, 50-fold scanning power) 
and the subsequent GJ exchange of calcein was monitored 
by confocal time-lapse imaging and normalized to calcein 
signal from remote, non-bleached cells.
FRET monitoring with high temporal resolution
Cells on coverslips were placed on an inverted NIKON Mi-
croscope and excited at 425 nm. Emission of CFP and YFP 
was detected simultaneously through 470 +/- 20 and 530 
+/- 25 nm bandpass filters. Data were digitized with a 500 
ms interval and FRET was expressed as ratio of CFP to YFP 
signals, the value of which was set to 1.0 at the onset of 
the experiments. Changes are expressed as percent devi-
ation from this initial value of 1.0. Agonists and inhibitors 
were added from concentrated stocks.
FRET monitoring with spatio-temporal resolution in 
multi-position mode
FRET was monitored on a Leica TCS-SP2 coupled to a 
Coolsnap CCD camera. Using Leica’s ASMDW acquisition 
software, time-lapse series were recorded simultaneously 
in multiple cells on predefined locations on the cover slip. 
CFP and YFP images were simultaneously detected by 
projection on two halves of the CCD chip, respectively, 
via a Dual View Filter Cube comprised of a dichroic filter 
and mirrors (Leica, Mannheim). Ratios of background-
corrected CFP and YFP were calculated from the signal in 
manually defined Regions Of Interest (ROIs) in cells and 
background areas. 
SDS-PAGE and immunoblotting
Cells were harvested in Laemmli sample buffer (LSB, 
50mM TrisHCl pH 6.8; 2%SDS; 10% glycerol;5% β-
mercaptoethanol;0.1% bromophenol blue). Samples in 
LSB were boiled for 10 minutes, subjected to SDS-page 
and transferred to nitrocellulose filters. Filters were 
blocked in 5% milk in TBST and incubated with rabbit 
polyclonal anti-Cx43 antibody and subsequent HRP-con-
jugated swine anti-rabbit secondary antibody (DAKO). 
Loading control was with mouse anti-α-tubulin and HRP-
conjugated rabbit anti-mouse (Sigma).
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Abstract
Cell-cell communication through connexin43 (Cx43)-based gap junction channels is  rapidly inhibited 
upon activation of various G protein-coupled receptors; however, the mechanism is unknown. Here, 
we show that Cx43-based cell-cell communication is inhibited by depletion of phosphatidylinositol 
4,5-bisphosphate (PI(4,5)P2) from the plasma membrane. Knockdown of phospholipase C β3 
(PLCβ3) inhibits PI(4,5)P2 hydrolysis and keeps Cx43 channels open after receptor activation. Using a 
translocatable 5-phosphatase, we show that PI(4,5)P2 depletion is sufficient to close Cx43 channels. 
When PI(4,5)P2 is overproduced by PtdIns(4)P 5-kinase, Cx43 channel closure is impaired. We find 
that the Cx43-binding partner ZO-1 interacts with PLCβ3 via its third PDZ domain. ZO-1 is essential 
for PI(4,5)P2-hydrolyzing receptors to inhibit cell-cell communication, but not for receptor-PLC 
coupling. Our results show that PI(4,5)P2 is a key regulator of Cx43 channel function, with no role 
for other second messengers, and suggest that ZO-1 assembles PLCβ3 and Cx43 into a signalling 




Communication between adjacent cells through gap 
junctions occurs in nearly every tissue and is fundamental 
to coordinated cell behaviour. Gap junctions are composed 
of connexins, consisting of an intracellular N-terminus, 
four transmembrane domains and a cytosolic C-terminal 
tail. Six connexins oligomerize into a pore-forming 
connexon, and alignment of two connexons in apposing 
cell membranes forms a gap junction channel. These 
channels allow direct cell-to-cell diffusion of ions and small 
molecules (<1-2 kDa), including nutrients, metabolites, 
second messengers and peptides, without transit through 
the extracellular space [1-3]. Gap junctions play important 
roles in normal tissue function and organ development 
[4-6] and have been implicated in a great diversity of 
biological processes, notably electrical synchronization 
of excitable cells, energy metabolism, growth control, 
wound repair, tumour cell invasion and antigen cross-
presentation [7-13]. The importance of gap junctions is 
highlighted by the discovery that mutations in connexins 
underlie a variety of genetic diseases, including peripheral 
neuropathy, skin disorders and deafness [5,14].  
Connexin43 (Cx43) is the most abundant and best 
studied mammalian connexin. Cx43-based gap junctional 
communication is of a particular interest since it is 
regulated by both physiological and pathophysiological 
stimuli. In particular, Cx43-based cell-cell coupling 
is rapidly disrupted following stimulation of certain G 
protein-coupled receptors (GPCRs), such as those for 
endothelin, thrombin, nucleotides and bioactive lipids 
[15-21]. Disruption is transient as  communication is 
restored after about 20-60 min., depending on the GPCR 
involved [22]. GPCR-mediated inhibition of intercellular 
communication will have broad consequences for long-
range signalling in cells and tissues where Cx43 is vital, 
such as dermal fibroblasts, glial cells and heart. However, 
the link between receptor stimulation and Cx43 channel 
closure has remained elusive to date. Numerous studies 
on the ‘gating’ of Cx43 channels have focused on a 
possible role for phosphorylation of Cx43 by various 
protein kinases, in particular protein kinase C (PKC), 
mitogen-activated protein (MAP) kinase and c-Src, but the 
results remain ambiguous [23-25]. One of the difficulties 
with unravelling the regulation of Cx43 channel function 
is that Cx43 functions in a multiprotein complex that is 
currently ill understood [26]. One established component 
of this assembly is the scaffold protein ZO-1, which binds 
directly to the C-terminus of Cx43 via its second PDZ 
domain [27,28]. ZO-1 has been suggested to participate 
in the assembly and proper distribution of gap junctions, 
but its precise role in the Cx43 complex remains unclear 
[29,30].
In the present study, we sought to identify the 
signalling pathway that leads to inhibition of Cx43 gap 
junctional communication in fibroblasts. Using a variety 
of experimental approaches, we show that the levels of 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) at the 
plasma membrane dictate the inhibition (and restoration) 
of Cx43 gap junctional communication in response to 
GPCR stimulation, with no role for PI(4,5)P2-derived 
second messengers. We further show that ZO-1, via its 
third PDZ domain, interacts with phospholipase C β3 
(PLCβ3) and is essential for Gq/PLC-coupled receptors to 
abrogate Cx43-based cell-cell communication. Our results 
suggest a model in which ZO-1 serves to organize Cx43 
and PLCβ3 into a complex to allow exquisite regulation of 
Cx43 channel function by localized changes in PI(4,5)P2.
Figure 1.      Cx43 is the only 
functional connexin in Rat-1 cells
A) Rat-1 cells were transduced with Cx43 
shRNA (Cx43min) or with a non-functional 
shRNA (control). Top panel: Immunoblot 
showing that stable expression of Cx43 
shRNA  leads to disappearance of Cx43 
(Cx43min cells), while leaving ZO-1 ex-
pression unaltered. Actin served as load-
ing control. Bottom panel: wide-field im-
ages of control and Cx43min Rat-1 cells. 
Cx43min cells lack cell-cell communication 
as determined by Lucifer Yellow (LY) dif-
fusion.
B) Confocal images of control and Cx43min 
cells immunostained for Cx43 (red) and 
ZO-1 (green) (scale bars, 5 mm).
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Results
Regulation of Cx43 gap junctional communication 
by the Gαq-PLCβ-PI(4,5)P2 hydrolysis pathway 
Rat-1 fibroblasts are ideally suited for studying Cx43 
channel function since they express Cx43 as the only 
functional connexin [31,32]. Stable knockdown of Cx43 
expression (using pSuper shRNA) resulted in a complete 
loss of intercellular communication, consistent with Cx43 
being the only functional gap junction protein in Rat-1 
cells (Fig. 1A). Fig. 1B shows that the Cx43-binding 
partner ZO-1 retains its submembranous localization in 
Cx43 knockdown cells.
To assess which G protein(s) mediate(s) inhibition of 
gap junctional communication, we introduced active ver-
sions of Gαq, Gαi, Gα12 and Gα13 subunits into Rat-1 cells 
and examined their impact on cell-cell coupling. Expres-
sion of active Gαq resulted in complete inhibition of inter-
cellular communication, whereas active Gαi, Gα12 and Gα13 
left cell-cell coupling unaltered, as evidenced by Lucifer 
Yellow (LY) diffusion and electrophysiological assays (Fig. 
2A). Disruption of gap junctional communication induced 
by active Gαq was persistent, as opposed to the transient 
inhibition observed after GPCR stimulation [33]. Similarly, 
treatment of Rat-1 cells with Pasteurella multocida toxin, 
a direct activator of Gαq [34], caused persistent abroga-
tion of cell-cell coupling (Fig. 2B). Gαq couples to PLCβ to 
trigger PI(4,5)P2 hydrolysis leading to production of the 
second messengers inositol-(1,4,5)-trisphosphate (IP3) 
and diacylgycerol (DAG) [35]. We monitored PI(4,5)P2 in 
living cells by using a GFP fusion protein of the PH domain 
of PLCδ1 (GFP-PH) as a probe [36-38]. In control cells, 
the PI(4,5)P2 probe was concentrated at the plasma mem-
brane. In cells expressing active Gαq, however, the probe 
was spread diffusely throughout the cytosol, indicative 
of PI(4,5)P2 depletion from the plasma membrane (Fig. 
2C). While these results are consistent with Gαq mediating 
agonist-induced inhibition of intercellular communication, 
they should be interpreted with caution since constitutive 
depletion of PI(4,5)P2 from the plasma membrane pro-
motes apoptosis [39,40]. 
To monitor the kinetics of PI(4,5)P2 hydrolysis and 
Figure 2.     Activated Gαq disrupts Cx43-based gap junctional communication: correlation with PI(4,5)P2  
depletion.
A)  Intercellular communication in Rat-1 cells transfected with various activated  (GTPase-deficient) Gα subunits. Upper panel: 
Electrical cell-cell coupling measured by a single patch-clamp electrode [18]. Whole-cell current responses to 10-mV voltage pulses 
(duration 100 ms; holding potential -70 mV) were recorded from confluent Rat-1 cells. Note dramatic increase in cellular input 
resistance (i.e. a decrease in conductance) by activated Gαq but not other Gα subunits. Middle and bottom panels: Rat-1 cells 
cotransfected with active Gα subunits and GFP (10:1 ratio). GFP-positive cells were microinjected with Lucifer Yellow (LY) and dye 
diffusion from the microinjected cells was monitored.  Wide field pictures of GFP and LY diffusion as indicated (scale bars, 10 mm).
B)  Disruption of gap junctional communication by Pasteurella multocida toxin (PMT; 1 mg/ml; 3 hrs preincubation), an activator of 
Gαq, as measured by LY diffusion (scale bars, 20 mm).
C)  Depletion of  from the plasma membrane by activated Gαq. HEK293T cells were transfected with the PI(4,5)P2 sensor GFP-PH, 
alone or together with active Gαq (1:10 ratio). GFP-PH localizes to the plasma membrane where it binds PI(4,5)P2 (left panel). Co-
expression with activated Gαq causes GFP-PH to relocalize to the cytosol (right panel).  Scale bars : 10 mm.
D)  Monitoring PI(4,5)P2 levels (red trace) and intercellular communication (black; n>20 per time point) in Rat-1 cells following 
addition of endothelin (50 nM) (upper panel ) or TRP (50 mM) (lower panel). Data points show the percentage of injected cells that 
spread LY to their neighbors. Temporal changes in plasma membrane-bound PI(4,5)P2 were measured by changes in FRET between 
CFP-PH and YFP-PH. Ionomycin, which evokes an immediate and complete depletion of PI(4,5)P2 from the plasma membrane when 
applied at high doses (5 mM) together with 5 mM Ca2+ [34] was used for calibration.  
98
Chapter 7
resynthesis with high temporal resolution, we made use 
of the fluorescence resonance energy transfer (FRET) 
between the PH domains of PLCδ1 fused to CFP and YFP, 
respectively [41]. When bound to plasma membrane 
PI(4,5)P2, CFP-PH and YFP-PH are in close proximity and 
show FRET. Following PI(4,5)P2 breakdown, the probes 
dilute out into the cytosol and FRET ceases. The prototypic 
Gq-coupled receptor agonist endothelin, acting through 
endogenous ET(A) receptors, induced an acute  and 
substantial decrease in PI(4,5)P2, reaching a maximum 
after 30-60 sec.; thereafter, PI(4,5)P2 slowly recovered 
to near basal levels over a period lasting as long as 45-
60 min. (Fig. 2D, upper panel; red trace). Sustained 
PI(4,5)P2 hydrolysis by ET(A) receptors has been reported 
previously [42] and may be explained by the fact that 
activated ET(A) receptors follow a recycling pathway back 
to the cell surface rather than the lysosomal degradation 
route [43]. The kinetics of endothelin-induced inhibition 
and recovery of cell-cell communication followed those of 
PI(4,5)P2 hydrolysis and resynthesis, respectively, with 
communication being restored after about 75 min. (Fig. 
2D, upper panel; black trace). 
More transient PI(4,5)P2 depletion and recovery 
kinetics were observed with a thrombin receptor (PAR-1) 
activating peptide (TRP), which correlated with a more 
short-lived inhibition of gap junctional communication (Fig. 
2D, lower panel). Furthermore, a desensitization-defective 
mutant NK2 receptor (for neurokinin A) that mediates 
prolonged PI(4,5)P2 hydrolysis [44] inhibits gap junctional 
communication for prolonged periods of time when 
compared to the wild-type NK2 receptor [45]. While these 
results reveal a close correlation between the duration of 
PI(4,5)P2 depletion and that of communication shutoff, 
we note that the restoration of cell-cell communication 
consistently lagged behind the recovery of PI(4,5)P2 levels. 
Nevertheless, our findings strongly suggest that the Gq/
PLCβ-mediated hydrolysis and subsequent resynthesis of 
PI(4,5)P2 dictate the inhibition and restoration of Cx43 
gap junctional communication, respectively.
Knockdown of PLCβ3 prevents cell-cell uncoupling 
The Gαq-activated PLCβ enzymes comprise four members 
(β1-4) [35]. PLCβ1 and β3 are ubiquitously expressed, 
whereas PLCβ2 and β4 expression is  restricted to hemat-
opoietic cells and neurons, respectively. Rat-1 cells ex-
press PLCβ3, but no detectable PLCβ1 (Fig. 3A and results 
not shown). We stably suppressed PLCβ3 expression using 
the pSuper short hairpin RNA (shRNA) expression vector 
[46]. Four different target sequences were selected to cor-
rect for clonal variation and off-target effects. Immunoblot 
analysis shows a marked reduction in PLCβ3 expression 
in different clones (Fig. 3A). When comparing PI(4,5)P2 
dynamics in PLCβ3 knockdown versus control cells, ago-
nist-induced PI(4,5)P2 breakdown was strongly reduced in 
the PLCβ3-deficient cells (Fig. 3B). PLCβ3 knockdown cells 
showed normal basal cell-cell communication but failed to 
shut off cell-cell communication following GPCR stimula-
tion (Fig. 3C). These results indicate that PLCβ3 is a key 
player in the control of intercellular communication, sup-
porting the view that GPCRs inhibit gap junctional com-
munication through the G(α)q/PLCβ3-PI(4,5)P2 hydrolysis 
pathway.
PLC-mediated PI(4,5)P2 hydrolysis generates 
the second messengers IP3 and DAG, leading to Ca
2+ 
mobilization and protein kinase C (PKC) activation, 
respectively. Previous pharmacological studies already 
suggested that neither Ca2+ nor PKC have a critical role 
in GPCR-mediated inhibition of cell-cell coupling [47], a 
notion supported by additional experiments using ‘caged’ 
IP3, the cell-permeable Ca
2+ chelator BAPTA-AM and a 
PKC-activating bacterial PLC [48] (data summarized in 
Supplemental Table 1). Whether PI(4,5)P2-derived second 
messengers are dispensable for Cx43 channel closure 
upon GPCR activation remains debatable, however, since 
the supporting pharmacological evidence is indirect.  
Figure 3.     Targeted knockdown of PLCβ3 prevents receptor-mediated PI(4,5)P2 hydrolysis and inhibition of 
junctional communication.
A)  PLCβ3 knockdown in Rat-1 cells as detected by immunoblotting. Expression of PLCβ3 in Rat-1 cells expressing a non-functional 
shRNA (control) and in four subclones (1-4) stably expressing different PLCβ3 shRNA constructs. Total cell lysates were immunoblotted 
for PLCβ3, Cx43 and α-tubulin as indicated.
B)  Temporal changes in plasma-membrane PI(4,5)P2 levels following thrombin receptor stimulation of normal (red trace) and PLCβ3-
deficient Rat-1 cells (blue trace). TRP, 50 mM; Ionomycin, 5 mM. 
C)  Bar graphs showing the percentage of communicating cells in control and PLCβ3 knockdown cells (clone1) treated with either 
endothelin (Et, 50 nM) or TRP (50 mM), as indicated (n >25 for each dataset). LY injections were done at 2 min. after addition of 
agonist.
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Conversion of PI(4,5)P2 into PI(4)P by 
phosphoinositide 5-phosphatase is sufficient to 
inhibit cell-cell communication 
To examine whether the depletion of PI(4,5)P2 suffices 
to inhibit Cx43 gap junctional communication, we  used 
a newly developed method to rapidly deplete PI(4,5)P2 
without activating PLC. In this approach, PI(4,5)P2 at the 
plasma membrane is converted into PI(4)P and free phos-
phate by rapamycin-inducible membrane targeting of the 
human type IV phosphoinositide 5-phoshatase (5-ptase) 
[49] (see also [50]. The method is based on the rapamy-
cin-induced heterodimerzation of FRB (fragment of mam-
malian target of rapamycin [mTOR] that binds FKB12) and 
FKBP12 (FK506-binding protein 12), as  schematically il-
lustrated in Fig. 4A. In this approach, a mutant version 
of 5-ptase with a defective membrane targeting domain 
(CAAX-box) is fused to FKBP12 and tagged with monomer-
ic red fluorescent protein (mRFP), while its binding partner 
FRB (fused to CFP) is tethered to the plasma membrane 
through palmitoylation (construct PM-FRB-CFP) [51]. In 
the absence of rapamycin, 5-ptase resides in the cytosol 
and leaves PI(4,5)P2 levels at the plasma membrane un-
altered (Fig. 4A, left panel). Upon addition of rapamycin 
(100 nM), FKBP and FRB undergo heterodimerization and 
the 5-ptase is recruited to the plasma membrane (Fig. 4A, 
right panel). 
We expressed the mRFP-FKBP-5-ptase and PM-FRB-
CFP fusion proteins in Rat-1 cells and confirmed their 
proper intracellular localization by confocal microscopy 
(not shown). Addition of rapamycin caused a rapid 
and complete depletion of PI(4,5)P2, as shown by the 
disappearance of  the PI(4,5)P2 sensor YFP-PH from the 
plasma membrane (Fig. 4B and 4C, upper trace n=10). 
As expected, no Ca2+ signal was detected following the 
5-ptase-mediated conversion of PI(4,5)P2 into PI(4)
P (n=4; Fig. 4C). To determine how the 5-ptase-
induced hydrolysis of PI(4,5)P2 affects gap junctional 
communication, we measured the intercellular diffusion 
of calcein (added as membrane-permeable calcein-AM) 
using FRAP (Fluorescence Recovery After Photobleaching) 
[52] (Fig. 4D). Rat-1 cells expressing mRFP-FKBP-5-ptase 
and PM-FRB-CFP showed efficient intercellular transfer 
of calcein. At 2 min after rapamycin addition, however, 
Figure 4.      PI(4,5)P2 depletion by 5-phosphatase inhibits gap junctional communication.
A)  Schematic representation of rapamycin-induced PI(4,5)P2 degradation at the plasma membrane. Rapamycin induces dimerization 
of FKBP domains to FRB domains. Rapamycin recruits the phosphoinositide-5-phosphatase-FKBP fusion protein (mRFP-FKBP-5-
ptase) to FRB tethered to the plasma membrane (PM-FRB-CFP), resulting in the rapid conversion of PI(4,5)P2 into PI(4)P. 
B)  Confocal images of YFP-PH in Rat-1 cells before (left) and after (right) addition of rapamycin (100nM). In addition to YFP-PH, 
PM-FRB-CFP and mRFP-FKBP-5-ptase were also correctly expressed (images not shown). Note that the translocation of YFP-PH into 
the cytoplasm is complete, indicative of massive PI(4,5)P2 hydrolysis.
C)  Representative responses to rapamycin and ionomycin. Top, cytosolic levels of YFP-PH; bottom, Ca2+ dye Oregon Green. 
Ionomycin treatment could not induce further translocation of YFP-PH, indicating that rapamycin-induced PI(4,5)P2 degradation was 
complete (n=10). Rises in cytosolic Ca2+ were never observed (n=4), confirming that PI(4,5)P2 hydrolysis did not generate second 
messengers.
D)  Gap junctional communication in Rat-1 cells transfected with PM-FRB-CFP and mRFP-FKBP-5-ptase, assayed by fluorescence 
recovery after photobleaching (FRAP) of calcein. While cells showed efficient communication before rapamycin-treatment, gap 
junctional exchange was significantly decreased at 2 min after addition of rapamycin (0.25 x recovery rate before rapamycin, n=15, 
p<0.005). The gap junction blocker 2-APB was added at 50 mM.
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intercellular dye diffusion was inhibited as inferred from 
a strongly reduced fluorescence recovery rate (Fig. 4D; 
n=15, p<0.005; about 0.25 x the recovery rate before 
rapamycin addition). The recovery of calcein fluorescence 
could not be  decreased any further by addition of the gap 
junction blocker 2-APB (2-aminoethoxy-diphenylborane; 
50 mM; Fig. 4D) [53]. Rapamycin did not affect cell-cell 
communication in non-transfected cells (data not shown). 
Thus, PI(4,5)P2 depletion by 5-phosphatase activation is 
sufficient to inhibit Cx43 gap junctional communication, 
with no need for PI(4,5)P2-derived second messengers.
Overexpression of PI(4)P 5-kinase prevents 
inhibition of cell-cell communication
PI(4,5)P2 at the plasma membrane is generated mainly 
from PI(4)P by PI(4)P 5-kinase (PIP5K) [54,55]. As a 
further test of the PI(4,5)P2 hypothesis, we stably over-
expressed PIP5K (type Iα, fused to GFP) in Rat-1 cells 
in an attempt to prevent PI(4,5)P2 depletion following 
GPCR stimulation (Fig. 5A). As shown in Fig. 5B, trans-
fected GFP-PIP5K localizes to the plasma membrane. In 
the PIP5K-overexpressing cells, PI(4,5)P2 levels remain 
elevated (i.e. above FRET threshold levels) after agonist 
addition (Fig. 5C). Nonetheless, GPCR agonists still 
induced transient rises in IP3 and Ca
2+ (Fig. 5C), indicating 
that excessive synthesis of PI(4,5)P2 does not interfere 
with its hydrolysis. Basal cell-cell communication in PIP5K-
overexpressing cells was not significantly different from 
that in control cells. However, the PIP5K-overexpressing 
cells failed to close their gap junction channels upon 
addition of TRP and, to a lesser extent, endothelin (Fig. 
5D). That endothelin is still capable of evoking a residual 
response in PIP5K-overexpressing cells may be explained 
by the fact that endothelin is by far the strongest inducer 
of PI(4,5)P2 depletion (Fig. 2D). 
Expression of a ‘kinase-dead’ version of PIP5K had 
no effect on either PI(4,5)P2 hydrolysis or inhibition of 
cell-cell communication (Fig. 5D). We conclude that Cx43 
channel closure is prevented when PI(4,5)P2 is maintained 
at adequate levels. 
 
No detectable PI(4,5)P2 binding to the C-terminal 
tail of Cx43
PI(4,5)P2 can modulate the activity of various ion channels 
and transporters, apparently through direct electrostatic 
interactions [56,57]. By analogy, regulation of Cx43 
channels by PI(4,5)P2 would imply that basic residues 
in Cx43 bind directly to the negatively charged PI(4,5)
P2. Indeed, the regulatory cytosolic tail of Cx43 (aa 228-
382) contains a membrane-proximal stretch of both 
B)  Localization of GFP-PIP5K in Rat-1 cells (scale bar, 10 mm). 
C)  Temporal changes in the levels of PI(4,5)P2, IP3 and Ca
2+ measured by the respective FRET-based sensors, as detailed in the 
Methods section.
Control and PIP5K-overexpressing Rat-1 cells were stimulated with TRP (50 mM). In control cells (red trace), PI(4,5)P2 levels rapidly 
fall after TRP stimulation, whereas PIP5K overexpression (blue trace) largely prevents the drop in FRET indicating that PI(4,5)P2 
levels remain high (i.e. above FRET threshold). Ionomycin, 5 mM. 
D)  Bar graphs showing the percentage of communicating cells (LY diffusion) in control Rat-1 cells and cells expressing 
either wild-type (wt) or kinase-dead (KD) PIP5 kinase. Cells were left untreated (C) or stimulated with GPCR agonists 
(endothelin, 50 nM; TRP, 50 mM) as indicated (n >20 for each dataset). Residual response to endothelin is explained by 
excessive depletion of PI(4,5)P2 (cf. Fig. 2D). LY injections were done at 2 min. after addition of agonist
Figure 5.     Overexpression of PI(4)P 5-kinase 
attenuates agonist-induced PI(4,5)P2 depletion 
and keeps junctional communication largely 
intact. 
A)  Stable expression of GFP-PIP5K (wild-type, WT, and 
‘kinase-dead’, KD) in Rat-1 cells. Total cell lysates were 
immunoblotted for GFP, Cx43 and α-tubulin as indicated.
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basic and hydrophobic residues (231VFFKGVKDRVKGK/
R243) that could constitute a potential PI(4,5)P2 binding 
site. Local depletion of PI(4,5)P2 might then dissociate 
the juxtamembrane region of the Cx43 tail from the 
plasma membrane leading to channel closure. We 
reasoned that if the Cx43 juxtamembrane domain binds 
PI(4,5)P2 in situ, mutations within this domain might 
interfere with PI(4,5)P2-regulated channel closure. We 
therefore neutralized the membrane-proximal Arg and Lys 
residues by mutation to alanine resulting in eight distinct 
Cx43 mutants, notably K237A,K241A; R239A,R243A; 
K241A,R243A; R239A,K241A; K237A,R239A; 
R239A,K241A,R243A; K237A,R239A,K241A and the ‘4A’ 
mutant, K237A,R239A,K241A,K243A. When expressed 
in Cx43-deficient cells, however, all these mutants were 
trapped intracellularly and failed to localize to the plasma 
membrane (Supplemental Fig. 1A). While this result 
reveals a previously unknown role for the membrane-
proximal Arg/Lys residues in Cx43 trafficking, it precludes 
a test of the Cx43-PI(4,5)P2 interaction hypothesis.
We next examined whether PI(4,5)P2 can specifically 
bind to either the Cx43 C-terminal tail (Cx43CT; aa 
228-382) or a Cx43CT-derived juxtamembrane peptide 
(Cx43JM; aa 228-263) in vitro. We generated a GST-
Cx43CT fusion protein and determined its ability to bind 
phosphoinositides in vitro using three distinct protocols. 
GST-PH(PLCδ1) was used as a positive control. In the 
first approach, agarose beads coated with either PI(4,5)
P2 or PI(4)P were incubated with GST-Cx43CT or GST-PH 
and then pulled down by centrifugation. PI(4,5)P2 beads 
readily brought down the GST-PH polypeptide but not GST-
Cx43CT (Supplemental Fig. 2A). Second, we incubated 
GST-Cx43CT with 32P-labeled PI(4,5)P2 and examined the 
ability of excess phosphoinositides to displace bound 32P-
PI(4,5)P2. While GST-PH showed again strong PI(4,5)P2 
binding that could readily be displaced by excess PI(4,5)
P2, there was no detectable binding of PI(4,5)P2 to Cx43CT 
above that observed with GST alone (Supplemental 
Fig. 2B). Finally, we found that PI(4,5)P2 (and other 
phosphoinositides) immobilized on nitrocellulose strips 
failed to bind either Cx43CT or a 35-aa juxtamembrane 
domain peptide (Cx43JM; aa 228-263; [55]) (results not 
shown). Thus, PI(4,5)P2 does not detectably bind to the 
juxtamembrane domain of Cx43, nor to the full-length 
regulatory tail (aa 228-362), at least in vitro.
ZO-1 is required for GPCRs to inhibit junctional 
communication
The very C-terminus of Cx43 binds directly to the second 
PDZ domain of ZO-1, but the functional significance of 
the Cx43-ZO-1 interaction is not understood. We asked if 
ZO-1 has a role in modulating gap junctional communica-
tion in response to GPCR stimulation. We already showed 
that RNAi-mediated depletion of Cx43 does not signifi-
cantly affect the levels and localization of ZO-1 (Fig. 1B). 
Conversely, when ZO-1 expression was knocked down by 
shRNA, Cx43 levels were unaltered (Fig. 6A). ZO-1 knock-
down Rat-1 cells retained their fibroblastic morphology 
Figure 6.     Knockdown of ZO-1 largely prevents agonist-
induced disruption of  junctional communication, while leaving 
Ca2+ mobilization intact.
A)  Immunoblots showing strongly reduced ZO-1 expression by adenoviral 
ZO-1 RNAi  compared to control virus (‘empty vector’). ZO-1 knockdown did 
not affect Cx43 expression, as indicated. 
B)  Immunostaining of Cx43 in control and ZO-1 knockdown Rat-1 cells. Note 
that ZO-1 knockdown does not affect Cx43 punctate staining patterns.
C)  Bar graphs showing communication in control (‘empty vector’) and ZO-1 
knockdown cells (ZO-1 RNAi)  before and after addition of endothelin (Et, 
50 nM) (data sets represent totals of at least two independent experiments; 
number (n) of injected cells: empty vector -/+ Et, n=53/85; ZO-1 RNAi -/+ Et, 
n=43/56). LY injections were done at 2 min. after addition of agonist.
D)  GPCR-mediated Ca2+ mobilization in control cells (red trace) and ZO-1 
knockdown cells (blue trace). Ca2+ was measured using the FRET-based Yellow 
Cameleon probe. TRP, 50 mM; Ionomycin, 5 mM.
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and showed normal Cx43 punctate staining and cell-cell 
coupling (Fig. 6B,C), showing that ZO-1 is dispensable 
for the formation of functional gap junctions. When ZO-1 
knockdown cells were stimulated with endothelin, however, 
the inhibition of cell-cell communication was severely im-
paired (Fig. 6C). Importantly, overall PI(4,5)P2-dependent 
Ca2+ mobilization was not affected in the ZO-1 knockdown 
cells (Fig. 6D). We conclude that ZO-1 is essential for the 
regulation of gap junctional communication by Gq/PLC-
coupled receptors, but not for linking those receptors to 
PLC activation. A plausible explanation for these findings 
is that ZO-1 serves to bring the PI(4,5)P2-metabolizing 
machinery into proximity of Cx43 gap junctions.
Direct interaction between ZO-1 and PLCβ3
As a test of the above hypothesis, we examined if ZO-1 
can interact with PLCβ3. PLCβ3 can associate with at least 
two scaffold proteins, NHERF2 (in epithelial cells) and 
Shank2 (in brain), via a C-terminal PDZ domain-binding 
motif [58,59]. We co-expressed HA-PLCβ3 and GFP-ZO-1 
in HEK293 cells and performed immunoprecipitations us-
ing anti-GFP antibody (Fig. 7A). Cell lysates and immuno-
precipitates were blotted for GFP and HA. As shown in Fig. 
7B,  PLCβ3 and ZO-1 can indeed be coprecipitated. Next, 
we co-expressed ZO-1 and a PLCβ3 truncation mutant 
that lacks the C-terminal 14 residues (HA-PLCβ3-∆PBD; 
Fig. 7A), and performed anti-GFP immunoprecipitations. 
Fig. 7B shows that truncated PLCβ3 fails to interact with 
ZO-1, indicating that PLCβ3 interacts with ZO-1 through 
its very C-terminus, containing the PDZ domain-binding 
motif. Considering that ZO-1 has three distinct PDZ do-
mains, we examined which (if any) PDZ domain binds 
PLCβ3. We expressed GFP-tagged versions of the three 
individual PDZ domains in HEK293 cells, either alone or 
together with HA-PLCβ3. We immunoprecipitated PLCβ3 
using anti-HA antibody and blotted total cell lysates and 
precipitates for both HA and GFP.  As shown in Fig. 7C, we 
find that PLCβ3 binds to PDZ3 but not to PDZ1 or PDZ2. 
To verify that the ZO-1-PLCβ3 interaction exists en-
dogenously, we precipitated ZO-1 from Rat-1 cells and 
blotted for both ZO-1 and PLCβ3. Fig. 7D shows that 
PLCβ3 co-precipitates with ZO-1. The reverse co-precip-
itation could not be done, since precipitating antibodies 
against PLCβ3 are presently not available. Nonetheless, 
these results suggest that ZO-1, through its respective 
PDZ2 and PDZ3  domains, assembles Cx43 and PLCβ3 into 
a signalling complex and thereby facilitates regulation of 
gap junctional communication by PLC-coupled receptors.
Figure 7.       Association of ZO-1 with PLCβ3 
A)  Schematic representation of HA-PLCβ3. X, Y represent the catalytic domains; the C2 domain interacts with activated Gαq [32]; 
∆PBD: mutant PLCβ3 lacking the C-terminal residues 1220-1234 (comprising the PDZ domain binding motif). 
B)  Co-immunoprecipitation of GFP-ZO-1 and HA-PLCβ3 expressed in HEK293 cells. TL: total cell lysates; IP, denotes 
immunoprecipitation using anti-GFP antiserum. Samples were immunoblotted for GFP (top) and HA (bottom).
C)  Co-immunoprecipitation of HA-PLCβ3 and GFP-tagged individual PDZ domains of ZO-1 expressed in HEK293 cells. TL: total cell 
lysates; IP, denotes immunoprecipitation using anti-HA antibody. Samples were immunoblotted for GFP (top) and HA (bottom).
D)  Endogenous ZO-1 immunoprecipitated (IP) from Rat-1 cells. Total cell lysates (TL) and samples from ZO-1 immunoprecipitates 
(IP) were blotted for both ZO-1 and PLCβ3 as indicated. NMS: normal mouse serum.
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Discussion 
A critical and long-standing question in gap junction bi-
ology is how junctional communication is regulated by 
physiological and pathophysiological stimuli. Relatively lit-
tle progess has been made in identifying receptor-induced 
signalling events that modulate the channel function of 
Cx43, the best studied and most abundant mammalian 
connexin. In particular, regulation of Cx43 channel activ-
ity via G-protein signalling has not been systematically 
examined to date. In the present study, we identify the 
Gq-linked PLCβ-PI(4,5)P2 hydrolysis pathway as a key 
regulator of Cx43-based gap junctional communication in 
normal fibroblasts. We demonstrate that loss of PI(4,5)P2 
from the plasma membrane is necessary and sufficient to 
close Cx43 channels, without a role for PI(4,5)P2-derived 
second messengers. In other words, PI(4,5)P2 itself is the 
responsible signalling molecule. A second novel finding is 
that the Cx43-binding partner ZO-1 binds to PLCβ3 and is 
essential for PI(4,5)P2-hydrolyzing receptors to regulate 
gap junctional communication.   
PI(4,5)P2 as a key regulator 
Our conclusion that PI(4,5)P2 at the plasma membrane 
regulates Cx43 channel function is based on several lines 
of evidence. First, active Gαq (but not Gαi, Gα12 or Gα13) 
depletes PI(4,5)P2 from the plasma membrane and abro-
gates gap junctional communication. Second, knockdown 
of PLCβ3 inhibits agonist-induced PI(4,5)P2 depletion and 
prevents disruption of cell-cell communication. Third, 
conversion of PI(4,5)P2 into PI(4)P by a translocatable 
5-phosphatase is sufficient to inhibit intercellular commu-
nication. Fourth, maintaining PI(4,5)P2 at adequate levels 
by overexpression of PIP5K renders Cx43 channels refrac-
tory to GPCR stimulation, although second messenger 
generation still occurs. 
Acting as a signalling molecule in its own right, PI(4,5)
P2 can regulate local cellular activities when its levels rise 
and fall; in particular, PI(4,5)P2 can modulate the activ-
ity of various ion channels and transporters, presumably 
through electrostatic interactions [60,61]. Although the 
existence of such interactions in living cells remains large-
ly inferential and PI(4,5)P2-binding consensus sequences 
have not been clearly defined, the common theme is that 
the negatively charged PI(4,5)P2 binds to a motif with 
multiple positive charges interdispersed with hydrophobic 
residues [62,63]. The Cx43 C-terminal juxtamembrane 
domain indeed contains such a putative PI(4,5)P2-binding 
motif (aa 231-243), although this stretch also meets the 
criteria of a tubulin-binding domain [64]. Extension of the 
above model to Cx43 channel gating would then imply 
that local loss of PI(4,5)P2 could release the Cx43 regula-
tory tail from the plasma membrane to render it suscepti-
ble to a modification leading to channel closure. However, 
our investigations to detect specific binding of PI(4,5)P2 to 
the Cx43 C-terminal tail or its juxtamembrane domain in 
vitro yielded negative results. Rather, mutational analysis 
revealed that those basic residues in the juxtamembrane 
domain have a hitherto unrecognized role in the trafficking 
of Cx43 to the plasma membrane. These findings do not, 
of course, rule out the possibility that PI(4,5)P2 does bind 
directly to Cx43 in situ.
Aside from modulating ion channel activity, PI(4,5)P2 
has been implicated in cytoskeletal remodeling, vesicular 
trafficking and recruitment of cytosolic proteins to specific 
membranes [65,66]. Although Cx43 can interact with cy-
toskeletal proteins, such as tubulin and drebrin [67,68], 
cytoskeletal reorganization does not play a significant role 
in regulating Cx43 junctional communication because cy-
toskeleton-disrupting agents (cytochalasin D, nocodazole, 
Rho-inactivating C3 toxin) have no detectable effect on 
GPCR regulation of cell-cell coupling [69] and Supplemen-
tal Table 1). Furthermore, we found that GPCR-induced 
inhibition and recovery of gap junctional communication 
are insensitive to agents known to interfere with Cx43 
trafficking and internalization, including cycloheximide, 
brefeldin A, monensin, ammonium chloride and hyper-
tonic sucrose (Supplemental Table 1).
Numerous studies have suggested that closure of 
Cx43 channels in response to divergent stimuli somehow 
results from Cx43 phosphorylation [70,71]. Several protein 
kinases, including PKC, MAP kinase, casein kinase-1 and 
Src, are capable of phosphorylating Cx43 at multiple 
sites in the C-terminal tail. These phosphorylations 
Figure 8.      Schematic drawing of 
the proposed model
ZO-1 is proposed to assemble Cx43 and 
PLCβ3 into a complex, thereby facilitating 
regulation of Cx43 channel function by 
localized changes in PI(4,5)P2 upon receptor 
activation. Since we found no evidence for 
direct binding of PI(4,5)P2 to Cx43, PI(4,5)
P2 might regulate junctional communication 
in an indirect manner, for example via a 
Cx43-associated protein that modifies the 
Cx43 regulatory tail and thereby shuts off 
channel function. PM, plasma membrane. 
See text for details.
104
Chapter 7
have been implicated not only in Cx43 channel gating 
but also in Cx43 trafficking, assembly and degradation. 
The link between Cx43 phosphorylation and altered 
cell-cell coupling is largely correlative, however, as the 
functional significance of most of these phosphorylations 
has not been elucidated. Our previous studies suggested 
that c-Src-mediated tyrosine phosphorylation of Cx43 
underlies disruption of gap junctional communication, as 
inferred from experiments using both constitutively active 
and dominant-negative versions of c-Src [72,73]. To date, 
however, we have been unable to detect GPCR-induced 
tyrosine phosphorylation of Cx43 in a physiological 
context. Furthermore, the Src inhibitor PP2  does not 
prevent GPCR agonists from inhibiting Cx43-based gap 
junctional communication in either Rat-1 cells or primary 
astrocytes (Supplemental Table 1; [74]. Therefore, 
tyrosine phosphorylation of Cx43 leading to loss of cell-
cell coupling, as observed with constitutively active c-Src 
and v-Src [75], may not actually occur under physiological 
conditions; an issue that warrants further investigation.
Essential role for ZO-1
Another novel finding of the present study concerns the 
role of ZO-1, an established binding partner of Cx43 
[76,77]. Originally identified as a major component of 
epithelial tight junctions [78], ZO-1 is thought to serve 
as a platform to scaffold various transmembrane and cy-
toplasmic proteins. ZO-1 and its close relative ZO-2 have 
several protein-interaction domains, including three PDZ 
domains, one SH3 domain and one GUK domain. In epi-
thelial cells, ZO-1 and ZO-2 act redundantly to some ex-
tent in the formation of tight junctions [79,80]. In non-
epithelial cells lacking tight junctions, ZO-1 has been at-
tributed a role in the assembly and stabilization of Cx43 
gap junctions [81-83], but its precise role has remained 
elusive. Our knockdown studies herein show that ZO-1 is 
essential for Gq/PLC-coupled receptors to inhibit intercel-
lular communication, but not for coupling those receptors 
to PLC activation, as inferred from Ca2+ mobilization ex-
periments; this result suggests that loss of ZO-1 at Cx43 
gap junctions is not compensated for by ZO-2. We find 
that ZO-1 binds directly to the very C-terminus of PLCβ3 
via its third PDZ domain. In the simplest model compat-
ible with our findings, ZO-1 serves to assemble Cx43 and 
PLCβ3 into a complex to permit regulation of gap junc-
tional communication by localized changes in PI(4,5)P2, 
as schematically illustrated in Fig. 8. Since we found no 
evidence for direct binding of PI(4,5)P2 to Cx43 in vitro, 
PI(4,5)P2 might regulate junctional communication in an 
indirect manner, for example via a Cx43-associated pro-
tein that modifies the Cx43 regulatory tail and thereby 
shuts off channel function. Precisely how PI(4,5)P2 regu-




Materials were obtained from the following sources: en-
dothelin, thrombin receptor-activating peptide (TRP; 
sequence SFLLRN), neurokinin A, Cx43 polyclonal and 
α-tubulin monoclonal antibodies from Sigma (St. Louis, 
MO); Pasteurella multocida toxin from Calbiochem-Novabi-
ochem (La Jolla, CA);  Cx43 NT monoclonal antibody from 
Fred Hutchinson Cancer Research Center (Seattle WA ); 
actin monoclonal from Chemicon International (Temecula, 
CA); polyclonal PLCβ3 antibody from Cell Signalling; ZO-1 
monoclonal antibody from Zymed; HRP-conjugated sec-
ondary antibodies from DAKO and secondary antibodies 
for immunofluorescence (goat-anti-mouse, Alexa488 and 
goat-anti-rabbit, Alexa594) from Molecular Probes. HA, 
Myc and GST monoclonal antibodies were purified from 
hybridoma cell lines 12CA5, 9E10 and 2F3, respectively. 
GFP antiserum was generated in our institute. 
cDNA constructs 
Constructs encoding active (GTPase-deficient) Gα subu-
nits, eGFP-PHPLCδ1, eCFP-PHPLCδ1, eYFP-PHPLCδ1, eGFP-tagged 
mouse type-Iα PI(4)P 5-kinase have been described 
[84-86]. Mouse PLCβ3 cDNA was obtained from MRC 
gene service, cloned into pcDNA3-HA by PCR (primers 
listed in Table S2) and ligated into pcDNA3-HA XhoI/NotI 
sites. HA-PLCβ3-∆PBD was obtained by restriction of the 
full-length construct with Eco47III, cleaving off the very 
C-terminal 14 residues. Human ZO-1 was cloned into 
XhoI and KpnI sites of peGFP C2 (Clontech). GFP-based 
Yellow Cameleon 2.1 has been described [87]. Constructs 
encoding cytosolic 5-phosphatase fused to FKB12-mRFP 
and PM-FRB-CFP have been described [88]. 
Cell culture and cell-cell communication assays
Cells were cultured in DMEM containing 8% fetal calf se-
rum, L-glutamine and antibiotics. For cell-cell communi-
cation assays, cells were grown in 3-cm dishes and se-
rum starved for at least 4 hrs prior to experimentation. 
Monitoring the diffusion of Lucifer Yellow (LY) from single 
microinjected cells and single-electrode electrophysiologi-
cal measurements of cell-cell coupling were done as de-
scribed [89]. Images were acquired on a Zeiss Axiovert 
135 inverted microscope, equipped with an Achroplan × 
40 objective (N.A. 0.60) and a Nikon F301 camera.
SDS-PAGE, immunoblotting and 
immunoprecipitation
Cells were harvested in Laemmli sample buffer (LSB), 
boiled for 10 min. and subjected to immunoblot analysis 
according to standard procedures. Filters were blocked in 
TBST/5% milk, incubated with primary and secondary an-
tibodies, and visualized by enhanced chemoluminescence 
(Amersham Pharmacia). For immunoprecipitation, cells 
were harvested in 1% NP-40, 0.25% sodium desoxycho-
late lysis buffer. Lysates were spun down and the superna-
tants were subjected to immunoprecipitation using protein 
A-conjugated antibodies for 4 hrs at 4°C. Proteins were 
eluted by boiling for 10 min. in LSB and analyzed by im-
munoblotting. 
PI(4,5)P2 regulates Cx43-based gap junctional communication
105
Immunostaining and fluorescence microscopy
Cells grown on coverslips were fixed in 3.7% formalde-
hyde in PBS for 15 min. Samples were blocked and per-
meabilized in PBS containing 1% BSA and 0.1% Triton 
X-100 for 30 min. Subsequently, samples were incubated 
with primary and secondary antibodies for 30 min. each 
in PBS/1% BSA, washed five times with PBS and mounted 
in MOWIOL (Calbiochem). Confocal fluorescence images 
were obtained on a Leica TCS NT (Leica Microsystems, 
Heidelberg, Germany) confocal system, equipped with an 
Ar/Kr laser. Images were taken using a  63x NA 1.32 oil 
objective. Standard  filter combinations and Kalman av-
eraging were used. Processing of images for presentation 
was done on a PC using the software package Photoshop 
(Adobe Systems Incorporated Mountain View, California, 
USA).
Live-cell imaging
All live imaging and time-lapse experiments were per-
formed in bicarbonate-buffered saline containing (in mM) 
140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, 23 NaH-
CO3, 10 HEPES (pH 7.2), kept under 5% CO2, at 37°C. 
Images of live cells expressing GFP-PH and GFP-PIP5K 
were recorded on a Leica TCS-SP2 confocal microscope 
(Mannheim, Germany), using a 63x lens, N.A. 1.4. 
PI(4,5)P2, IP3 and Ca
2+ imaging by FRET ratiometry 
Temporal changes in PI(4,5)P2 levels in living cells were 
assayed by the FRET-based PI(4,5)P2 sensor, PH-PLCδ1, 
as described [90]. In brief,  Rat-1 cells were transiently 
transfected with CFP-PH and YFP-PH constructs (1:1 ratio) 
using Fugene transfection agent and placed on a NIKON 
inverted microscope equipped with an Achroplan × 63 (oil) 
objective (N.A. 1.4). Excitation was at 425±5 nm. CFP and 
YFP emissions were detected simultaneously at 475±15 
and 540±20 nm, respectively and recorded with PicoLog 
Data Acquisition Software (Pico Technology).  FRET is ex-
pressed as the ratio of acceptor to donor fluorescence. 
At the onset of the experiment, the ratio was adjusted to 
1.0, and FRET changes were expressed as relative devia-
tions from base line. Temporal changes in IP3 levels were 
monitored using a FRET-based IP3 sensor, in which the 
IP3-binding domain of the human type-I IP3 receptor (aa 
224 to 605) is fused between CFP and YFP, essentially 
analogous to the sensor described previously [91]. In 
vitro binding studies showed that it bound IP3 with an ap-
parent Kd of approx. 5 nM. Intracellular Ca
2+ mobilization 
was monitored using the CFP/YFP-based Ca2+ sensor Yel-
low Cameleon 2.1 [35,92,93]. Traces were smoothened in 
Microsoft Excel using a moving average function ranging 
from 3 to 6. 
PI(4,5)P2 depletion by rapamycin-induced 
translocation of phosphoinositide 5-phosphatase 
Rat-1 cells were transiently transfected with PM-CFP-FRB 
and mRFP-tagged FKBP-phosphoinositide 5-phosphatase 
(mRFP-FKBP-5-ptase) [94]. Cells were selected for 
experimentation when sufficient protein levels were 
expressed as judged by CFP and mRFP fluorescence. 
For PI(4,5)P2 measurements, the YFP-PH construct 
was cotransfected. For Ca2+ measurements, cells were 
loaded with Oregon-Green-AM. To monitor gap junctional 
communication cells were loaded with calcein-AM and 
analyzed by Fluorescence Recovery After Photobleaching 
(FRAP) [95]. These experiments were performed on a Leica 
TCS-SP2 confocal microscope (Mannheim, Germany), 
using 63x lens, N.A. 1.4. 
Overexpression of PI(4)P 5-kinase
To overexpress PI(4)P 5-kinase (PIP5K; type Iα) [96], vi-
rus containing the LZRS-PIP5K constructs was generated 
as described above. Rat-1 cells were incubated with 1 ml 
of viral supernatant supplemented with 10 µl Dotap. 48 
hrs after infection, cells were plated in selection medium. 
Transfected cells were selected on zeocin (200 mg/ml, In-
Vitrogen) for 2 weeks and colonies were examined for 
PIP5K expression. 
RNA interference 
To generate Cx43-deficient Rat-1 cells, Cx43 was knocked 
down by stable expression of retroviral pSuper (pRS) [97] 
containing the RNAi target sequence GGTGTGGCTGT-
CAGTGCTC. pRS-Cx43 was transfected into Phoenix-Eco 
package cells and the supernatant containing viral parti-
cles was harvested after 72 hrs. For infection, cells were 
incubated with 1 ml of viral supernatant supplemented 
with 10 µl Dotap (Roche; 1 mg/ml). 48 hrs after infection, 
cells were selected on puromycin (2 mg/ml) for 2 weeks. 
Single cell-derived colonies were tested for Cx43 expres-
sion and communication. PLCβ3 was stably knocked down 
by retroviral expression of PLCβ3 shRNA. Four different 
target sequences were selected, namely ACTACGTCT-
GCCTGCGAAATT, GATTCGAGAGGTACTGGGC, TTACGTTG
AGCCCGTCAAG,`CCCTTTGACTTCCCCAAGG). Non-func-
tional shRNA was used as a control. ZO-1 was transiently 
knocked down by adenoviral expression of ZO-1 RNAi. First, 
ZO-1 RNAi oligos containing the ZO-1 target sequence 
GGAGGGCCAGCTGAAGGAC were ligated into pSuper 
after oligo annealing. Next, the oligos together with the 
H1 RNA promotor were subcloned into pEntr1A (BamHI/
XhoI) and recombinated into pAd/PL-Dest according 
to protocol (Virapower Adenoviral Expression System; 
InVitrogen). Virus was produced in 293A packaging cells 
according to standard procedures. Supernatant containing 
virus particles was titrated on Rat-1 cells to determine the 
amount needed for ZO-1 knockdown. 
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Confocal images of Cx43-deficient Rat-1 cells 
expressing wild-type Cx43(wt) and Cx43-4A, in 
which basic Arg/Lys residues in the C-terminal 
juxtamembrane domain were neutralized by 
mutation into Ala. Cells were immunostained 
for Cx43 (red) and α-tubulin (green). Note 
intracellular accumulation of Cx43-4A 
and lack of detectable plasma membrane 
staining. Similar intracellular accumulation 
was observed with seven other Cx43(K/R-
>A) mutants, notably K237A,K241A; 
R239A,R243A; K241A,R243A; R239A,K241A; 
K237A,R239A; R239A,K241A,R243A; and 
K237A,R239A,K241A. Scale bars: 5 mm.
Suppl Fig 1.        Cx43-4A mutant accumulates intracellularly
A)  Pull-down of GST alone, GST-PH and 
GST-Cx43CT (aa 227-382) fusion proteins 
using PI(4)P- and PI(4,5)P2 -coated agarose 
beads (Molecular Probes), as indicated. GST 
fusion proteins were purified from DH5a 
bacteria following standard procedures. 
Anti-GST monoclonal antibody was purified 
from hybridoma cell line 2F3. 10 mg of GST 
or fusion protein was incubated with 7 ml 
of beads (~70 pmol) in 300 ml Triton-X100 
buffer for 4 hrs at 4°C; beads were spun down 
by centrifugation. 20 ml of the supernatant 
(S) was used as input control. Protein was 
eluded from the beads (B) by boiling for 10 
min. in Laemmli sample buffer and analyzed 
by SDS-PAGE and immunoblotting for the 
presence of GST or GST-fusion protein. 
B)  Binding of 32P-labeled PI(4,5)P2 to GST 
fusion proteins. GST, GST-PH and GST-
Cx43CT were coupled to glutathione beads 
and incubated with [32P]-PI(4,5)P2 alone or 
together with excess unlabeled PI, PI(4)P or 
PI(4,5)P2 for 1 hr at 4°C, as indicated. Beads 
were washed extensively (after centrifugation) 
and bound 32P activity was measured.
Suppl Fig 2.        No detectable phosphoinositide binding to the Cx43 C-terminal tail (CT) 
PI(4,5)P2 regulates Cx43-based gap junctional communication
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Supplemental Tables
Suppl Table 1.      
Pharmacological agents showing no effect on either basal or GPCR-regulated cell-cell communication. 
Cell-cell communication in Rat-1 cells was determined by LY diffusion. See also Postma et al. [18].
Suppl Table 2.    
Oligos used for cloning, mutagenesis and RNAi constructs.  
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Abstract
We recently reported on CFP-Epac-YFP, an Epac-based single polypeptide FRET reporter to resolve 
cAMP levels in living cells. In this study, we compared and optimized the fluorescent protein donor/
acceptor pairs for use in biosensors such as CFP-Epac-YFP. Our strategy was to prepare a wide 
range of constructs consisting of different donor and acceptor fluorescent proteins separated by 
a short linker. Constructs were expressed in HEK293 cells and tested for FRET and other relevant 
properties. The most promising pairs were subsequently used in an attempt to improve the FRET 
span of the Epac-based cAMP sensor. The results show significant albeit not perfect correlation 
between performance in the spacer construct and in the Epac sensor. Finally, this strategy enabled 
us to identify improved sensors both for detection by sensitized emission and by fluorescent lifetime 




Fluorescence Resonance Energy Transfer (FRET), the ra-
diationless transfer of energy from a donor fluorophore to 
an acceptor, has become an important tool in cell biology 
because it allows visualization of protein-protein interac-
tions by light microscopy. FRET is also ideally suited as the 
read-out for so-called ‘sensors’, i.e. genetically engineered 
constructs that report on the conformation or activation 
state of proteins. We previously reported on CFP-Epac-YFP 
[1], a sensor construct that consists of part of the cAMP-
binding protein Epac1 sandwiched between cyan- and yel-
low fluorescent proteins. The construct unfolds upon bind-
ing of the second messenger cAMP to the Epac moiety and 
cAMP increases are thus easily followed as a drop in FRET. 
Whereas the cAMP-induced FRET change in CFP-Epac-YFP 
is already quite robust (CFP/YFP emission ratio changes by 
~30%), the recent introduction of a range of new fluores-
cent proteins prompted us to further optimize FRET span 
and other properties of the sensor by systematic variation 
of the donor- and acceptor fluorescent proteins.
The physical requirements for resonant energy 
transfer are summarized in 2 equations:   
 E = 1  / (1 + (r/R0)
6 )   [2]
with 
 R0 = [cκ
2η-4ϕdεaJ(λ)]
1/6   [2,3].
As can be seen from the inverse 6th power in equation 1, 
transfer efficiency E depends steeply on the distance (r) 
between donor and acceptor, relative to the characteristic 
Förster radius (R0, the distance at which transfer is half-
maximal for that particular FRET pair). R0 in turn depends 
on several factors including κ2 , which describes the align-
ment of donor- and acceptor fluorescent dipoles and J(λ), 
which represents the overlap of donor emission spectrum 
and acceptor excitation spectrum. Furthermore, donor 
quantum yield (ϕd) and acceptor absorption coefficient (εa) 
are important determinants of R0. Why these considera-
tions are important for FRET constructs will become clear 
in the following.
FRET changes may be detected by several micro-
scopical techniques [4], the most important of which are 
sensitized emission (SE) and fluorescence lifetime imag-
ing (FLIM). In SE the donor is excited with light of suit-
able wavelength, and energy transfer is quantified from 
the ratio of donor and acceptor emission. Given proper 
correction for spectral bleedthrough and cross excitation 
completely quantitative results can be obtained [5]. In 
contrast, FLIM measurements rely on the donor signal 
only. In these measurements, the characteristic decay of 
donor fluorescence upon excitation is followed with sub-ns 
time resolution. FRET is then apparent as a shortening of 
the donor decay time, essentially as: E=1-τD+A / τD, where 
τD+A and τD are the excited-state lifetimes of the donor in 
the presence and absence of the acceptor, respectively.
Recent years have seen an enormous expansion in 
the number of available fluorescent proteins (FPs). Almost 
every month new versions that differ in color, brightness 
or other characteristics are being added. Many of these 
have potential for use in FRET pairs. What makes a good 
FRET pair for in vivo sensors? Keeping with the example of 
CFP-Epac-YFP, even if we ignore the design considerations 
for the cAMP-sensing core and focus on just the FPs, the 
answer is already complicated. Loosely grouped, we can 
distinguish photophysical-, biological- and detection con-
siderations. 
Photophysics 
Obviously, for optimal FRET imaging one needs a con-
stellation that maximizes FRET span when cAMP levels 
change. Thus, Förster radius of the FRET pair, brightness 
and dipole orientation enter the equation. Other impor-
tant photophysical properties concern photostability (e.g. 
bleach rate and photochromism [6]), insensitivity to mi-
croenviromental conditions such as pH or ionic strength 
[7] and, in case of uncaging experiments, insensitivity to 
UV light. Finally, FPs must fold efficiently at 37°C and they 
must rapidly attain their final spectral properties (matura-
tion). 
Biology
As sensors must be biologically inert, the fluorescent 
moieties may not influence cellular function and localiza-
tion of the tagged protein. For that matter, the size of at-
tached fluorophores must be minimal and their tendency 
to dimerize or aggregate excluded [8]. In general, longer 
excitation wavelengths are preferred over near-UV or blue 
excitation for reasons of phototoxicity [9,10,11], tissue 
penetration and autofluorescence. Unfortunately, many 
red FPs start their life as immature green protein which 
might complicate their use in FRET applications [12]. Ob-
viously, this makes quick maturation an extremely impor-
tant parameter. 
Detection
To complicate things even further, different detection tech-
niques stress different qualities of the FPs. For example, 
low cross-excitation and high acceptor brightness (i.e., 
high quantum yield and high absorption) are important for 
SE determinations, whereas for FLIM detection these fac-
tors are less important. In fact, a high acceptor quantum 
yield may even be unfavorable for FLIM [13]. Conversely, 
SE is insensitive to multi-exponential decay of the fluores-
cent donor whereas FLIM analysis is severely hampered 
when more than one decay constant is present [14]. For 
another example, the photomultiplier detectors generally 
used in confocal imaging setups are most sensitive in the 
blue range of the spectrum, whereas the charge-coupled 
device (CCD) or avalanche photodiode (APD) detectors 
found in most FLIM setups favor red colors. 
In all, an overwhelming amount of design consider-
ations dazzle the beginner FRET constructionist. In this 
paper we describe the results of a study aimed at optimiz-
ing FRET pairs for use in biosensors like the Epac-based 
cAMP sensor. Our strategy was to create a wide selection 
of FP combinations separated by a short spacer, express 
them in HEK293 cells and test for FRET efficiency and 
other relevant properties mentioned above. Besides spec-
tral variants, we also included dipole orientation mutants 
Fluorophore optimization in the FRET sensor for cAMP
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Figure 1.      Schematic overview of the constructs 
used in this study.
Donor and acceptor fluorophore are connected by a peptide 
stretch (Linker A: SGLRSRYPFASEL) or by the Epac1(∆DEP-
C.D.) sensor core [1]. Within this stretch, the amino acids 
PF were replaced by the Epac domain itself, leaving linkers 
B: SGLRSRY and C: ASEL. For truncated donor constructs 
(CFP∆ and GFP∆) GITLGMDELYK was deleted from the donor 
FPs and SGLRS from the linker. In tandem acceptor constructs 
the acceptors were separated by a supplementary linker 
(Linker D: PNFVFLIGAAGILFVSGEL) except for tdHcRed and 
tdTomato which have distinct linkers, namely NG(GA)6PVAT) 
and (GHGTGSTGSGSSGTASSEDNNMA), respectively.
and constructs with duplicate (tandem) acceptors in our 
study. The most promising pairs were then cloned into 
the Epac FRET sensor and tested for performance as cAMP 
indicator in living cells. Based on the above-mentioned de-
sign considerations, we identify two of the new sensors, 
CFP-Epac-cp173Venus and GFP∆-Epac-mRFP, as improved 
alternatives for SE and FLIM detection, respectively. The 
results further show overall good correlation between 
performance of FRET pairs in the linker construct and in 
the Epac sensor. Therefore, the present overview should 
be generally helpful in guiding development of new FRET 
sensors.
Results
Primary considerations and constructs included in 
the study
Our search for optimal FRET pairs is guided by three pri-
mary considerations. 
(i) Optimization of FPs in the CFP-YFP part of the 
spectrum. The original EPAC sensor contains CFP and YFP 
[15]. These first-generation FPs are extremely popular 
for FRET, and therefore many laboratories have equip-
ment and filters for detection in this part of the spectrum. 
Whereas CFP-Epac-YFP competes with the best FRET sen-
sors in displaying robust FRET changes, we observed dur-
ing extended characterization that this particular acceptor 
displays some reversible photochromism when excited 
with UV light (i.e., during cAMP uncaging experiments). 
Furthermore, the enhanced YFP shows some pH- and Cl--
dependence [16,17] Ponsioen, unpublished observations). 
Therefore, the aim of this part of the study was to optimize 
CFP-Epac-YFP with respect to FRET span, pH resistance 
and UV-insensitivity. Constructs included are summarized 
in Fig. 1-3. For details on constructs and molecular cloning 
the reader is referred to the Methods section.
(ii) The broad emission spectrum of CFP shows consid-
erable overlap with that of YFP. The often weak sensitized 
emission signals may thus be obscured in CFP leakthrough 
of several times its magnitude. For FRET ratiometry this 
is particularly unfavorable because a rise in FRET will re-
sult in opposing signals in the acceptor channel: sensitized 
emission of the acceptor increases, but this is masked in 
part by the concomitant drop in CFP leakthrough. In this 
part of our study, we therefore aimed to maximize FRET 
span by minimizing spectral overlap between donor and 
acceptor emission. We tested a range of red-shifted ac-
ceptors for their effectiveness in combination with the CFP 
donor (Fig. 2-3).
(iii) Finally, we tested a series of constructs that had 
GFP as fluorescent donor. The rationale is fourfold: first, 
GFP is almost twice as bright as CFP, and second, its lon-
ger optimal excitation wavelength (489 nm versus 432 for 
CFP) nicely matches 488nm laser lines present in most 
confocal microscopes. Third, 488-nm excitation is signifi-
cantly less harsh for the cells. Fourth, GFP is intrinsically 
better suited for FLIM measurements because its fluo-
rescence decays mono-exponentially, as opposed to the 
double decay time constants observed for CFP [14,18].
In all cases, initial experiments were performed on 
constructs consisting of fluorescent donors and accep-
tors separated by a small flexible spacer (13 amino acids; 
Fig. 1). FRET efficiency was tested by frequency-domain 
FLIM on a wide-field microscope (Fig. 2). Selected FP pairs 
were then inserted in the Epac sensor and tested for per-
formance by FRET ratiometry (Fig. 3), see Methods for 
details. 
CFP-YFP FRET pair analysis
Effect of dimerization
GFP-derivatives such as CFP and YFP have an inherent 
tendency to form dimers at high concentrations [19] [20]. 
The presence of two FPs in single-polypeptide FRET con-
structs multiplies this potential problem. A dimerization-
disrupting mutation (A206K, [19]; here denoted as nd for 
non-dimerizing) was therefore introduced in both FPs in 
the construct (CFPnd-linker-YFPnd; Fig. 2). Following expres-
sion in HEK293 cells, FRET was determined by imaging the 
lifetime of CFP (see Methods). Both constructs gave es-
sentially similar FRET efficiencies (E=0.16). Thus, dimeri-
zation does not seem to influence FRET in these constructs 
although conceivably the short 13-aa linker could restrict 
freedom of orientation in this construct, thereby masking 
the possible effect of the mutation. 
We next investigated the effects of nd-mutations in 
the Epac sensor. CFPnd-Epac-YFPnd was prepared by insert-
ing the cAMP-sensitive protein fragment Epac(∆DEP-C.D.) 
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Figure 2.      FRET in donor-linker-
acceptor constructs as detected by 
frequency-domain FLIM. 
The indicated constructs were expressed 
in HEK293 cells and FRET efficiency E 
was determined as detailed in Material 
and Methods. Shown are mean (bars), 
standard deviation (SD) and standard 
error of the mean (SEM) of 20-400 cells. 
For further detail, see text.
Figure 3.      FRET span in cAMP 
sensors.
The indicated constructs were expressed 
in HEK-293 cells and assayed for cAMP-
induced changes in donor to acceptor 
ratio on a fluorescence microscope 
equipped with dual photometers. Donor 
and acceptor emission were read out 
simultaneously, and the baseline ratio 
was set to 1.0 at the onset. FRET span 
∆R was determined by calculating the 
ratio change following addition of IBMX 
and Forskolin. This raises intracellular 
cAMP levels maximally and saturates the 
sensor. For further detail, see the text 
and Methods. 
Fluorophore optimization in the FRET sensor for cAMP
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[1] into the linker region. To directly compare this con-
struct to the parental CFP-Epac(∆DEP-C.D.)-YFP sensor, 
both were expressed in HEK293 cells and subjected to 
ratiometry on a dual-photometer setup (see Methods). 
Following recording of a baseline, cells were treated with a 
mix of forskolin (25 μM) and the phosphodiesterase inhibi-
tor IBMX (100μM) to saturate cAMP binding to EPAC [1] 
(Fig. 4). The FRET span ∆R was then taken to be the rela-
tive drop in ratio. Remarkably, the A206K mutations had 
very little effect on the FRET span (∆R = 0.26 and 0.25 for 
A206K (nd) and control (d), respectively; Fig. 3). Thus, 
in both these configurations dimerization seems to be of 
little importance, although we anticipate that in other con-
figurations the effects may be significant. 
While imaging these cells by confocal microscopy, 
we noted that in some cell types the constructs displayed 
a slight tendency to form highly fluorescent aggregates 
(speckles) in a fraction of the cells (Fig. 5). Surprisingly, 
the constructs containing nd mutations did not perform 
better in this respect. We speculate that this may be be-
cause although the dimerization constant for individual 
non-dimerizing FPs is significantly diminished [19], the 
presence of two FP moieties increases avidity of the con-
structs, but alternative explanations may also hold true. 
The insert is also an important factor determining aggre-
gation because in the Epac(∆DEP-C.D.) containing con-
structs speckle formation was cured almost completely. 
Substitution of YFP for Venus
From studies on YFP-expressing cells we deduced that 
both pH dependence and UV-induced photochromism in 
CFP-linker-YFP reside within the YFP moiety. We therefore 
replaced it by Venus [21], a variant with significantly lower 
pKa that therefore should be less pH-sensitive. We tested 
the constructs for UV-induced photochromism by subject-
ing cells to brief flashes of UV from a Mercury arc lamp, fil-
tered through a Dapi filter cube (Fig. 6). In YFP-containing 
constructs, this caused an intensity-dependent increase 
in YFP brightness that amounted to up to 10% in the ac-
ceptor channel. In contrast, Venus proved completely re-
sistant to a similar UV treatment. Moreover, Venus also 
significantly boosted the FRET efficiency of the construct 
(E = 0.21) as compared to YFP (E = 0.16; Fig. 2). Note 
however that Venus lacks the non-dimerizing mutation.
We next tested Venus in the cAMP sensor by prepar-
ing CFP-Epac-Venus. Ratiometric determination of cAMP-
induced FRET changes (Fig. 3) showed that Venus boosted 
the FRET span significantly (∆R = 0.31, compared to ∆R 
= 0.25 for CFP-Epac-YFP). Thus, both in terms of UV-in-
sensitivity and in FRET span of the sensor Venus proves a 
much better FRET acceptor. 
Varying donor-acceptor distance
Systematic studies into the effect of linker length on FRET 
have clearly demonstrated the importance of minimiz-
ing donor-acceptor distance for FRET efficiency [22,23]. 
In general, very little can be removed from the N- or 
C-termini of FPs without adversely influencing their per-
formance [24]. In an attempt to minimize distance, we 
removed 11 C-terminal aa from CFP, as well as 5 more aa 
from the linker (CFP∆; Fig. 1). Indeed, removal of these 
16 aa resulted in significantly improved FRET efficiency 
(E = 0.31, as compared to E = 0.21 for the control Venus 
construct; Fig. 2). Note however that apart from bringing 
donor and acceptor closer together, this deletion may also 
diminish rotational freedom.
Whether the CFP∆ deletion is advantageous for any 
particular FRET sensor construct will of course depend on 
the tertiary conformation of- and rotational freedom within 
these chimeras. The equivalent deletion in the Epac-sensor 
yielded a small drop rather than an increase in FRET span 
(∆R = 0.29 versus ∆R = 0.31 for the control construct CFP-
Epac-Venus; Fig. 3). Thus, inclusion of the CFP∆ mutation 
proved of no advantage for the Epac sensor.
Dipole alignment
FRET depends not only on spectral overlap and on donor-
acceptor distance but also strongly on fluorescent dipole 
orientation [3]. We next set out to systematically vary 
the orientation of Venus to CFP by substituting the YFP 
Figure 4.       Typical FRET responses in HEK293 cell expressing CFPnd-Epac-cp173Venus to stimulation with 
IBMX/Forskolin.
A)  Left : CFP and YFP emission from a single HEK293 cell expressing the improved cAMP sensor were detected at 4 
samples per second, following addition of IBMX and Forskolin. Right : the YFP/CFP ratio dropped by almost 35% within 
minutes. Shown is a typical recording.
B)  A single cell spectral fingerprint, obtained before (black) and after (grey) IBMX and Forskolin using a spectrometer. 
For further detail see Methods.
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acceptor with a set of orientation mutants, the so-called 
circularly permuted (cp) FP versions [25] [26]. In these 
mutants, tilting of the dipole is achieved by relocating the 
amino- and carboxyl termini of the acceptor fluorophore 
to alternative locations on the surface of the FP barrel. All 
6 cpVenus versions [27] were inserted in the linker con-
struct. FLIM analysis of cells expressing these constructs 
showed that only cp173Venus insertion resulted in a sig-
nificant improvement (E = 0.27), whereas other permuta-
tions gave comparable (cp157) or even worse (cp49/145/195/229) 
FRET values than the precursor (E = 0.21; Fig. 2).
As dipole orientation in the cAMP sensor may differ 
from that in the linker construct, a selection of cpVenus 
mutants were also tested in the Epac construct. To inves-
tigate the effect of rotation of the dipole along two axes, 
we tested cp195, which has its N-terminus on the same 
side of the barrel as wtVenus, and cp173, the N-terminus 
of which is on the opposing side of the barrel. Fret spans 
of cp195Venus (∆R = 0.33) and cp173Venus (∆R = 0.36) 
both exceeded that of the CFP-Epac-Venus construct (∆R 
= 0.31; Fig. 3). It was also checked that cp173 retained 
the favorable UV-insensitivity (Fig. 6). In conclusion, both 
in the linker construct and in the cAMP sensor inclusion of 
cp173Venus increases performance significantly.
Tandem acceptors
Finally, we studied the effect of presenting the fluorescent 
donors with duplicate (tandem) acceptors. This may be 
expected to increase FRET by raising the effective absorp-
tion of the acceptor, albeit at the cost of increased con-
struct size. The two fluorophores in a tandem acceptor are 
also likely to be oriented differently, thereby easing on the 
requirement of donor-acceptor dipole alignment. Double 
acceptors have previously been used to minimize the ef-
fects of dimerization caused by FPs [28] [29]. To increase 
the possibility of presenting acceptors at a favorable an-
gle, three types of tandem acceptors were made: tandem 
Venus, tandem cp173Venus, and a tandem of cp173Venus 
with Venus. As compared to the control construct CFP-
linker-Venus (E = 0.21), each of the tandem receptors 
yielded a significantly higher FRET efficiency (range: E = 
0.26-0.27; Fig. 2) with CFP-linker-cp173Venus-Venus giv-
ing the best results. This suggests that the strategy to 
present the donor with acceptors at different angles may 
be fruitful to some degree. We therefore also combined 
the tandems cp173Venus-Venus and Venus-Venus with the 
effective 16aa deletion. The resulting constructs once 
more showed increased FRET efficiencies (E = 0.28 and 
0.31, respectively), although they did not surpass the 
CFP∆-linker-Venus construct (E = 0.31). In these cases, 
the increased construct size is thus not balanced by im-
proved FRET efficiency. However, it is worthwhile to note 
that these tandem acceptor constructs displayed no ten-
dency to form aggregates in cells (Fig. 5).
Finally, we tested a subset of these FRET pairs in the 
Epac sensor. In these constructs, the 12aa C-terminal de-
letion of CFP was combined with the tandem acceptors 
cp173Venus-Venus and cp173Venus-cp173Venus. The result-
ing cAMP sensors showed cAMP-induced FRET changes of 
∆R = 0.36 and ∆R = 0.29, respectively (Fig. 3). Thus, the 
increased size of the construct is again not compensated 
by a significant increase in FRET span. 
Figure 5.      Speckle formation.
HEK293 cells were transfected with indicated constructs and further cultured for 24-36 hours. Shown are confocal sections chosen 
to maximally visualize any speckles. Note that most speckles go unnoticed by wide-field fluorescence microscopy. Also indicated are 
estimated percentages of cells showing at least some speckles. Scale bar, 10 mm.
Figure 6.      UV-induced photochromism.
Change in ratio of YFP to CFP emission in CFPnd-linker-YFPnd 
(squares) and CFPnd-linker-Venusd (triangles) following 
exposure to UV light for the indicated times. CFPnd-linker-
YFPnd as well as free YFP (data not shown) display a 
dose-dependent increase in emission that maximizes at 
about 10%, whereas Venus and cp173Venus (not shown) 
are insensitive to UV exposure. See Methods for further 
detail.
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Overall, our data show significant, albeit not perfect cor-
relation between performance of FP pairs in the linker 
construct and in the Epac sensor. In the linker construct, 
beneficial effects resulted from changing distance (the C-
terminal deletion CFP∆), orientation (cp173Venus), as well 
as from doubling the acceptor. 
Importantly, incorporation of Venus in the cAMP sensor 
cured pH- and UV-sensitivity. Several additional altera-
tions boosted the FRET span, including the cp173Venus and 
the tandem acceptor versions. For future experiments, the 
former variant (CFP-EPAC-cp173Venus) combines a good 
FRET span with small size. The CFP∆-Epac-cp173Venus-
Venus is the favorable candidate if speckle formation is 
a problem.
CFP-RFP FRET pair analysis
As outlined before, spectral overlap of CFP and YFP com-
plicates quantitative FRET measurements and it dimin-
ishes the FRET span of ratiometric sensors. Red-shifted 
acceptors could cure these drawbacks, but these are also 
likely to have less spectral overlap with CFP and thus less 
FRET. Whether this is a curse or a blessing depends on the 
FRET sensor at hand. 
Efficient FRET from CFP to the Discosoma RFP 
(DsRed) [30] has been demonstrated before [31] [32] 
[33]. However, DsRed is a somewhat cumbersome ac-
ceptor because it forms tetramers and shows very slow 
green-to-red maturation [12]. Therefore we tested some 
of the newer red FPs, notably mRFP1 [28], mCherry, 
mOrange [8] and HcRed [34]. Also tested were tandem 
versions of Tomato ([8]; not tested as monomer), and of 
HcRed [35] and mCherry.
Monomeric red acceptors
In the linker construct CFP-linker-YFP, substitution of the 
acceptor moiety by the monomeric red acceptors mRFP1, 
mCherry and mOrange (Fig. 2) yielded E values of 0.16, 
0.12 and 0.04, respectively, as compared to E = 0.16 for 
the parent construct. The significant FRET in the former 
two constructs is somewhat surprising because these red-
shifted acceptors have much less spectral overlap with the 
CFP donor than YFP. Note further that the “improved” suc-
cessors mCherry and mOrange did not outperform their 
ancestor mRFP1. In fact, of these three red acceptors 
mOrange is the brightest and spectrally it matches CFP 
best [8], but it performs worst as FRET acceptor in the 
linker constructs. We observed that standard deviations 
in these experiments were relatively large (Fig. 2 & 3). 
This may be attributed to the slow green-(em. 430-550)-
to-red (em. 550-700) maturation of the red FPs [12]. Im-
mature forms emit in the donor channel thereby biasing 
the fluorescence lifetimes significantly. 
In the Epac sensor, we next replaced YFP with mRFP1 
or mCherry, respectively. Both constructs displayed ro-
bust cAMP-induced FRET changes (∆R = 0.24 and 0.21, 
respectively; Fig. 3), comparable to the starting material 
CFP-Epac-YFP (∆R = 0.25). Whereas donors and acceptors 
have better spectral separation, this did thus not materi-
alize in improved FRET span in the ratiometric assay, and 
in fact the constructs were no match for sensors such as 
CFP-Epac-cp173Venus.
Tandem acceptors
We next prepared versions with tandem repeats of the 
red acceptor FPs. CFP-linker- tdTomato (E = 0.16), CFP-
linker- tdmCherry (E = 0.17) and CFP-linker- tdHcRed (E 
= 0.15) all yielded good FRET efficiency, with the latter 
two slightly outperforming their respective monomeric ac-
ceptor constructs (Fig. 2). 
In addition, in these tandem-acceptor constructs the 
16 aa deletion in the linker moiety again proved beneficial. 
Thus, CFP∆-linker-tdTomato showed a FRET efficiency E = 
0.31, as compared to 0.16 for CFP-linker-tdTomato. This 
constitutes an improvement of 0.15, and it shows that red 
FPs can function as very efficient acceptors for CFP. 
Finally, we tested performance of tdTomato as accep-
tor for CFP in the Epac sensor. CFP-Epac-tdTomato showed 
a robust cAMP-induced change in FRET ratio (∆R = 0.24) 
but again no performance increase was observed when 
compared to CFP-Epac-mRFP (Fig. 3). In addition, in this 
construct the maturation issues of tdTomato were clearly 
apparent. Simple visual inspection using a CFP/YFP/RFP 
triple filter cube plainly revealed a wide variety of matura-
tion stages (Fig. 7A). Importantly, the maturation stage 
of the acceptor also significantly influences E values as 
determined by FLIM (Fig. 7B).
In conclusion, whereas these experiments show that 
efficient FRET from CFP to a variety of red FP acceptors is 
possible, the improved spectral separation did not result in 
superior ratiometric FRET sensors in our experiments. 
Figure 7.      Slow green-to-red maturation of 
tdTomato and its effects on FRET.
A)  Cells expressing CFPnd-EPAC-tdTomato for 24 hr display a 
spectrum of colors when viewed by eye using an Omega X154 
triple-color (CFP-YFP-RFP) cube. For reproduction reasons, the 
confocal picture shows a mix of green (470-530 nm) and red 
(570-670) emission to closely match the image visible by eye. 
In contrast, CFPnd-EPAC-mRFP and CFPnd-EPAC-mCherry show 
a more homogeneous red color. 
B) Cell-to-cell variability in maturation of CFPnd-linker-tdTomato 
causes significant deviations in the fluorescence decay times 
detected in the CFP channel, as measured by frequency-
domain FLIM. Scale bar, 12 mm.
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GFP-RFP FRET pair analysis
We next set out to assess performance of constructs con-
taining GFP as FRET donor (Fig. 2). As compared to CFP, 
the better brightness and longer excitation wavelength of 
GFP (489 nm versus 432 for CFP) should aid in prevent-
ing phototoxicity, and its single-exponential decay is well-
suited for FLIM measurements. 
Initially, we prepared GFPnd-linker-constructs with 
the red acceptors mRFP and tdHcRed (Fig. 2). FRET ef-
ficiencies as detected by FLIM were E = 0.08 for GFPnd-
linker-mRFP and E = 0.10 for GFPnd-linker-tdHcRed. In an 
attempt to boost these values, we next replicated the C-
terminal deletion of the donor that had proved so effective 
for CFP donors. Indeed, GFPnd∆-linker-mRFP showed a sig-
nificantly enhanced E value of 0.21. Thus, the C-terminal 
deletion appears to be equally effective in GFP.
We further tested the newer variants mCherry, tdTo-
mato and mOrange for performance with the GFP donor. 
GFPnd-linker-mCherry and GFPnd-linker-tdTomato showed 
good FRET (E = 0.18 and E = 0.20, respectively) but the 
value for GFPnd-linker-mOrange, E = 0.09, was disap-
pointing. Thus, again, although theoretically it has a bet-
ter spectral fit to the donor, mOrange did not live up to 
its promise in these experiments. On the other hand, the 
good FRET efficiency observed with mCherry is promis-
ing for future development of FLIM sensors, in particular 
since Time-Correlated Single Photon Counting (TCSPC) 
experiments confirmed that the fluorescent decay of the 
GFP donor in this construct is well-described by a single 
exponent [36].
The most promising of these FRET pairs were subse-
quently tested in the Epac sensor. GFPnd∆-Epac-mRFP,
GFPnd-Epac-mCherry and GFPnd-Epac-tdTomato all dis-
played robust cAMP-induced ratio changes in HEK293 cells 
(∆R = 0.29, 0.23 and 0.27, respectively; Fig. 3). 
Which of these constructs is recommendable as cAMP 
sensor in FLIM and ratiometric experiments? GFPnd∆-Epac-
mRFP showed the largest FRET change but mRFP pho-
tobleaches more easily than the other two [8]. For FLIM 
and emission-ratio experiments this should not present 
a problem, but acceptor bleaching would limit the useful 
lifespan of this construct in quantitative sensitized emis-
sion experiments [5] because for this technique separate 
acceptor images must be collected. The second-best con-
struct, GFPnd-Epac-tdTomato, shows an almost equally 
large FRET span and it is very resistant to photobleaching. 
On the other hand, in addition to its larger size, the td-
Tomato moiety introduced maturation problems similar to 
those observed for CFP-Epac-TdTomato and we therefore 
do not recommend it for future experiments. Consequent-
ly, for sensitized emission imaging GFPnd-Epac-mCherry is 
the best choice because it combines good maturation and 
bleaching resistance with a decent FRET span. For FLIM 
and simple ratiometric experiments GFPnd∆-Epac-mRFP is 
preferred. 
Conclusions and discussion
This study aimed 1) to determine optimal donor – ac-
ceptor pairs for FRET and 2) to use this information to 
improve the performance of our Epac-based cAMP FRET 
sensor as a model for single-polypeptide type FRET sen-
sors in general. Performances of linker constructs and 
cAMP sensors were evaluated bearing in mind the differ-
ent requisites for FLIM and ratiometric detection. Based 
on our results, we recommend CFPnd-Epac-cp173Venus 
and CFPnd∆-Epac-cp173Venus-Venus (which is somewhat 
larger, but completely devoid of speckles) as best choices 
for ratiometric as well as quantitative SE detection. Both 
show a 44% increase to the already robust FRET span 
of the originally published sensor [1] and in addition are 
much more refractory to pH changes and UV illumination. 
For detection at longer wavelengths and in particular for 
FLIM measurements, we present GFPnd∆-Epac-mRFP and 
GFPnd-Epac-mCherry as preferred choices. For sensitized 
emission experiments, the latter outperforms the former 
in having better acceptor photostability at the expense of 
a somewhat decreased FRET span. 
Noting that a wide, but by no means exhaustive 
range of FPs was included in this study, our further obser-
vations should be helpful in guiding future development 
of FRET sensors. These observations may be summarized 
as follows. 
First, within the linker construct the majority of FP 
combinations yielded decent to excellent FRET efficiency 
(0.1 < E < 0.31). Spectral match of donors to acceptors 
varies widely between these constructs and therefore it 
appears that the amount of spectral overlap is not the 
prime determinant of FRET efficiency in these constructs. 
In general, good FRET of a particular FP pair in the linker 
construct correlated with a good FRET span in the Epac 
sensor, which should come as no surprise for a sensor that 
relies on cAMP-induced loss of basal FRET efficiency. 
Second, by comparing results from the linker con-
structs, the general trend is that C-terminal truncation 
of the donor (the CFP∆ / GFP∆ mutants) has a beneficial 
effect on FRET efficiency, particularly when introduced in 
constructs exhibiting moderate basal E values. This im-
provement is seen irrespective of the acceptor species, 
but the similar truncation did not result in significant im-
provement in the Epac sensors, most likely reflecting a 
different orientation and/or degree of rotational freedom 
in the latter constructs.
Third, when introduced in constructs with moder-
ate FRET levels, double-acceptor moieties also signifi-
cantly enhanced E values (compare CFP-linker-Venus 
to CFP-linker-Venus-Venus and CFP-linker-cp173Venus-
cp173Venus; compare CFP-linker-mCherry to CFP-linker-
mCherry-mCherry; compare CFP-linker-HcRed to CFP-
linker-HcRed-HcRed). Again, this effect was not seen in 
constructs that already showed high E values (compare 
CFP∆-linker-Venus to CFP∆-linker-Venus-Venus and CFP∆-
linker-cp173Venus-Venus; compare CFP-linker-cp173Venus 
to CFP-linker-cp173Venus-cp173Venus). In the cAMP sensor, 
no beneficial effects were observed (Fig. 3). However, ir-
respective of the effects of this modification on E values, 
it is worthwhile to include the tandem acceptors in the FP 
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repertoire because it cured the tendency to form aggre-
gates displayed by some constructs and can substitute for 
extensive testing of circularly permuted variants.
Fourth, the range of CFP-redFP constructs demon-
strates that various red FPs are good acceptors for CFP. 
These constructs were prepared in order to boost FRET 
span by having better spectral separation between donors 
and acceptors, but in our Epac sensor this theoretical ad-
vantage did not materialize.
Fifth, we observed clear positive effects of incorpora-
tion of circular permutation mutants of Venus in the linker 
constructs and Epac sensors. This would seem to indicate 
that dipole alignment is all-important, but putting our 
observations in the context of published data may raise 
some doubt on this interpretation. Both in the linker- and 
the Epac constructs substitution of Venus by cp173Venus 
yielded the largest improvement. This would indicate that 
in both these constructs N- and C-terminus of the inserts 
are in comparable locations and that rotational freedom 
of the FPs is similar. This is unlikely, given the nature of 
the very different inserts. Even more remarkable is that 
cp173Venus also is the favorite acceptor in other single 
chain FRET sensors published to date [27,37,38]. Thus, 
the widespread preference for cp173Venus acceptors raises 
the suspicion that other qualities, rather than the dipole 
orientation, cause cp173Venus to be such a good acceptor.
 
Throughout this study we have emphasized that besides 
FRET efficiency or -span other qualities are equally im-
portant for FRET sensors. Slow green-to-red maturation 
terminated some of the otherwise most promising FRET 
pairs, e.g. those with tdTomato as acceptor. Similarly, the 
tendency to form bright speckles (aggregates; vesicles) 
is an undesirable property that was found in some con-
structs. We found that introduction of non-dimerizing mu-
tations (A206K) in the FPs had little effect on speckle for-
mation. However, the insert was of significant influence, 
as the Epac constructs generally were less hampered by 
speckles. Orientation of donors and acceptors within the 
linker construct conceivably is such that it allows both FPs 
of one polypeptide to interact with those of another, effec-
tively increasing the avidity. Importantly, introduction of 
tandem accepters cured this flaw. We speculate that this 
is due to internal dimerization of the tandem acceptors but 
this was not investigated systematically. 
As the double exponential fluorescence decay of CFP 
is inherently poorly suited for FLIM we based our FLIM 
sensors on GFP. However, the red acceptors for GFP all 
exhibit some degree of green-to-red maturation. In prac-
tice, mRFP and mCherry which mature relatively fast (< 
1 hr and <15 min, respectively) performed well in FLIM 
sensors. For future development, one must also consider 
another promising approach that was recently reported. 
Here, the donor is combined with a dark (i.e., non-fluo-
rescent) acceptor termed REACh, for Resonance Energy 
Accepting Chromoprotein [13]. REACh is a YFP variant 
that may be combined with GFP in the Epac sensors, al-
lowing lifetime measurements of this single-exponential 




The previously published construct CFPnd-Epac1(∆DEP-
C.D.)-YFPnd [1] was used to generate all described con-
structs. Linker constructs were obtained by excising the 
Epac1(∆DEP-C.D.) domain using EcoRV/NheI and replac-
ing it with a linker (GATATCCTTTTGCTAGC, restriction 
sites EcoRV-NheI are underlined), yielding a 13aa linker 
(SGLRSRYPFASEL) between the two fluorophores. CFPd 
and YFPd were obtained by introducing the pointmutation 
K206A [19] in CFPnd and YFPnd using QuikChange (Strata-
gene). Donor fluorophore truncations (GFP∆/CFP∆) were 
generated by PCR and lacked the C-terminal part of the 
fluorophore (GITLGMDELYK) as well as the N-terminal part 
of the linker (SGLRS). Using HindIII/EcoRV, these PCR 
products were used to replace CFP. Venus and cpVenus 
FPs were generated by PCR using the following templates: 
Venus [21] and cpVenus (from Ycam 3.2, 3.3, 3.6, 3.7 and 
3.9; [27]). Using NheI/EcoRI these PCR products were 
used to replace YFP. Tandem versions were generated 
by digesting EcoRI/Xba and inserting an additional linker 
(AATTTTGTCTTCCTGATCGGCGCCGCAGGAATACTCTTCG-
TATCTAGAGTGAATTCCTAA, newly situated restriction sites 
Xba-EcoRI are underlined). This linker was digested with 
XbaI/EcoRI and an additional fluorophore was inserted 
using NheI/EcoRI, resulting in two acceptor fluorophores 
separated by a 19aa (PNFVFLIGAAGILFVSGEL) linker. For 
RFP replacements an identical strategy was followed, how-
ever, using additional templates mRFP1 [28], mCherry, td-
Tomato, mOrange [8], HcRed [34] and tdHcRed [35].
Materials
IBMX, Forskolin and Ionomycin were obtained from Calbi-
ochem-Novabiochem Corp. (La Jolla, CA).
Cell culture and transfection
HEK293 cells were seeded on 25-mm glass coverslips in 
six-well plates in DMEM supplemented with 10% FCS and 
antibiotics. Constructs were transfected using calcium 
phosphate precipitate, at ~0.8 mg DNA per well.
Microscopy
Cells in bicarbonate-buffered saline (containing, in mM, 
140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, 23 NaHCO3, 
10 HEPES), pH 7.2, kept under 5% CO2, at 37ºC were 
routinely inspected using a Leica DM-6000 inverted micro-
scope with 63x, 1.32 NA oil immersion objective. For the 
experiments described in Fig. 7A, a triple band fluores-
cence filter cube (CFP-YFP-RFP), type X154 (Omega) was 
used. Confocal images were collected using a TCS-SP5 
confocal scanhead attached to the DM6000 microscope 
(Leica, Mannheim, Germany). Agonists and inhibitors 
were added from concentrated stocks. 
For spectral fingerprinting, an Ocean Optics Type 
USB2000 spectrometer (Dunedin, Florida, USA) was fit-
ted to an inverted microscope. The emission of single 
transfected cells was captured (integration time, 1-8 s). 
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Excitation was from a arc lamp equipped with a mono-
chromator. 
To assess UV sensitivity (Fig. 6), cells were followed 
using time-lapse imaging. After establishing a baseline, 
cells were subjected to a brief (1 s = 1,000,000 ms) flash 
of UV illumination using a DAPI filter cube and an EL-6000 
light source (Leica) at full power. For lower exposures, 
the exposure was attenuated by different combinations of 
shutter times and neutral density filters, and expressed 
as equivalent shutter time in ms. Flash-induced change 
in YFP/CFP ratio was plotted versus equivalent exposure 
time.
Dynamic FRET monitoring
Cells on coverslips were placed on an inverted NIKON Dia-
phot microscope and excited at 425 nm (CFP) or 470 nm 
(GFP). Emission was detected using optical filters as fol-
lows: (band-pass filters) CFP, 470 ± 20nm; GFP, 510 ± 
30 nm; YFP, 530 ± 25nm; (long pass filter) orange and 
red FP variants, 590 LP filter. Data from donor and ac-
ceptor were collected simultaneously, digitized and FRET 
was expressed as ratio of donor to acceptor signals. The 
FRET value of the baseline was set to 1.0 at the onset 
of the experiments. Cells were then stimulated with 25 
mM Forskolin and 100 mM IBMX to maximally raise the in-
tracellular cAMP concentration. Changes are expressed as 
percent deviation from the initial value of 1.0. Data are 
from 6–20 cells per experiment. Note that for FRET pairs 
with widely different spectral properties the FRET span can 
not be quantitatively compared because of inevitable dif-
ferences in filters and detector sensitivity.
Fluorescence lifetime imaging
FLIM experiments were performed on an inverted Leica DM-
IRE2 microscope using a Lambert Instruments (Leutinge-
wolde, the Netherlands) frequency domain lifetime attach-
ment, controlled by the vendors LI-FLIM software. CFP & 
GFP were excited with ~4mW of light from a 442nm and a 
470nm LED, respectively, modulated at 40MHz and emis-
sion was collected at 450–490 and 500–540 nm, respec-
tively, using an intensified CCD camera. Lifetimes were 
referenced to a 1 mM solution of Rhodamine-G6 in saline 
that was set at 4.11 ns lifetime. The measured lifetimes 
(calculated from phase differences) of CFP and GFP in the 
absence of acceptors were 2.7 ns. FRET efficiency E was 
calculated as E = 1-(measured lifetime of FRET pair)/
(measured lifetime of donor). FRET efficiencies are means 
of 20–400 cells per construct.
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Abstract
Epac1 and Epac2 are guanine nucleotide exchange factors for the small G-proteins Rap1 and Rap2. 
Epac is activated by direct binding of cAMP. The cAMP analogue 8-pCPT-2’-O-Me-cAMP (alias: 007) 
can activate Epac, but not protein kinase A and is widely used as a selective activator of Epac. To 
increase membrane permeability and thus to improve bioavailability we have synthesised the AM-
ester of 8-pCPT-2’-O-Me-cAMP. The resultant 8-pCPT-2’-O-Me-cAMP-AM (007-AM) activates Epac 
much more rapidly and at much lower extracellular concentrations than 007, as demonstrated in 
vivo by the use of an Epac1-based FRET sensor. In line with this, we observed efficient activation of 





Cyclic adenosine monophosphate (cAMP) is a common 
second messenger involved in the regulation of any dif-
ferent cellular processes through the activation of protein 
kinase A (PKA), exchange protein directly  activated by 
cAMP (Epac) and cyclicnucleotide-regulated ion channels 
[1]. Adenylyl cyclases are responsible for catalysing the 
formation of cAMP from ATP. Levels of cAMP can be raised 
in cells in response to a large variety of extracellular stim-
uli, which act via receptors coupled to heterotrimeric G 
proteins, which stimulate the activity of adenylyl cyclase. 
In addition, cAMP levels are controlled by phosphodieste-
rases (PDE), which catalyse the degradation of cAMP to 
AMP. In cells, cAMP levels can be artificially elevated by 
forskolin, which activates adenylyl cyclase directly. Fur-
thermore, cAMP levels can be raised by inhibiting PDEs. 
These approaches are commonly used in tissue culture 
experiments, but, by generating cAMP, they do not dis-
criminate between the various target proteins that are 
activated. Alternatively, membrane-permeable cAMP ana-
logues, which selectively interact with particular receptor 
proteins, can be applied. For example, signalling pathways 
activated by PKA and Epac can be distinguished by using 
6-Bnz-cAMP and 8-pCPT-2’-O-Me-cAMP, respectively [2]. 
The latter, 8-pCPT-2’-O-Me-cAMP will from here on be re-
ferred to by its alias: 007.
Epac is a guanine nucleotide exchange factor for the 
small G protein Rap. Rap cycles between a signalling-in-
active GDPbound state and a signalling-active GTP-bound 
state. cAMP-activated Epac catalyses the exchange of Rap-
bound GDP for GTP. Epac and Rap function in a number 
of different cellular processes including insulin secretion, 
inhibition of cell scattering, neurotransmitter release and 
cAMP-induced barrier function in endothelial cells [3]. 
Even though 007 has become a widely used tool in 
Epac-related research, its biological application is lim-
ited by its low membrane permeability, caused by the 
negatively charged phosphate. However, the negatively 
charged singly bonded oxygen on the phosphate group 
can be masked by labile esters. Such a precursor is ex-
pected to enter the cell efficiently, where the ester is hy-
drolysed either directly by water or by cellular esterases 
to liberate the active compound [4]. We therefore syn-
thesised 007-AM from 007 by attaching a acetoxymethyl 
(AM) ester to one of the oxygens of the phosphate. We 
could demonstrate that this analogue can be used effi-
ciently in cell culture systems and activates Epac at lower 
doses and with increased efficiency.
Results and Discussion
We synthesised 8-pCPT-2’-O-Me-cAMP-AM (or 007-
AM) from 8-pCPT-2’-O-Me-cAMP (007), whereby ac-
etoxymethyl bromide was used as a donor for the AM 
group. The product that was obtained had a purity ex-
ceeding 97% and consisted of a mixture of the equatorial 
and the axial isomers of the ester (described in Material 
and Methods, see Fig. 1). Even though the isomers could 
be resolved by repetitive analytical HPLC runs, efficient 
separation on a preparative scale was not possible. Or-
ange peel acetylesterase and esterase from porcine liver 
cleaved the equatorial isomer about five times more ef-
ficiently than the axial isomer within minutes (data not 
shown). The pharmacokinetics of both isomers are thus 
expected to be similar, justifying the application of a mix-
ture of both isomers to cells. In any case, the  isomeric 
ratio of an individual synthesis can be easily quality con-
trolled by 31P NMR. 
To compare the efficiency of 007-AM and 007 in ac-
tivating Epac1 in vivo, an Epac1-based fluorescence res-
onance energy transfer (FRET) probe was used. In this 
assay, activation of Epac1 by the binding of cAMP to the 
Epac1-FRET probe is measured as a reduction in the FRET 
signal [5]. A431 cells transfected with the FRET probe 
were stimulated with 007 or 007-AM (Fig. 2). Stimulation 
of cells with 100 mm 007 resulted in a decrease of the 
FRET signal that was approximately one order of mag-
nitude slower than the decrease obtained upon stimula-
tion with 1 mm 007-AM. Furthermore, activation of Epac1 
following stimulation with 100 mm 007 could be further 
enhanced by the addition of forskolin, whereas 1 mm 007-
AM induced maximal activity of Epac1 under the given 
Figure 1.    Synthesis and application of 8-pCPT-2’-O-Me-cAMP-AM. 
A) 8-pCPT-2’-O-Me-cAMP (007) is converted into 8-pCPT-2’-O-Me-cAMP-AM (007-AM) with acetoxymethyl bromide as a donor of the 
acetoxymethyl group in the presence of N,N-diisopropylethylamine in N,N-dimethylformamide. A mixture of the equatorial (B) and 
axial (C) isomers of the ester is obtained. D) 8-pCPT-2’-O-Me-cAMP-AM is cleaved by esterases to 8-pCPT-2’-O-Me-cAMP and the 
by-products formaldehyde and acetic acid.
Characterization of 007-AM
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conditions. The activation of Epac by 007-AM occurs with-
in one minute after application. This is comparable with 
the kinetics of forskolin-induced Epac activation, and thus 
007-AM mimics the “natural” response time upon adenylyl 
cyclase activation. 
The activity of endogenous Epac can be monitored 
by isolating selectively Rap·GTP from cell lysates. Prima-
ry human umbilical vein endothelial cells (HUVEC) were 
stimulated with different concentrations of 007 and 007-
AM (Fig. 3A). Partial activation of Rap was induced by 10 
mm 007, and full activation of the G protein was stimu-
lated by 100 mm 007. In contrast, treatment of the cells 
with just 0.1 mm 007-AM was sufficient to induce full Rap 
activation.
To determine if 007-AM could efficiently stimulate 
Rap-dependent processes, biological assays were carried 
out. In HUVECs, Rap induces a tightening of cell–cell junc-
tions that can be measured as an increase in the electrical 
resistance of a cell layer grown on an electrode. 007-AM 
induced junction tightening at much lower concentrations 
than 007 (Fig. 3B). Similarly, 007-AM induced adhesion 
of Jurkat-Epac1 cells to fibronectin more efficiently than 
007 (Fig. 3C). 
Thus, 007-AM induces Epac1 and Rap1 activation at con-
centrations that are two to three orders of magnitude 
lower than those required of the parent compound. In HU-
VEC cells, sustained Rap1 activation was observed after 
application of only 0.01 mm 007-AM (Fig. 3A). This con-
centration is far below the AC50 of 007 for Epac1, which 
was determined to be 1.8 mm in vitro [6]. This indicates 
that 007  accumulates in the cell after the cleavage reac-
tion, which is in accordance with results obtained for other 
cyclic nucleotide-AM esters [7]. Indeed, 007-AM seems to 
enter cells much more quickly than 007, as shown by the 
more rapid activation of the Epac1-FRET sensor by 007-
AM in comparison to 007 (Fig. 2). 
Figure 2.     
Epac1 activation in A431 cells. 
A431 cells were transfected with the 
Epac1-FRET sensor and stimulated with 
100 mm 8-pCPT-2’-O-Me-cAMP (007) or 
1 mm 8-pCPT-2’-O-Me-cAMP-AM (007-
AM) followed by 25 mm forskolin (FK) or 
stimulated by 25 mm forskolin followed by 1 
mm 007-AM. The FRET signal was monitored 
over time and plotted as normalised change 
in FRET (DF); all traces are representative 
for at least 10 independent experiments.
Figure 3.     
007-AM acts efficiently on 
cells. 
A) HUVEC cells were stimulated 
with different concentrations of 
8-pCPT-2’-O-Me-cAMP (007) or 
8-pCPT-2’-O-Me-cAMP-AM (007-
AM), and the levels of Rap1·GTP 
were measured. 
B) HUVECs grown on an electrode 
were stimulated with different 
concentrations of 007 or 007-
AM as indicated. The change 
in transendothelial electrical 
resistance (DR) was measured in 
real time. 
C) Jurkat-Epac1 cells were 
stimulated with different 
concentrations of 007-cAMP or 
007-AM and seeded on fibronectin 
coated plates. Adhesion (Ad) was 
measured after 15 min.
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Chapter 9
The biological selectivity of 007 is probably its greatest 
benefit for biological research. However, the application of 
007-AM causes the accumulation of 007 in cells. To exclude 
the possibility that a putative high intracellular concentra-
tion of 007 caused side effects, 007-AM was applied to 
cells expressing a PKA-based FRET sensor (Fig. 4A). Upon 
application of 1 mm 007-AM, no change in the PKA-FRET 
signal was observed. In addition, the phosphorylation sta-
tus of a PKA substrate, vasodilatorstimulated phosphopro-
tein (VASP), was monitored as a biological measure of the 
activity of the enzyme. Whereas a clear band shift of VASP 
is observed after stimulation with forskolin, no effect is 
observed with 1 mm 007-AM (Fig. 4B). 
To summarise, we have described the synthesis of 
007-AM, a precursor that selectively activates Epac and is 
more efficiently delivered into cells than its parent com-
pound. 007-AM works with high efficiency under biological 
conditions by stimulating Epac and by  activating Rap1-
dependent processes, as demonstrated in two model sys-
tems. We found that 007-AM is stable for at least two 
hours in aqueous solution, but in general less stable in 
sera containing esterases. In addition, it is possible that 
toxic side effects might be caused by the by-products of 
the esterase reaction. However, related prodrugs, such 
as pivampicillin or HepseraTM, both of which release a 
carboxylic acid and formaldehyde, or EnalaprilTM or ace-
tylsalicylic acid, both of which release acetic acid, are in 
clinical use arguing for the general safety of AM-ester-
based precursors[8]. 007-AM is thus expected to become 





Synthesis was performed with some minor modifications 
as described. [9,10] 360 μmol 8-pCPT-2’-O-Me-cAMP 
(007), diisopropylethylammonium salt, were suspended 
in 1000 μl DMF. After addition of 1800 μmol (180 μl; 5 
equivalents) acetoxymethyl bromide and 1080 μmol 
(185 μl; 3 equivalents) diisopropylethylamine, the reac-
tion mixture was stirred at ambient temperature for 30 
minutes. Progress of AM-ester formation was monitored 
by analytical HPLC with 40% acetonitrile as eluent. The 
reaction was stopped by evaporation of all volatile com-
ponents in a speed-vac centrifuge under reduced pres-
sure with oil pump vacuum, re-dissolved in 0.8 ml DMF, 
and purified by preparative HPLC using 40% acetonitrile 
as eluent. The productcontaining fractions were collected 
and evaporated. 110 μmoles of 8-pCPT-2’-O-Me-cAMP-AM 
(007-AM) were isolated as mixture of axial and equatorial 
isomers with a purity of > 97% (yield: 30.6%). Formula: 
C20H21ClN5O8PS (MW: 557.9) ESI-MS pos. mode: m/z 
558 (M+H)+, m/z 486 (M-AM+H)+, neg. mode: m/z 556 
(M-H)-, m/z 484 (M-AM-H)-; UV-VIS (pH 7.0) λmax 282 
nm (ε = 16000). All chromatographic experiments were 
performed at ambient temperature. The analytical HPLC-
system consisted of a L 6200 pump, a L 4000 variable 
wavelength UV-detector, and a D 2500 GPC integrator (all 
Merck-Hitachi, Germany). The stationary phase was Kro-
masilTM (Eka Nobel, Sweden) C 8-100, 10 μm, in a 250 
x 4.6 mm stainless steel column. Preparative HPLC was 
accomplished with KromasilTM C 8-100, 5 μm material 
in a 250 x 16 mm stainless steel column. Mass spectra 
were obtained with an Esquire LC spectrometer (Bruker, 
Germany) in the ESI-MS mode with 50 % isopropanol / 
49.9 % water / 0.1 % formic acid as matrix. UV-spectra 
were recorded with a Helios β-spectrometer (Spectronic 
Unicam, United Kingdom) in aqueous phosphate buffer, 
pH 7.0. All reagents where of analytical grade or the best 
grade available from commercial suppliers.
Application of 007-AM
Stock solutions of 007-AM were prepared in absolute 
DMSO at concentrations up to 10 μM and 007-AM was 
applied directly to the cell culture dish. When required, 
007-AM were pre-diluted in PBS buffer immediate prior 
to the application. Any exposure of 007-AM to medium, 
especially to serum, prior to the application was avoided, 
since esterases, which are present in particular in serum, 
cause rapid degradation of the AM-ester.
Dynamic FRET monitoring
Dynamic FRET monitoring was done as described 
Figure 4. 
Selectivity of 007-AM. 
A) Ovcar3 cells were transfected with the PKA-FRET probe and 
stimulated successively with 1 mm 007-AM and a combination of 
25 mm forskolin (FK) and 100 mm 3-isobutyl-1-methylxanthine 
(IBMX). The FRET signal was monitored over time and is 
plotted here as normalised change in FRET (∆F). The trace is a 
representative of three independent experiments. 
B) Ovcar3 cells were stimulated with 1 mm or 0.1 mm of 007-
AM or with a combination of 50 mm forskolin and 500 mm IBMX 
(PDE inhibitor), and phosphorylation of VASP was monitored 
by a phosphorylation-induced mobility shift after the indicated 




previously[5]. Briefly, cells grown on coverslips and trans-
fected with the FRET probe were placed on an inverted 
NIKON microscope and excited at 425 nm. Emission of 
CFP and YFP was detected simultaneously through 470 ± 
20 and 530 ± 25 nm band-pass filters. Data were digitized 
and FRET was expressed as ratio of YFP to CFP signals, the 
value of which was set to 1.0 at the onset of the experi-
ments. Activation of Epac1 was followed using the FRET 
probe CFP-Epac1-YFP, and activation of PKA using the PKA 
regulatory subunit type II fused to CFP and the PKA cata-
lytic subunit fused to YFP [5,11]. Binding of cAMP to both 
probes induces loss of FRET.
Rap1 activation assay
Rap1 activation assays were performed as previously de-
scribed [12]. Briefly, equal amounts of cell lysates were 
incubated with the Ras-binding domain (RBD) of Ral-GDS 
fused to glutathione S-transferase. This fusion protein was 
pre-coupled to glutathione–agarose beads to specifically 
pull down the GTP-bound form of Rap. Samples were ana-
lysed by western blotting using Rap1 antibodies (Santa 
Cruz Biotechnology, USA) and the phosphorylation state 
of VASP was visualised as band sift upon western blotting 
with an antibody against VASP (BD Transduction Labora-
tories, USA).
Transendothelial electrical resistance 
measurements
Primary human umbilical vein endothelial cells (HUVEC) 
were seeded at 7x104 cells per well (0.8 cm2) on fi-
bronectin coated electrode arrays and grown to conflu-
ency (Applied BioPhysics Inc., Troy, USA). Measurements 
of transendothelial electrical resistance were performed 
in real time at 400Hz, 37ºC, 5% CO2, using an electrical 
cell-substrate impedance sensing system (ECIS; Applied 
BioPhysics Inc., Troy, USA). [13] For comparison between 
different samples, the resistance is plotted as a difference 
to the basal level of resistance.
Adhesion assay
Jurkat-Epac1 cells transiently transfected with pCMV-luci-
ferase were harvested, resuspended in TSM buffer (20 mM 
Tris-HCl pH 8.0, 150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2, 
0.5% BSA) and gently rotated for 1 hour at 37 ºC to al-
low recovery [14]. 96-well Nunc Maxisorp plates (Corning, 
USA) were coated overnight at 4 ºC with human serum-
purified Fibronectin (5 mg/l in PBS) and blocked for 1 hour 
with 1% BSA in TSM. Subsequently, cells were  added to 
the coated wells in the absence or presence of 007 or 007-
AM at the indicated concentrations and allowed to adhere 
for 45 minutes at 37 ºC. Non-adherent cells were removed 
with warmed TSM and adherent cells were lysed at 4 ºC 
in luciferase lysis buffer (15% glycerol, 25 mM Tris-phos-
phate pH 7.8, 1% Triton X-100, 8 mM MgCl2, 1mM DTT). 
Luciferase activity was determined using a luminometer 
(Lumat LB9507). Unseeded cells were lysed separately 
to determine luciferase counts in the total input. Specific 
adhesion was determined (counts in cells bound / counts 
in total input x 100) and plotted directly. Error bars repre-
sent standard deviation within each experiment.
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Cells respond to extracellular cues via receptor signal-
ing. In this manner, cellular behavior is under strict 
control of hormones, growth factors or neurotrans-
mitters. Binding of a ligand to its cognate receptor 
triggers a cascade of intracellular signaling events. In 
general, these cascades branch into different series of 
molecular conversions leading to, for instance, activa-
tion of transcription factors, regulation of metabolic 
processes or changes in cell morphology.
To regulate such ‘organized complexity’, molecu-
lar interactions in the cell are specific and regula-
ted. Specificity is guaranteed by recognition domains 
and regulation of interactions or catalytic conversions 
means that they can be ‘swithched on or off’. The lat-
ter can be realized, for instance, by a conformational 
change that alters the accessibility of an interaction 
domain. 
Intriguingly, most signaling components function 
in multiple signaling cascades. For example, the >800 
members of the G Protein-Coupled Receptor (GPCR) 
family trigger a vast variety of cellular responses via a 
relatively limited set of signaling components. This is 
achieved by compartmentalization of the signaling 
pathways. For example, GPCRs and multiple down-
stream signaling components are often clustered into 
signaling complexes by so-called scaffolding proteins. 
Such spatial restriction facilitates the coupling of the 
receptor to its effectors, while it leaves other signa-
ling compartments unaffected. Thus, compartmenta-
lization confers specificity to signaling cascades. In 
addition, such spatial organization can direct signaling 
activity towards the appropriate subcellular location, 
depending on the involved process. 
Signaling complexes are dynamically regulated, 
i.e. they can be assembled in response to extracellular 
signals. The dynamic targeting of a signaling mole-
cule to a specialized compartment becomes manifest 
as a stimulus-induced translocation. In this thesis, 
we studied the translocations of two proteins: that of 
chloride intracellular channel 4 (CLIC4) and that of ex-
change protein directly activated by cAMP 1 (Epac1). 
Central in these studies were the microscopical tech-
niques that allowed visualization of these transloca-
tions with maximal spatiotemporal resolution, most 
prominently via confocal imaging and measurement 
of fluorescence resonance energy transfer (FRET). 
Chapter 1 presents a general introduction into the 
phenomenon of translocations as they occur in cell 
signaling. The focus lies on signaling cascades acti-
vated by GPCRs since these are most relevant to the 
experimental work described in this thesis. Further-
more, this chapter introduces the microscopical tech-
niques  that have been employed to reveal and study 
‘our‘ translocations. 
In chapter 2, we show that CLIC4 transloca-
tion is selectively observed in response to G(α)13-
activating GPCR agonists and requires active RhoA. 
Contrasting with the ‘membrane insertion model’, the 
proposed activation mechanism for CLIC proteins [1], 
we show that CLIC4 translocation does not preceed 
channel formation in the plasma membrane. Instead, 
the translocation anchor is the ligand-activated recep-
tor complex itself. Although we await final proof, our 
data strongly suggest that recruited CLIC4 plays a re-
gulatory role in the signal transfer from the stimulated 
GPCR to RhoA activation. In support of this hypothe-
sis, CLIC4 has been reported to interact with the scaf-
fold proteins AKAP350 [2] and 14-3-3 [3]. AKAP-Lbc, 
a family member of AKAP350, serves both as a GPCR 
scaffold and as a guanine exchange factor (GEF) cou-
pling G(α)12 to RhoA [4] and is, furthermore, under 
the regulation of 14-3-3 [5]. Therefore, we hypoth-
esize that CLIC4 translocates to a signaling compart-
ment containing the activated receptor, G(α)13 and an 
AKAP scaffold with GEF activity towards RhoA. In this 
model, the spatial regulation of CLIC4 will undoubted-
ly add to the switch-like regulation of RhoA activity.
Chapters 3 and 4 describe two distinct plasma 
membrane translocations of Epac1. The cAMP effector 
Epac1 is a GEF for the GTPase Rap. Interestingly, Rap 
activity at the plasma membrane induces cell adhesi-
on. The two types of Epac1 translocation are triggered 
by cAMP binding and by phosphorylation of Ezrin/Ra-
dixin/Moesin (ERM) proteins, respectively. Binding of 
cAMP induces a conformational change, that not only 
elicits GEF activity by Epac1 [6], but also releases an 
affinity for the plasma membrane. As a consequence, 
Epac1 becomes uniformly distributed along the plas-
ma membrane upon elevated cAMP levels. In contrast, 
recruitment of Epac1 by ERM proteins is regulated on 
the level of the ERM proteins. When phosphorylated, 
they directly bind Epac1, regardless of Epac1’s activa-
tion state, and thereby recruit the GEF to asymmetri-
cal regions of the plasma membrane. 
Since both translocation mechanisms could be 
specifically disabled by mutagenesis, we were able 
to assess their relative importances for the ability of 
Epac1 to induce Rap-dependent cell adhesion. Inte-
restingly, we found that the two targeting mecha-
nisms cooperate in this process. We conclude that the 
targeting mechanisms dynamically compartmentalize 
cAMP-Epac1-Rap signaling at the plasma membrane, 
thereby enhancing the efficiency and specificity of ac-
tion. 
Besides Epac1 signaling, also the classical cAMP 
effector PKA is extensively compartmentalized. To 
date, more than 50 A kinase anchoring proteins 
(AKAPs) have been identified. Among the clustered 
signaling components are PKA, PKA substrates as well 
as the enzymes that synthesize cAMP (adenylyl cycla-
ses) and degrade cAMP (phosphodiesterases) [7,8]. 
Clearly, to study compartmentalization of the second 
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messenger cAMP, measurement with spatiotemporal 
resolution is required. For this, gene-encoded sensors 
based on FRET are indispensible. Chapter 5 descri-
bes the development of CFP-Epac-YFP, an Epac-based 
FRET-sensor for cAMP. The cAMP-induced conforma-
tional change is registered as a loss of FRET between 
the terminally fused fluorophores. This novel cAMP 
sensor has several advantages over the previously 
reported PKA-based cAMP sensor. Most importantly, it 
measures over an increased dynamic range of cAMP 
concentrations and displays larger changes in FRET. 
Furthermore, for the study of cAMP compartmental-
ization, the single polypeptide CFP-Epac-YFP can be 
targeted to specific subcellular compartments [9], 
which would be highly complicated (if not impossible) 
for the two constructs that constitute the PKA-based 
sensor. 
In chapter 6, we imaged cAMP with spatiotem-
poral resolution. Not subcellularly though, but ‘inter-
cellularly’. By mixing cells with and without glucagon 
receptors, we could monitor intercellular transfer of 
cAMP through gap junctions after glucagon stimula-
tion. From this, we learned that gap junctional ex-
change of cAMP occurs over the entire range of phy-
siological cAMP concentrations and that phosphodies-
terases are the main determinant in controlling  the 
amount of communicated cAMP. 
The studies presented in Chapters 7, 8 and 9 are not 
directly related to the theme of compartmentalization, 
but have evolved from the previous chapters. Chapter 
7 shows that the plasma membrane lipid PI(4,5)P2 di-
rectly regulates communication via connexin43-based 
gap junctions. The trigger for gap junctional closure is 
the phospholipase C β3 (PLCβ3)-mediated hydrolysis 
of PI(4,5)P2 itself rather than the concomitantly produ-
ced second messengers diacylglycerol (DAG) or inosi-
toltriphosphate (IP3). Chapter 8 describes the optimi-
zation of the fluorophore pairs used in the Epac-based 
cAMP sensor. Comparative analyses revealed optimal 
donor-acceptor pairs depending on the method em-
ployed to measure FRET. For the frequently applied 
ratiometric FRET assays, optimal properties are dis-
played by the CFP-cp173Venus pair. Finally, in Chapter 
9 the Epac1-based FRET sensors were employed to 
characterize the new Epac1-specific cAMP analogue 
8-pCPT-2’-O-Me-cAMP-AM (also known as 007-AM). 
The hydrophobic acetoxymethyl (AM) ester was at-
tached to render the compound more membrane-per-
meable than the parent compound 007. Once 007-AM 
passes the plasma membrane, the AM-group will be 
cleaved off by intracellular esterases and as a con-
sequence the trapped 007 rapidly accumulates in the 
cytoplasm. Indeed, our sensors demonstrated the ac-
celerated kinetics and increased efficiency of Epac1 
activation in comparison to 007.
In conclusion, heaving read this thesis one may ap-
preciate that the use of sophisticated imaging tech-
niques and the development of gene-encoded sensors 
go hand in hand with expanding insights in the com-
partmentalization of cell signaling.
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Samenvatting
Cellen zijn eenheden van leven, maar functioneren 
niet alleen. Binnen een organisme houden ze elkaar 
voortdurend op de hoogte van wat ze moeten doen: 
beïnvloeden en beïnvloed worden. Voor het overbren-
gen van dergelijke boodschappen bestaat een uit-
gebreid repertoir aan signaalmoleculen, waaronder 
hormonen, groeifactoren en neurotransmitters. De 
ontvangers van deze moleculaire vorm van communi-
catie zijn de receptoren, die door de buitenmembraan 
van de cel steken. Als een hormoon aan de poorten 
rammelt, vertaalt de bijbehorende hormoonreceptor 
het signaal naar het inwendige van de cel, alwaar het 
stokje wordt doorgegeven door een opeenvolging van 
verschillende signaalmoleculen. Hun gezamelijke ac-
tiviteit mondt uit in een respons die specifiek is voor 
dat hormoon, bijvoorbeeld het aflezen van bepaalde 
genen, een vormverandering of een aanpassing van 
metabolische processen. Een dergelijke lawine van 
zich vertakkende activatiestappen wordt een signale-
ringscascade genoemd. Om dit alles in goede banen 
te leiden, bevatten signaalmoleculen specifieke do-
meinen voor de herkenning van hun interactiepart-
ners. Verder wordt signaaloverdracht nauw geregu-
leerd door weer andere signaleringspaden. Alles bij 
elkaar vormen de signaleringspaden dus een complex 
wegennet van chemische omzettingen. 
Waar op dit wegennet een signaalmolecuul actief 
is, is zeer bepalend voor de effecten die het sorteert. 
Signaleringscascades worden sterk gecompartimen-
taliseerd binnen de cel: meerdere opeenvolgende 
schakels van een signaleringsketen worden bijeen-
gebracht in daartoe bestemde complexen. Die maken 
efficiënte signaaloverdracht mogelijk en garanderen 
bovendien dat deze overdracht niet ‘doorlekt’ naar 
andere compartimenten. Dit zijn dus de knooppun-
ten op het wegennet van de celsignalering. Dergelijke 
compartimentalisatie verklaart dat signaleringsmole-
culen betrokken kunnen zijn bij een verrassend groot 
aantal verschillende cellulaire functies. Zo effectue-
ren de (ruim) 800 receptoren van de familie der G 
protein-coupled receptors (GPCRs) vele  verschillende 
responsen middels een relatief beperkt arsenaal aan 
intracellulaire boodschappermoleculen. 
Op instigatie van extracelullaire signalen wordt 
het wegennet regelmatig verlegd. In een mum van tijd 
kan een nieuw knooppunt zodoende een nieuw type 
signaaloverdracht mogelijk maken. Dergelijke dyna-
mische herschikkingen van signalerinscomponenten 
manifesteren zich als translocaties. Voortschrijdend 
inzicht in de ruimtelijke organisatie en de veranderlijk-
heid van signaleringscascaden vereist microscopische 
technieken, die deze zichtbaar maken met ruimtelijke 
en tijdsresolutie. De techniek bij uitstek is fluorescen-
tiemicroscopie, waarbij de gedragingen van een spe-
cifiek eiwit nauwgezet kunnen worden gevolgd, nadat 
het met behulp van genetische modificatie is voor-
zien van een fluorescent ‘label’. Met gebruikmaking 
van fluorescentiemicroscopie zijn wij gedurende de 
totstandkoming van dit proefschrift op translocaties 
gestuit van twee eiwitten: CLIC4 en Epac1. 
Hoofdstuk 1 van dit proefschrift geeft een algemene 
introductie over translokaties in celsignalering, met 
speciale aandacht voor cascades die worden geacti-
veerd door GPCRs. Dit schept tegelijk het kader voor 
beknopte omschrijvingen van de translokaties die zijn 
gevonden gedurende deze promotie. Daarnaast be-
handelt het de microscopische technieken, die deze 
onderzoekingen mogelijk hebben gemaakt.
In hoofdstuk 2 beschrijven we hoe CLIC4, dat 
staat voor chloride intracellular channel 4, naar de 
plasma membraan translokeert als de cel wordt gesti-
muleerd met de GPCR-agonist lysophosphatidic acid 
(LPA). Van de kleine CLIC eiwitten wordt veronder-
steld dat ze chloridekanalen kunnen vormen als ze 
worden aangezet tot membraaninsertie. Het is echter 
belangrijk te onderstrepen dat hierover nog contro-
verse bestaat. Onze interesse werd gewekt door het 
feit dat LPA zowel een chloridestroom over de plas-
mamembraan veroorzaakt als de plasma membraan-
translocatie van CLIC4. We hebben echter moeten 
vaststellen dat tussen deze twee gebeurtenissen 
géén causaal verband bestaat. Wel hebben we kun-
nen identificeren welke signaleringscomponenten bij 
CLIC4 translokatie betrokken zijn en naar welke be-
stemming het voert. CLIC4 translokatie wordt selectief 
veroorzaakt door stimulatie van G(α)13-gekoppelde 
receptoren en vereist de actieve vorm van RhoA, 
een belangrijk signaalmolecuul dat verderop in de 
G(α)13-signaleringscascade functioneert. Transloke-
rend CLIC4 vervoegt zich bij het signaleringscomplex 
rondom de zojuist geactiveerde receptor. Al moet de-
finief bewijs nog geleverd worden, onze experimenten 
suggereren dat CLIC4 een regulerende rol speelt in 
de signaaloverdracht van G(α)13 naar RhoA. De LPA-
geïnduceerde translokatie van CLIC4 naar het geac-
tiveerde LPA-receptor-complex zou kunnen bijdragen 
aan de markering van het knooppunt waar G(α)13 de 
‘afslag RhoA’ kiest. Interessant detail: deze hypothese 
impliceert dat CLIC4 een functie zou hebben die in het 
geheel niet aansluit bij de naam van het eiwit.
Hoofdstukken 3 en 4 beschrijven twee verschil-
lende mechanismen waarop Epac1, een exchange pro-
tein directly activated by cyclic AMP, naar de plasma 
membraan translokeert. Deze effector van het veel 
voorkomende boodschappermolecuul cAMP dient als 
activator van Rap en beïnvloedt daarmee de adhesie 
van cellen. Het ‘ene’ type translokatie wordt geïniti-
eerd door de directe binding van cAMP. De daarmee 
gepaard gaande conformationele verandering van 
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Epac1 maakt een affiniteit voor de plasma membraan 
los en als gevolg hiervan verdeelt Epac1 zich uniform 
over de plasma membraan. Het ‘andere’ type translo-
katie vindt plaats wanneer zogenaamde ERM eiwitten 
(naar de drie familieleden ezrin, radixin en moesin) 
van conformatie veranderen. Na openvouwing kun-
nen ze Epac1 aan zich binden en zodoende recruteren 
naar het subcompartiment van de plasma membraan 
waar zij zich verschansen. 
De twee translocaties worden dus door verschil-
lende signalen in gang gezet en resulteren in andere 
ruimtelijke verdelingen van Epac1. Wat ze wél ge-
meen hebben is dat ze beide een belangrijke bijdrage 
leveren aan de functie van Epac1 om Rap-afhankelijke 
celadhesie te stimuleren. We concluderen dan ook, 
dat de twee translokatiemechanismen samenwerken 
in het aanleggen van een compartiment, waarin effi-
ciënte signaaloverdracht mogelijk wordt gemaakt van 
cAMP, via Epac1, naar Rap.
In hoofdstuk 5 laten we zien dat een cAMP 
sensor kan worden gemaakt door een blauw en een 
geel fluorescent eiwit (CFP en YFP) te fuseren aan de 
twee uiteinden van Epac1. Er vindt dan fluorescence 
resonance energy transfer (FRET) plaats tussen de 
twee fluorescente uiteinden, maar deze neemt af als 
cAMP Epac1 van conformatie doet veranderen. Door 
FRET binnen CFP-Epac1-YFP te meten kan dus wor-
den gevisualiseerd hoe cAMP concentraties in de cel 
veranderen in tijd en plaats. Op grond van grondige 
karakterisaties hebben we kunnen aantonen dat deze 
nieuwe cAMP sensor meerdere voordelen biedt ten 
opzichte van een eerder gepubliceerde FRET sensor 
voor cAMP. 
Deze FRET-gebaseerde methoden zijn onontbeer-
lijk in het bestuderen van de ruimtelijke organisatie 
van cAMP signalering. Immers, net als Epac1 vertoont 
ook de klassieke cAMP effector protein kinase A (PKA) 
een hoge mate van compartimentalisatie; er zijn meer 
dan 50 verschillende ankereiwitten bekend, die PKA-
signaleringscomplexen bijeenbrengen op specifieke 
subcellulaire organellen. Kortom, de toekomstige toe-
passing van cAMP sensors belooft veel bij te dragen 
aan het begrip van de ruimtelijke aspecten van cAMP 
signalering. 
In hoofdstuk 6 zetten we de nieuwe cAMP sensor 
in om uitwisseling van cAMP tussen cellen te volgen 
met ruimtelijke en tijdsresolutie. cAMP uitwisseling 
vindt plaats via zogenaamde gap junctions, kanaaltjes 
die de inwendige milieus van naburige cellen koppe-
len. Dat een cAMP molecuul in principe door een gap 
junction past was al bekend, maar hier laten wij voor 
het eerst zien dat cAMP-uitwisseling ook werkelijk 
plaatsvindt over de gehele spanne van fysiologische 
cAMP niveaux. Daarnaast vinden we dat de activiteit 
van fosfodiesterases, enzymen die cAMP afbreken, 
bepalend is voor de hoeveelheid uitgewisseld cAMP.
Hoofdstukken 7, 8 en 9 relateren niet direct aan het 
thema compartimentalisatie, maar zijn vertakkingen 
van de onderzoekingen in de voorafgaande hoofd-
stukken. Hoofdstuk 7 laat zien dat de plasma mem-
braan lipide PI(4,5)P2 een regulerende rol heeft in het 
open en dicht gaan van gap junctions, die zijn opge-
bouwd uit connexin43. Sluiting van deze gap juncti-
ons is het directe gevolg van PI(4,5)P2 hydrolyse door 
fosfolipase β3 (PLCβ3), maar staat los van de daaruit 
voortkomende signaalmoleculen diacylglycerol (DAG) 
of inositoltrifosfaat (IP3). 
In hoofdstuk 8 optimalizeren we het fluorescen-
te FRET paar van de Epac-gebaseerde cAMP sensor. 
Na uitgebreid vergelijk hebben we voor verschillende 
FRET methodieken een optimale combinatie van kleur-
varianten kunnen aanwijzen. De veelvuldig toegepaste 
ratiometrische FRET analyse werkt bijvoorbeeld het 
best met de combinatie CFP-Epac1-cp173Venus. 
In hoofdstuk 9 worden de Epac-gebaseerde 
sensors ingezet ter karakterisatie van de verwante 
stoffen 8-pCPT-2’-O-Me-cAMP (alias 007) en 8-pCPT-
2’-O-Me-cAMP-AM (alias 007-AM). Beiden zijn cAMP 
analoga, die specifiek Epac activeren, maar PKA on-
gemoeid laten. Beiden zijn daarom van groot belang 
voor het ontrafelen van cAMP-afhankelijke celsignal-
ering. De hydrophobe acetoxymethyl (AM-) groep is 
toegevoegd om 007 makkelijker de plasma membraan 
te laten passeren. Eenmaal over de membraan wordt 
de AM-groep verwijderd door intracellulaire enzymen, 
waarna het overgebleven 007 binnenin de cel gevan-
gen blijft. Inderdaad kon deze versnelde ophoping du-
idelijk zichtbaar gemaakt worden met gebruik van de 
fluorescente Epac-gebaseerde sensors. 
Over het geheel laat dit proefschrift zien hoe geavan-
ceerde microscopische technieken en de ontwikkeling 
van genetisch gecodeerde fluorescente sensors de 
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